WO2012175474A1

WO2012175474A1 - 1,2,3 triazole pesticides

Info

Publication number: WO2012175474A1
Application number: PCT/EP2012/061663
Authority: WO
Inventors: Pierre Joseph Marcel Jung; Ottmar Franz Hueter; Peter Renold; Thomas Pitterna
Original assignee: Syngenta Participations Ag
Priority date: 2011-06-20
Filing date: 2012-06-19
Publication date: 2012-12-27

Abstract

The present invention relates to novel triazole derivatives of formula (I) having insecticidal activity, to processes and intermediates for preparing them, to insecticidal, acaricidal, nematicidal or molluscicidal compositions comprising them and to methods of using them to combat and control insect, acarine, nematode or mollusc pests wherein A¹, A², A³, A⁴, G^1, R¹, R², R³, Q¹and Q² are as defined in claim 1; or salts or N-oxides thereof.

Description

1,2,3 TRIAZOLE PESTICIDES

The present invention relates to novel triazole derivatives having insecticidal activity, to processes and intermediates for preparing them, to insecticidal, acaricidal, nematicidal or molluscicidal compositions comprising them and to methods of using them to combat and control insect, acarine, nematode or mollusc pests.

Accordingly, the present invention provides a compound of formula (I)

wherein

A¹, A², A³ and A⁴ are each independently C-X or nitrogen, wherein each X may be the same or different and provided that no more than two of A¹, A², A³ and A⁴ are nitrogen;

R¹ is hydrogen, d-C₄alkyl, H₂NC(0)-Ci-C₄alkyl, or Ci-C₄alkylcarbonyl;

R² is hydrogen, halogen, Ci-C₄alkyl, Ci-C₆ haloalkyl or cyano;

G¹ is oxygen or sulfur;

X is hydrogen, halogen, cyano, Ci-C₄alkyloxy, Ci-C₄alkyl or Ci-C₄haloalkyl;

Q¹ is aryl or heterocyclyl, each optionally substituted by one to five substituents R³, which may be the same or different;

or Q¹ is Ci-C₈alkyl or Ci-C₈alkyl substituted by one to five R⁴, C₂-C₈alkenyl, C₂-C₈alkenyl substituted by one to five R⁴, C₂-C₈alkynyl, C₂-C₈alkynyl substituted by one to five R⁴, C₃- Ciocycloalkyl, C₃-Ci₀cycloalkyl substituted by one to five R⁴ or Ci-C₈alkyl-(CO)-N-Ci- C₈alkyl or Ci-C₈alkyl-(CO)-N-C C₈alkyl substituted by one to five R⁴;

R³ is selected from cyano, amino, nitro, hydroxy, halogen, Ci-C₄alkyl, Ci-C₄haloalkyl, C₂-C₄alkenyl, C₂-C₄haloalkenyl, C₂-C₄alkynyl, C₂-C₄haloalkynyl, C₃-C₆cycloalkyl,

C₃-Cehalocycloalkyl, Ci-C₃alkoxy, Ci-C₃haloalkoxy, Ci-C₃alkylthio, Ci-C₃haloalkylthio, Ci-C₃alkylsulfinyl, Ci-C₃haloalkylsulfinyl, Ci-C₃alkylsulfonyl, Ci-C₃haloalkylsulfonyl, Ci-C₄alkylamino, di-(Ci-C₄alkyl)amino, Ci-C₄alkylcarbonyl, Ci-C₄alkylcarbonyloxy, Ci-C₄alkoxycarbonyl, Ci-C₄alkylcarbonylamino and phenyl; each R⁴ is independently halogen, cyano, nitro, hydroxy, Ci-dalkoxy-, Ci-dhaloalkoxy-, Ci-Csalkylthio-, Ci-Cshaloalkylthio-, Ci-Csalkylsulfinyl-, Ci-Cshaloalkylsulfinyl-, Ci- dalkylsulfonyl-, Ci-dhaloalkylsulfonyl-, Ci-dalkylcarbonyl-, Ci-dalkoxycarbonyl-, aryl or aryl substituted by one to five R³, or heterocyclyl or heterocyclyl substituted by one to five R³;

Q² is a moiety of formula (II) or (III)

Y¹ and Y⁵ are independently of each other halogen, cyano, Ci-dalkyl, Ci-dhaloalkyl, Ci- C₄alkoxy-Ci-C₄-alkyl-, d-Cgalkylthio-, Ci-C₈haloalkylthio-, d-Cgalkylsulfinyl-, Ci- dhaloalkylsulfinyl-, Ci-dalkylsulfonyl-, or Ci-Cshaloalkylsulfonyl-;

Y³ is d-dperfiuoroalkyl, Ci-dperfluoroalkyithio-, Ci-Csperfluoroalkylsulfinyl-, Ci-dper- fluoroalkylsulfonyl, or C₂-C₈ fluoroalkyl substituted by a phenyl optionnaly substituted by one to five halogen, cyano, Ci-C₈alkyl, Ci-C₈haloalkyl ;

Y² and Y⁴ are independently of each other hydrogen, halogen, or Ci-dalkyl;

Y⁶ and Y⁹ are independently of each other halogen, cyano, Ci-dalkyl, Ci-dhaloalkyl, Ci- C alkoxy-Ci-C -alkyl-, Ci-Csalkylthio-, Ci-Cshaloalkylthio-, Ci-Csalkylsulfinyl-, Ci- Cshaloalkylsulfinyl-, Ci-Csalkylsulfonyl-, or Ci-Cshaloalkylsulfonyl-;

Y⁸ is C₂-C₈perfluoroalkyl, Ci-dperfluoroalkylthio-, Ci-Csperfluoroalkylsulfinyl-, or d- dperfluoroalkylsulfonyl-;

Y⁷ is hydrogen, halogen, or Ci-dalkyl; or a salt or N-oxide thereof.

The compounds of formula (I) may exist in different geometric or optical isomers (enantiomers and/or diasteroisomers) or tautomeric forms. This invention covers all such isomers and tautomers and mixtures thereof in all proportions as well as isotopic forms such as deuterated compounds.

Unless otherwise indicated, alkyl, on its own or as part of another group, such as alkoxy, alkylcarbonyl or alkoxycarbonyl, may be straight or branched chain and may preferably contain from 1 to 6 carbon atoms, more preferably 1 to 4, and most preferably 1 to 3. Examples of alkyl include methyl, ethyl, /? -propyl, z^'so-propyl, n-butyl, sec -butyl, z^'so-butyl and tert-butyl.

Unless otherwise indicated, alkenyl and alkynyl, on their own or as part of another substituent, may be straight or branched chain and may preferably contain 2 to 6 carbon atoms, preferably 2 to 4, more preferably 2 to 3, and where appropriate, may be in either the (E)- or (^-configuration. Examples include vinyl, allyl and propargyl.

Halogen means fluorine, chlorine, bromine or iodine.

Haloalkyl groups may contain one or more identical or different halogen atoms, and includes, for example, trifluoromethyl, chlorodifluoromethyl, 2,2,2-trifluoroethyl or

2,2-difluoroethyl. Perfluoroalkyl groups are alkyl groups which are completely substituted with fluorine atoms and include, for example, trifluoromethyl, pentafluoroethyl and heptafluoroprop-2-yl.

Haloalkenyl and haloalkynyl groups may contain one or more identical or different halogen atoms, and include, for example, 2,2-difluorovinyl, l ,2-dichloro-2-fluorovinyl or l-chloroprop-2-yn-l-yl.

Unless otherwise indicated, cycloalkyl may be mono- or bi-cyclic, may be optionally substituted by one or more Ci-C₆alkyl groups, and preferably contain 3 to 8 carbon atoms, more preferably 3 to 6 carbon atoms. Examples of cycloalkyl include cyclopropyl,

1- methylcyclopropyl, 2-methylcyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.

Halocycloalkyl groups may contain one or more identical or different halogen atoms, and includes, for example, 2,2-dichlorocyclopropyl, 2,2-dichloro- 1-methylcyclopropyl and

2- chloro-4-fluorocyclohexyl.

Aryl includes phenyl, naphthyl, anthracenyl, indenyl, phenanthrenyl and biphenyl, with phenyl being preferred.

Heteroaryl means a mono-, bi- or tricyclic, aromatic hydrocarbon, containing 5 to 14, preferably 5 to 10, more preferably 6 to 8, ring-atoms, including 1 to 6, preferably 1 to 4, heteroatoms independently selected from nitrogen, oxygen and sulfur. Examples include furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, triazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, tetrazinyl, indolyl, benzothiophenyl, benzofuranyl, benzimidazolyl,

benzothiadiazolyl, indazolyl, benzotriazolyl, benzothiazolyl, benzoxazolyl, quinolyl, isoquinolyl, phthalazinyl, quinoxalinyl, quinazolinyl, cinnolinyl and naphthyridinyl. Heterocyclyl, as used herein, includes heteroaryl, and in addition may be a saturated or partially unsaturated cyclic hydrocarbon containing from 3 to 10 ring-atoms up to 4 of which are heteroatoms selected from nitrogen, oxygen and sulfur, and may be optionally substituted by one or more groups independently selected from halogen, nitro, cyano, alkyl, alkoxy. Examples of non-aromatic heterocyclyl groups are Thietane, Thietane 1 -oxide, Thietane 1,1 -dioxide, oxiranyl, azetidinyl, tetrahydrofuranyl, thiolanyl, pyrrolidinyl, pyrrolinyl, imidazolidinyl, imidazolinyl, sulfolanyl, dioxolanyl, dihydropyranyl,

tetrahydropyranyl, piperidinyl, pyrazolinyl, pyrazolidinyl, dioxanyl, morpholinyl, dithianyl, thiomorpholinyl, piperazinyl, azepinyl, oxazepinyl, thiazepinyl, thiazolinyl and diazapanyl.

Preferred values of A¹, A², A³, A⁴, R¹, R², R³, G¹, X, Q¹, Q², R⁵, R⁶, R⁷ are, in any combination, as set out below.

Preferably A¹ is C-X.

Preferably A² is C-X.

Preferably A³ is C-X.

Preferably A⁴ is C-X.

Preferably, X is hydrogen, halogen, cyano, methyl, trifluoromethyl or methoxy.

More preferably, X is hydrogen, fluoro, chloro, cyano, trifluoromethyl or methoxy. Even more preferably, X is hydrogen, fluoro, cyano or methoxy. Most preferably, X is hydrogen, fluoro or cyano.

More preferably, A¹, A², A³ and A⁴ are C-X and each X is independently selected from hydrogen, halogen, cyano, methyl, trifluoromethyl and methoxy and preferably A² and A³ both are CH; and A¹ and A⁴ are C-X and each X is independently selected from hydrogen, halogen, cyano, methyl, trifluoromethyl and methoxy and more preferably each X is independently selected from hydrogen, fluoro, cyano and methoxy. Even more preferably, A¹, A², A³ and A⁴ are C-X and each X is independently selected from hydrogen, fluoro, cyano and methoxy. Most preferably, A¹ is CH, C-CN, C-Cl or C-F; and A², A³ and A⁴ are CH or A¹, A² and A³ are CH and A⁴ is CH, C-OCH₃ or C-F. Most preferred are A¹ is CH, C- CN, C-Cl or C-F; and A², A³ and A⁴ are CH. Further most preferred are A¹, A² and A³ are CH and A⁴ is CH, C-OCH₃ or C-F.

Preferably, G¹ is oxygen.

Preferably, R¹ is hydrogen, methyl, ethyl or acetyl. More preferably, R¹ is hydrogen, methyl or ethyl. Most preferably, R¹ is hydrogen. Preferably, R² is hydrogen, methyl, trifluoromethyl or halogen. More preferably, R² is hydrogen, trifluoromethyl or halogen. Even more preferably, R² is hydrogen or halogen. Most preferably, R² is hydrogen.

Preferably, Q¹ is aryl or heterocyclyl or C3-Ciocycloalkyl, or Ci-Csalkyl, or C₂- Csalkenyl, or C^Csalkynyl_,; each optionally substituted by one to five substituents independently selected from cyano, nitro, hydroxy, bromo, chloro, fluoro, methyl, trifluoromethyl, methoxy, trifiuoromethoxy, methylthio, methylsulfmyl, methylsulfonyl and phenyl.

More preferably, Q¹ is cyclopropyl, cyclobutyl, cyclopentyl, benzyl, Pyridin-2-yl - methyl, thietan3-yl, ethyl, propyl, butyl, allyl, propargyl, phenyl, 2-pyridyl; each optionally substituted by one to four substituents independently selected from cyano, nitro, hydroxy, bromo, chloro, fluoro, methyl, trifluoromethyl, methoxy, trifiuoromethoxy, methylthio, methylsulfmyl, methylsulfonyl and phenyl.

Even more preferably, Q¹ is phenyl, cyclopropyl and ethyl; each optionally substituted by one to four substituents independently selected from cyano, nitro, hydroxy, bromo, chloro, fluoro, methyl, ethyl, trifluoromethyl, methoxy, trifiuoromethoxy, methylthio, methylsulfmyl, methylsulfonyl and phenyl.

Even more preferably, Q¹ is cyclopropyl and ethyl; each optionally substituted by one to four substituents independently selected from cyano, nitro, hydroxy, bromo, chloro, fluoro, methyl, ethyl, trifluoromethyl, methoxy, trifiuoromethoxy, methylthio,

methylsulfmyl, methylsulfonyl and phenyl.

Preferred examples of Q¹ include Pyridin-2-yl -methyl, thietan3-yl, ethyl, butyl, cyclopropyl, benzyl, phenyl.

Preferably Q² is a moiety of formula (II).

Preferably Y¹ is halogen, cyano, methyl, ethyl, trifluoromethyl, or methoxymethyl, more preferably bromo, chloro, methyl, ethyl, methoxymethyl, most preferably bromo, chloro, methyl, ethyl.

Preferably Y² is hydrogen, chloro, fluoro, or methyl, most preferably hydrogen.

Preferably Y³ is heptafluoro-propyl, heptafiuoro-prop-2-yl, heptafluoro-propylthio-, heptafluoro-propylsulfinyl-, heptafluoro-propylsulfonyl-, heptafluoro-prop-2-ylthio-, heptafluoro-prop-2-ylsulfinyl-, heptafluoro-prop-2-ylsulfonyl-, or nonafiuoro-but-2-yl.

In one embodiment Y³ is C₂-C₆perfiuoroalkyl, most preferably Y³ is heptafluoro- prop-2-yl or nonafluoro-but-2-yl. Preferably Y⁴ is hydrogen, chloro, fluoro, or methyl, most preferably hydrogen.

Preferably Y⁵ is halogen, cyano, methyl, ethyl, or trifluoromethyl, most preferably bromo, chloro, methyl, or ethyl.

Preferably Y⁶ is halogen, cyano, methyl, ethyl, trifluoromethyl, or methoxymethyl, more preferably bromo, chloro, methyl, ethyl, or methoxymethyl, most preferably bromo, chloro, methyl, or ethyl.

Preferably Y⁷ is hydrogen, chloro, fluoro, or methyl, most preferably hydrogen.

Preferably Y⁸ is heptafluoro-propyl, heptafluoro-prop-2-yl, heptafluoro-propylthio-, heptafluoro-propylsulfinyl-, heptafluoro-propylsulfonyl-, heptaf uoro-prop-2-ylthio-, heptafluoro-prop-2-ylsulfinyl-, heptafluoro-prop-2-ylsulfonyl-, or nonafluoro-but-2-yl.

In one embodiment Y⁸ is C2-C₆perfluoroalkyl, most preferably Y⁸ is heptafluoro- prop-2-yl or nonafluoro-but-2-yl.

Preferably Y⁹ is halogen, cyano, methyl, ethyl, trifluoromethyl, or methoxymethyl, more preferably bromo, chloro, methyl, ethyl, or methoxymethyl, most preferably bromo, chloro, methyl, or ethyl.

In a preferred embodiment Q² is 2-ethyl-6-methyl-4-(heptafluoro-prop-2-yl)-phenyl, or Q² is 2-bromo-6-methyl-4-(heptafluoro-prop-2-yl)-phenyl, or Q² is 2-bromo-6-ethyl-4- (heptafluoro-prop-2-yl)-phenyl, or Q² is 2,6-dichloro-4-(heptafluoro-prop-2-yl)-phenyl, or Q² is 2,6-dibromo-4-(heptafluoro-prop-2-yl)-phenyl, or Q² is 2-bromo-6-chloro-4- (heptafluoro-prop-2-yl)-phenyl, or Q² is 2-ethyl-6-methyl-4-(nonafluoro-but-2-yl)-phenyl, or Q² is 2-bromo-6-methyl-4-(nonafluoro-but-2-yl)-phenyl, or Q² is 2-bromo-6-ethyl-4- (nonafluoro-but-2-yl)-phenyl, or Q² is 2,6-dichloro-4-(nonafluoro-but-2-yl)-phenyl, or Q² is 2,6-dibromo-4-(nonafluoro-but-2-yl)-phenyl, or Q² is 2-bromo-6-chloro-4-(nonafluoro-but- 2-yl)-phenyl, or Q² is 2-ethyl-6-methyl-4-(heptafluoro-prop-2-yl)-phenyl, or Q² is 2-bromo- 6-methyl-4-(heptafluoro-prop-2-yl)-phenyl.

In a further preferred embodiment Q² is 2-bromo-6-ethyl-4-(heptafluoro-prop-2-yl)- phenyl.

In a further preferred embodiment Q² is 2,6-dichloro-4-(heptafluoro-prop-2-yl)- phenyl.

In a further preferred embodiment Q² is 2,6-dibromo-4-(heptafluoro-prop-2-yl)- phenyl.

In a further preferred embodiment Q² is 2-bromo-6-chloro-4-(heptafluoro-prop-2-yl)- phenyl. In a further preferred embodiment Q² is 2-ethyl-6-methyl-4-(heptafluoro-prop-2-yl)- phenyl.

In a further preferred embodiment Q² is 2-bromo-6-methyl-4-(heptafluoro-prop-2- yl)-phenyl.

In a further preferred embodiment Q² is 2-ethyl-6-methyl-4-(nonafluoro-but-2-yl)- phenyl.

In a further preferred embodiment Q² is 2-bromo-6-methyl-4-(nonafluoro-but-2-yl)- phenyl.

In a further preferred embodiment Q² is 2-bromo-6-ethyl-4-(nonafluoro-but-2-yl)- phenyl.

In a further preferred embodiment Q² is 2, 6-dichloro-4-(nonafluoro-but-2-yl)-phenyl. In a further preferred embodiment Q² is 2, 6-dibromo-4-(nonafluoro-but-2-yl)- phenyl.

In a further preferred embodiment Q² is 2-bromo-6-chloro-4-(nonafluoro-but-2-yl)- phenyl.

A preferred embodiment (El) the substituents in the compounds of Formula (I) have the following meaning:

R¹ is hydrogen, methyl, ethyl or acetyl;

R² is hydrogen, methyl, trifluoromethyl or halogen;

G¹ is oxygen;

Q¹ is aryl or heterocyclyl or C3-Ciocycloalkyl or Ci-Csalkyl; each optionally substituted by one to five substituents independently selected from cyano, nitro, hydroxy, bromo, chloro, fluoro, methyl, trifluoromethyl, methoxy, trifluoromethoxy, methylthio, methylsulfmyl, methylsulfonyl and phenyl.

Q² is is a moiety of formula (II)

Y¹ is halogen, cyano, methyl, ethyl, trifluoromethyl, or methoxymethyl, more preferably bromo, chloro, methyl, ethyl, methoxymethyl, most preferably bromo, chloro, methyl, ethyl. Y² is hydrogen, chloro, fluoro, or methyl, most preferably hydrogen.

Y³ is heptafluoro-propyl, heptafluoro-prop-2-yl, heptafluoro-propylthio-, heptafluoro- propylsulfmyl-, heptafluoro-propylsulfonyl-, heptafluoro-prop-2-ylthio-, heptafluoro-prop-2- ylsulfinyl-, heptafluoro-prop-2-ylsulfonyl-, or nonafluoro-but-2-yl. Y³ is C2-C₆perfluoroalkyl, most preferably Y³ is heptafluoro-prop-2-yl or nonafluoro-but-2- yi.

Y⁴ is hydrogen, chloro, fluoro, or methyl, most preferably hydrogen.

Y⁵ is halogen, cyano, methyl, ethyl, or trifluoromethyl, most preferably bromo, chloro, methyl, or ethyl.

A preferred embodiment (E2) the substituents in the compounds of formula (I) have the following meaning:

R¹ is hydrogen, methyl or ethyl;

R² is hydrogen, trifluoromethyl or halogen;

Q¹ is cyclopropyl, cyclobutyl, cyclopentyl, benzyl, Pyridin-2-yl -methyl, thietan3-yl, ethyl, propyl, butyl, phenyl, 2-pyridyl; each optionally substituted by one to four substituents independently selected from cyano, nitro, hydroxy, bromo, chloro, fluoro, methyl, trifluoromethyl, methoxy, trif uoromethoxy, methylthio, methylsulfmyl, methylsulfonyl and phenyl.

Q² is is a moiety of formula (II).

Y¹ is halogen, cyano, methyl, ethyl, trifluoromethyl, or methoxymethyl,

Y² is hydrogen, chloro, fluoro, or methyl,

Y³ is heptafluoro-propyl, heptafluoro-prop-2-yl, heptafluoro-propylthio-, heptafluoro- propylsulfmyl-, heptafluoro-propylsulfonyl-, heptafluoro-prop-2-ylthio-, heptafluoro-prop-2- ylsulfmyl-, heptafluoro-prop-2-ylsulfonyl-, or nonafluoro-but-2-yl.

Y⁴ is hydrogen, chloro, fluoro, or methyl,

Y⁵ is halogen, cyano, methyl, ethyl, or trifluoromethyl,

A preferred embodiment (E3) the substituents in the compounds of formula (I) have the following meaning:

R¹ is hydrogen, methyl or ethyl;

R² is hydrogen or halogen;

Q¹ is phenyl, cyclopropyl and ethyl; each optionally substituted by one to four substituents independently selected from cyano, nitro, hydroxy, bromo, chloro, fluoro, methyl, ethyl, trifluoromethyl, methoxy, trifluoromethoxy, methylthio, methylsulfmyl, methylsulfonyl and phenyl.

Q² is is a moiety of formula (II). Y¹ is bromo, chloro, methyl, ethyl, methoxymethyl

Y² is hydrogen.

Y³ is heptafluoro-propyl, heptafluoro-prop-2-yl, heptafluoro-propylthio-, heptafluoro- propylsulfinyl-, heptafluoro-propylsulfonyl-, heptafluoro-prop-2-ylthio-, heptafluoro-prop-2- ylsulfinyl-, heptafluoro-prop-2-ylsulfonyl-, or nonafluoro-but-2-yl.

Y⁴ is hydrogen.

Y⁵ is bromo, chloro, methyl, or ethyl.

A preferred embodiment (E4) the substituents in the compounds of formula (I) have the following meaning:

R¹ is hydrogen;

R² is hydrogen

Q¹ is cyclopropyl and ethyl; each optionally substituted by one to four substituents independently selected from cyano, nitro, hydroxy, bromo, chloro, fluoro, methyl, ethyl, trifluoromethyl, methoxy, trifluoromethoxy, methylthio, methylsulfmyl, methylsulfonyl and phenyl;

Q² is is a moiety of formula (II).

Y¹ is bromo, chloro, methyl, ethyl.

Y² is hydrogen.

Y³ is heptafluoro-prop-2-yl, nonafluoro-but-2-yl.

Y⁴ is hydrogen.

Y⁵ is bromo, chloro, methyl, or ethyl.

A preferred embodiment are compounds of formula (I) wherein A¹, A², A³ and A⁴ are C-X and each X is independently selected from hydrogen, halogen, cyano, methyl, trifluoromethyl and methoxy and the other substituents have the meaning as in the

Embodiment (El)

A preferred embodiment are compounds of formula (I) wherein A² and A³ both are CH; and A¹ and A⁴ are C-X and each X is independently selected from hydrogen, halogen, cyano, methyl, trifluoromethyl and methoxy and more preferably each X is independently selected from hydrogen, fluoro, cyano and methoxy and the other substituents have the meaning as in the Embodiment (El) A preferred embodiment are compounds of formula (I) wherein A¹, A², A³ and A⁴ are C-X and each X is independently selected from hydrogen, fluoro, chloro, cyano and methoxy and the other substituents have the meaning as in the Embodiment (El)

A preferred embodiment are compounds of formula (I) wherein A¹ is CH, C-CN, C- CI or C-F; and A², A³ and A⁴ are CH or A¹, A² and A³ are CH and A⁴ is CH, C-OCH₃ or C-F and the other substituents have the meaning as in the Embodiment (El)

A preferred embodiment are compounds of formula (I) wherein A¹ is CH, C-CN, C- Cl or C-F; and A², A³ and A⁴ are CH and the other substituents have the meaning as in the Embodiment (El)

A preferred embodiment are compounds of formula (I) wherein A¹, A² and A³ are CH and A⁴ is CH, C-OCH₃ or C-F and the other substituents have the meaning as in the

Embodiment (El)

Embodiment (E2)

A preferred embodiment are compounds of formula (I) wherein A² and A³ both are CH; and Al and A⁴ are C-X and each X is independently selected from hydrogen, halogen, cyano, methyl, trifluoromethyl and methoxy and more preferably each X is independently selected from hydrogen, fluoro, chloro, cyano and methoxy and the other substituents have the meaning as in the Embodiment (E2)

A preferred embodiment are compounds of formula (I) wherein A¹, A², A³ and A⁴ are C-X and each X is independently selected from hydrogen, fluoro, chloro, cyano and methoxy and the other substituents have the meaning as in the Embodiment (E2)

A preferred embodiment are compounds of formula (I) wherein A¹ is CH, C-CN, C-

Cl or C-F; and A², A³ and A⁴ are CH or A¹, A² and A³ are CH and A⁴ is CH, C-OCH₃ or C-F and the other substituents have the meaning as in the Embodiment (E2)

A preferred embodiment are compounds of formula (I) wherein A¹ is CH, C-CN, C- Cl or C-F; and A², A³ and A⁴ are CH methoxy and the other substituents have the meaning as in the Embodiment (E2)

Embodiment (E2) A preferred embodiment are compounds of formula (I) wherein A¹, A², A³ and A⁴ are C-X and each X is independently selected from hydrogen, halogen, cyano, methyl, trifluoromethyl and methoxy and the other substituents have the meaning as in the

Embodiment (E3)

A preferred embodiment are compounds of formula (I) wherein A² and A³ both are

CH; and Al and A⁴ are C-X and each X is independently selected from hydrogen, halogen, cyano, methyl, trifluoromethyl and methoxy and more preferably each X is independently selected from hydrogen, fluoro, chloro, cyano and methoxy and the other substituents have the meaning as in the Embodiment (E3)

A preferred embodiment are compounds of formula (I) wherein A¹, A², A³ and A⁴ are

C-X and each X is independently selected from hydrogen, fluoro, chloro, cyano and methoxy and the other substituents have the meaning as in the Embodiment (E3)

A preferred embodiment are compounds of formula (I) wherein A¹ is CH, C-CN, C- Cl or C-F; and A², A³ and A⁴ are CH or A¹, A² and A³ are CH and A⁴ is CH, C-OCH₃ or C-F and the other substituents have the meaning as in the Embodiment (E3)

A preferred embodiment are compounds of formula (I) wherein A¹ is CH, C-CN, C- Cl or C-F; and A², A³ and A⁴ are CH methoxy and the other substituents have the meaning as in the Embodiment (E3)

Embodiment (E3)

Embodiment (E4)

A preferred embodiment are compounds of formula (I) wherein A² and A³ both are CH; and Al and A⁴ are C-X and each X is independently selected from hydrogen, halogen, cyano, methyl, trifluoromethyl and methoxy and more preferably each X is independently selected from hydrogen, fluoro, chloro, cyano and methoxy and the other substituents have the meaning as in the Embodiment (E4)

A preferred embodiment are compounds of formula (I) wherein A¹, A², A³ and A⁴ are C-X and each X is independently selected from hydrogen, fluoro, chloro, cyano and methoxy and the other substituents have the meaning as in the Embodiment (E4) A preferred embodiment are compounds of formula (I) wherein A¹ is CH, C-CN, C- Cl or C-F; and A², A³ and A⁴ are CH or A¹, A² and A³ are CH and A⁴ is CH, C-OCH₃ or C-F and the other substituents have the meaning as in the Embodiment (E4)

A preferred embodiment are compounds of formula (I) wherein A¹ is CH, C-CN, C- CI or C-F; and A², A³ and A⁴ are CH methoxy and the other substituents have the meaning as in the Embodiment (E4)

Embodiment (E4)

A preferred embodiment (Ea) are compounds of formula (I) wherein A¹ is C-CN, and A², A³, and A⁴ are CH.

A preferred embodiment (Eb) are compounds of formula (I) wherein A⁴ is C-F, and , A², and A³ are CH.

A preferred embodiment (Ec) are compounds of formula (I) wherein A⁴ is C-OMe,

A¹, A² and A³ are CH.

A preferred embodiment (Ed) are compounds of formula (I) wherein A¹, A², A³, A⁴ are CH.

A preferred embodiment (Ee) are compounds of formula (I) wherein A¹ is C-Cl, A², A³ and A⁴ are CH.

A preferred embodiment (Ef) are compounds of formula (I) wherein A is C-F, and A², A³, and A⁴ are CH.

A preferred embodiment (Eg) are compounds of formula (I) wherein A is C-CF₃, and

A², A³, and A⁴ are CH.

A preferred embodiment (Eh) are compounds of formula (I) wherein A^q is N, A¹, A² and A³ are CH.

A preferred embodiment (Ei) are compounds of formula (I) wherein A⁴ is N, A¹ is CN, A² and A³ are CH.

A preferred embodiment (Ej) are compounds of formula (j) wherein A⁴ is N, A¹ is F, A² and A³ are CH. A preferred embodiment (Eal) are compounds of formula (I) wherein A¹ is C-CN, and A², A³, and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (El).

A preferred embodiment (Ebl) are compounds of formula (I) wherein A⁴ is C-F, and A¹, A², and A³ are CH and the other substituents have the meaning as given in the embodiment of (El).

A preferred embodiment (Eel) are compounds of formula (I) wherein A⁴ is C-OMe, A¹, A² and A³ are CH and the other substituents have the meaning as given in the

embodiment of (El).

A preferred embodiment (Edl) are compounds of formula (I) wherein A¹, A², A³, A⁴ are CH and the other substituents have the meaning as given in the embodiment of (El).

A preferred embodiment (Eel) are compounds of formula (I) wherein A¹ is C-Cl, A², A³ and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (El).

A preferred embodiment (Efl) are compounds of formula (I) wherein A¹ is C-F, and

A², A³, and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (El).

A preferred embodiment (Egl) are compounds of formula (I) wherein A¹ is C-CF₃, and A², A³, and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (El).

A preferred embodiment (Ehl) are compounds of formula (I) wherein A⁴ is N, A¹, A² and A³ are CH and the other substituents have the meaning as given in the embodiment of (El).

A preferred embodiment (Eil) are compounds of formula (I) wherein A⁴ is N, A¹ is CN, A² and A³ are CH and the other substituents have the meaning as given in the embodiment of (El).

A preferred embodiment (Ej 1) are compounds of formula (I) wherein A⁴ is N, A¹ is F, A² and A³ are CH and the other substituents have the meaning as given in the embodiment of (El).

A preferred embodiment (Ea2) are compounds of formula (I) wherein A¹ is C-CN, and A², A³, and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (E2). A preferred embodiment (Eb2) are compounds of formula (I) wherein A⁴ is C-F, and A¹, A², and A³ are CH and the other substituents have the meaning as given in the embodiment of (E2).

A preferred embodiment (Ec2) are compounds of formula (I) wherein A⁴ is C-OMe, A¹, A² and A³ are CH and the other substituents have the meaning as given in the

embodiment of (E2).

A preferred embodiment (Ed2) are compounds of formula (I) wherein A¹, A², A³, A⁴ are CH and the other substituents have the meaning as given in the embodiment of (E2).

A preferred embodiment (Ee2) are compounds of formula (I) wherein A¹ is C-Cl, A², A³ and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (E2).

A preferred embodiment (Ef2) are compounds of formula (If) wherein A¹ is C-F, and A², A³, and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (E2).

A preferred embodiment (Eg2) are compounds of formula (I) wherein A¹ is C-CF₃, and A², A³, and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (E2).

A preferred embodiment (Eh2) are compounds of formula (I) wherein A⁴ is N, A¹, A² and A³ are CH and the other substituents have the meaning as given in the embodiment of (E2).

A preferred embodiment (Ei2) are compounds of formula (I) wherein A⁴ is N, A¹ is CN, A² and A³ are CH and the other substituents have the meaning as given in the embodiment of (E2).

A preferred embodiment (Ej2) are compounds of formula (I) wherein A⁴ is N, A¹ is F, A² and A³ are CH and the other substituents have the meaning as given in the embodiment of (E2).

A preferred embodiment (Ea3) are compounds of formula (I) wherein A¹ is C-CN, and A², A³, and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (E3).

A preferred embodiment (Eb3) are compounds of formula (I) wherein A⁴ is C-F, and

A¹, A², and A³ are CH and the other substituents have the meaning as given in the embodiment of (E3). A preferred embodiment (Ec3) are compounds of formula (I) wherein A⁴ is C-OMe, A¹, A² and A³ are CH and the other substituents have the meaning as given in the

embodiment of (E3).

A preferred embodiment (Ed3) are compounds of formula (I) wherein A¹, A², A³, A⁴ are CH and the other substituents have the meaning as given in the embodiment of (E3).

A preferred embodiment (Ee3) are compounds of formula (I) wherein A¹ is C-Cl, A², A³ and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (E3).

A preferred embodiment (Ef3) are compounds of formula (I) wherein A¹ is C-F, and A², A³, and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (E3).

A preferred embodiment (Eg3) are compounds of formula (I) wherein A¹ is C-CF₃, and A², A³, and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (E3).

A preferred embodiment (Eh3) are compounds of formula (I) wherein A⁴ is N, A¹, A² and A³ are CH and the other substituents have the meaning as given in the embodiment of (E3).

A preferred embodiment (Ei3) are compounds of formula (I) wherein A⁴ is N, A¹ is CN, A² and A³ are CH and the other substituents have the meaning as given in the embodiment of (E3).

A preferred embodiment (Ej3) are compounds of formula (I) wherein A⁴ is N, A¹ is F, A² and A³ are CH and the other substituents have the meaning as given in the embodiment of (E3).

A preferred embodiment (Ea4) are compounds of formula (I) wherein A¹ is C-CN, and A², A³, and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (E4).

A preferred embodiment (Eb4) are compounds of formula (I) wherein A⁴ is C-F, and A¹, A², and A³ are CH and the other substituents have the meaning as given in the embodiment of (E4).

A preferred embodiment (Ec4) are compounds of formula (I) wherein A⁴ is C-OMe,

A¹, A² and A³ are CH and the other substituents have the meaning as given in the

embodiment of (E4). A preferred embodiment (Ed4) are compounds of formula (I) wherein A¹, A², A³, A⁴ are CH and the other substituents have the meaning as given in the embodiment of (E4).

A preferred embodiment (Ee4) are compounds of formula (I) wherein A¹ is C-Cl, A², A³ and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (E4).

A preferred embodiment (Ef4) are compounds of formula (I) wherein A¹ is C-F, and A², A³, and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (E4).

A preferred embodiment (Eg4) are compounds of formula (I) wherein A¹ is C-CF₃, and A², A³, and A⁴ are CH and the other substituents have the meaning as given in the embodiment of (E4).

A preferred embodiment (Eh4) are compounds of formula (I) wherein A⁴ is N, A¹, A² and A³ are CH and the other substituents have the meaning as given in the embodiment of (E4).

A preferred embodiment (Ei4) are compounds of formula (I) wherein A⁴ is N, A¹ is

CN, A² and A³ are CH and the other substituents have the meaning as given in the embodiment of (E4).

A preferred embodiment (Ej4) are compounds of formula (I) wherein A⁴ is N, A¹ is F, A² and A³ are CH and the other substituents have the meaning as given in the embodiment of (E4).

The intermediate compounds of formula (III) form a further aspect of the invention

1 2 3 4 2 2

wherein A , A , A , A , R and Q are as defined in relation to formula (I); or a salt thereof.

1 2 3 4 2 2

The preferences for A , A , A , A , R and Q are the same as the preferences set out for the corresponding substituents of the compounds of formula (I).

The intermediate compounds of formula (Illb), wherin R is Ci-C₆ alkyl forms a further aspect of the invention

wherein A 1 , A 2 , A 3 , A 4 , R 2 and Q 2 are as defined in relation to formula (I); or a salt thereof.

1 2 3 4 2 2

In a preferred embodiment, the invention provides a compound of formula (III) wherein A 1 , A 2 , A 3 and A 4 are CH; R 2 is hydrogen; Q 2 is a moiety of formula (II);.

In a further preferred embodiment, the invention provides a compound of formula

(III) wherein A 1

and A 4 are CH; R 2 is hydrogen; Q 2 is a moiety of formula (II);

In a further preferred embodiment, the invention provides a compound of formula

(III) wherein A 1 is C-F; A 2 , A 3 , and A 4 are CH; R 2 is hydrogen; Q 2 is a moiety of formula

(Π);

In a further preferred embodiment, the invention provides a compound of formula (III) wherein A 1 is C-Cl; A 2 , A 3 , and A 4 are CH; R 2 is hydrogen; Q 2 is a moiety of formula

(ii);

In a further preferred embodiment, the invention provides a compound of formula

(III) wherein A 4 is C-F; A 2 , A 3 , and A 1 are CH; R 2 is hydrogen; Q 2 is a moiety of formula

(ii);

In a further preferred embodiment, the invention provides a compound of formula

(III) wherein A 4 is C-OMe; A 2 , A 3 , and A 1 are CH; R 2 is hydrogen; Q 2 is a moiety of formula

(ii);

In a further preferred embodiment, the invention provides a compound of formula

(III) wherein A 4 is N; A 2 , A 3 , and A 1 are CH; R 2 is hydrogen; Q 2 is a moiety of formula (II);

In a further preferred embodiment, the invention provides a compound of formula

(HI) wherein A 4 is N; A 1 is CN,A 2 and A 3 are CH; R 2 is hydrogen; Q 2 is a moiety of formula

(ii); In a further preferred embodiment, the invention provides a compound of formula

(III) wherein A 4 is N; A 1 is F,A2 and A 3^J are CH; R 2 is hydrogen; Q 2 is a moiety of formula

(Π);

In a further preferred embodiment, the invention provides a compound of formula (Illb) wherein A¹ is C-CF3; A², A³, and A⁴ are CH; R² is hydrogen; Q² is a moiety of formula (II);

In a preferred embodiment, the invention provides a compound of formula (Illb) wherein A 1 , A 2 , A 3 and A 4 are CH; R 2 is hydrogen; Q 2 is a moiety of formula (II);.

In a further preferred embodiment, the invention provides a compound of formula

(Illb) wherein A 1

and A 4 are CH; R 2 is hydrogen; Q 2 is a moiety of formula

(ii);

In a further preferred embodiment, the invention provides a compound of formula (Illb) wherein A 1 is C-F; A 2 A 3\ and A 4 are CH; R 2 is hydrogen; Q 2 is a moiety of formula

(ii);

In a further preferred embodiment, the invention provides a compound of formula

(Illb) wherein A 1 is

and A 4 are CH; R 2 is hydrogen; Q 2 is a moiety of formula

(ii);

In a further preferred embodiment, the invention provides a compound of formula

(Illb) wherein A 4 is

and A 1 are CH; R 2 is hydrogen; Q 2 is a moiety of formula

(ii);

In a further preferred embodiment, the invention provides a compound of formula (Illb) wherein A⁴ is C-OMe; A², A³, and A¹ are CH; R² is hydrogen; Q² is a moiety of formula (II);

In a further preferred embodiment, the invention provides a compound of formula

(Illb)

and A 1 are CH; R 2 is hydrogen; Q 2 is a moiety of formula (II);

In a further preferred embodiment, the invention provides a compound of formula (Illb) wherein A⁴ is N; A¹ is CN,A² and A³ are CH; R² is hydrogen; Q² is a moiety of formula (II);

In a further preferred embodiment, the invention provides a compound of formula

(Illb) wherein A 4 is N; A 1 is F,A 2 and A 3^J are CH; R 2 is hydrogen; Q 2 is a moiety of formula

(ii); In a further preferred embodiment, the invention provides a compound of formula (nib) wherein A¹ is C-CF3; A², A³, and A⁴ are CH; R² is hydrogen; Q² is a moiety of formula (II); Table 1 :

Table 1 provides 73 specific compounds of formula (la) according to formula (I)

wherein A¹ is C-CN, A², A³ and A⁴ are C-H and Q² is 2-Bromo-6-chloro-4-( 1,2,2,2- tetrafluoro-l-trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Compound numbers Q¹

1.01 5 -bromo-furan-2-yl

1.02 2-bromo-phenyl

1.03 5 -bromo-pyrid-3 -yl

1.04 2-chloro-4-fluoro-phenyl

1.05 5 -chloro-2-fluoro-phenyl

1.06 2-chloro-4-nitro-phenyl

1.07 2-chloro-5 -nitro-phenyl

1.08 2-chloro-phenyl

1.09 3-chloro-phenyl

1.10 2-chloro-pyrid-3-yl

1.11 2-chloro-pyrid-4-yl

1.12 6-chloro-pyrid-3-yl

1.13 5-chloro-thiophen-2-yl

1.14 3 -chloro-5 -trifluoromethyl-pyrid-2-yl

1.15 4-cyano-phenyl

1.16 2,5-dichloro-phenyl Compound numbers Q¹

1.17 2,3 -difluoro-phenyl

1.18 1 ,3-dimethyl- lH-pyrazol-5-yl

1.19 2-fluoro-phenyl

1.20 4-fluoro-phenyl

1.21 2-fluoro-pyrid-3 -yl

1.22 2-fluoro-3 -trifluoromethyl-phenyl

1.23 2-fluoro-5 -trifluoromethyl-phenyl

1.24 4-fluoro-3 -trifluoromethyl-phenyl

1.25 furan-2-yl

1.26 2-methoxy-phenyl

1.27 2-methyl-phenyl

1.28 3 -methyl -pyrid-2-yl

1.29 4-methyl-l ,2,3-thiadiazol-5-yl

1.30 2-methylthio-pyrid-3 -yl

1.31 4-nitro-phenyl

1.32 phenyl

1.33 1 ,2,3-thiadiazol-4-yl

1.34 thiophen-2-yl

1.35 2-trifluoromethoxy-phenyl

1.36 4-trif uoromethoxy-phenyl

1.37 2-trif uoromethyl -phenyl

1.38 4-trif uoromethyl -phenyl

1.39 4-Pyridyl

1.40 2-chloro-4-cyano-phenyl

1.41 2, 6-difluoro-4-cyano-phenyl

1.42 2, 4, 6-trif uoro -phenyl

1.43 2-methyl-4-cyano-phenyl

1.44 2-methyl -4-nitro-phenyl

1.45 2-methyl-4-fluoro-phenyl

1.46 Cyclopropyl Compound numbers Q¹

1.47 Benzyl

1.48 2,2,2-Trifluoro-ethyl

1.49 Ethyl

1.50 n-Butyl

1.51 2-Methoxy- 1 -methyl-ethyl

1.52 N-(2,2,2-trifluoro-ethyl)-acetamide-2-yl

1.53 3 ,3 ,3-Trifluoro-propyl

1.54 sec-Butyl

1.55 (Tetrahydro-furan-2-yl)-methyl

1.56 Benzyl

1.57 2-Fluoro-benzyl

1.58 1-Phenyl-ethyl

1.59 4-Methoxy-benzyl

1.60 1 , 1 -Dioxo-thietan-3 -yl

1.61 (6-Chloro-pyridin-3 -yl)-methyl

1.62 3-Fluoro-phenyl

1.63 2,5-Dimethyl-2H-pyrazol-3-yl

1.64 4-Methyl-thiazol-2-yl

1.65 3-Methyl-thietan-3-yl

1.66 1 , 1 -Dimethyl -2 -methylsulfanyl-ethyl

1.67 1 -Oxo-thietan-3-yl

1.68 Thietan-3-yl

1.69 Bicyclo[2.2.1]hept-2-yl

1.70 Cyclobutyl

1.71 2-Methanesulfinyl-ethyl

1.72 2-Methylsulfanyl-ethyl

1.73 Tetrahy dro -thiophen-3 -yl

Table 2:

Table 2 provides 73 specific compounds of formula (lb) according to formula (I) wherein A⁴ is C-F, A¹, A² and A³ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,2-tetrafluoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 3:

Table 3 provides 73 specific compounds of formula (Ic) according to formula (I) wherein A⁴ is C-OMe, A¹, A² and A³ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,2-tetrafluoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 4:

Table 4 provides 73 specific compounds of formula (Id) according to formula (I) wherein A¹, A², A³ and A⁴ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,2-tetrafluoro-l-trifluoromethyl- ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in the table below.

Table 5:

Table 5 provides 73 specific compounds of formula (Ie) according to formula (I) wherein A¹ is C-Cl, A², A³ and A⁴ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,2-tetrafluoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 6:

Table 6 provides 73 specific compounds of formula (If) according to formula (I) wherein A¹ is C-F, A², A³ and A⁴ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,2-tetrafluoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 7:

Table 7 provides 73 specific compounds of formula (Ig) according to formula (I) wherein A¹ is C-CF₃, A², A³ and A⁴ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,2-tetrafluoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 8:

Table 8 provides 73 specific compounds of formula (Ih) according to formula (I) wherein A⁴ is N A¹, A² and A³ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,2-tetrafluoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 9:

Table 9 provides 73 specific compounds of formula (Ii) according to formula (I) wherein A⁴ is N, A¹ is CN, A² and A³ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,2-tetrafluoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 10:

Table 10 provides 73 specific compounds of formula (Ij) according to formula (I) wherein A⁴ is N, A¹ is F, A² and A³ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,2-tetrafluoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1. The 10 Tables 1A to 10A disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 1 to 10 exept that R¹ is H, R² is CH₃.

As an example the Table 1 A provides 73 specific compounds of formula (IaA) according to formula (I)

wherein A¹ is C-CN, A², A³ and A⁴ are C-H and Q² is 2-Bromo-6-chloro-4-( 1,2,2,2- tetrafluoro-l-trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is CH₃ and Q¹ has the values listed in Table 1. As a further example the Table 8A provides 73 specific compounds of formula (IhA) according to formula (I) wherein A⁴ is N A¹, A² and A³ are C-H and Q² is 2-Bromo-6-chloro- 4-(l,2,2,2-tetrafluoro-l-trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is CH₃ and Q¹ has the values listed in Table 1. The 10 Tables IB to 10B disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 1 to 10 exept that R¹ is H, R² is CH₂CH₃.

The 10 Tables 1C to IOC disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 1 to 10 exept that R¹ is CH₃, R² is CH₃.

The 10 Tables ID to 10D disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 1 to 10 exept that R¹ is CH₂CH₃, R² is H.

The 10 Tables IE to 10E disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 1 to 10 exept that R¹ is CH₃, R² is CH₂CH₃.

The 10 Tables 1G to 10G disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 1 to 10 exept that R¹ is CH₂CH₃, R² is CH₃.

The 10 Tables IF to 10F disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 1 to 10 exept that R¹ is CH₂CH₃, R² is CH₂CH₃. Table 11 :

Table 11 provides 20 specific compounds of formula (Illb) wherein Q² is 2-Bromo-6-chloro- 4-(l,2,2,2-tetrafiuoro-l-trifluoromethyl-ethyl)-phenyl, R² is H, R and A¹, A², A³, A⁴ has the values listed in the table below.

Compound number A¹ A² A³ A⁴ R

11.01 C-F C-H C-H C-H CH₃

11.02 C-CN C-H C-H C-H CH₃

11.03 C-H C-H C-H C-F CH₃

11.04 C-H C-H C-H C-OMe CH₃

11.05 C-H C-H C-H N CH₃

11.06 C-F C-H C-H N CH₃

11.07 C-CN C-H C-H N CH₃

11.08 C-CF3 C-H C-H C-H CH₃ Compound number A¹ A² A³ A⁴ R

11.09 C-H C-H C-H C-H CH₃

11.10 C-Cl C-H C-H C-H CH₃

11.11 C-F C-H C-H C-H CH₂CH₃

11.12 C-CN C-H C-H C-H CH₂CH₃

11.13 C-H C-H C-H C-F CH2CH3

11.14 C-H C-H C-H C-OMe CH2CH3

11.15 C-H C-H C-H N CH₂CH₃

11.16 C-F C-H C-H N CH₂CH₃

11.17 C-CN C-H C-H N CH₂CH₃

11.18 C-CF3 C-H C-H C-H CH₂CH₃

11.19 C-H C-H C-H C-H CH₂CH₃

11.20 C-Cl C-H C-H C-H CH₂CH₃

Table 11a:

Table 11a provides 20 specific compounds of formula (Illb) wherein Q² is 2-Bromo-6- chloro-4-(l,2,2,2-tetrafiuoro-l-trifluoromethyl-ethyl)-phenyl, R² is CH₂CH₃, R and A¹, A², A³, A⁴ has the values listed in the table 11 above.

Table l ib:

Table 11a provides 20 specific compounds of formula (Illb) wherein Q² is 2-Bromo-6- chloro-4-(l,2,2,2-tetrafluoro-l-trifluoromethyl-ethyl)-phenyl, R² is CH₃, R and A¹, A², A³, A⁴ has the values listed in the table 11 above.

Table 12:

Table 12 provides 10 compound of formula (III) wherein Q² is 2-Bromo-6-chloro-4-( 1,2,2,2- tetrafluoro-l-trifluoromethyl-ethyl)-phenyl , R² is H and A¹, A², A³, A⁴ has the values listed in the table below.

(I ll)

Compound number A¹ A² A³ A⁴

12.01 C-F C-H C-H C-H

12.02 C-CN C-H C-H C-H

12.03 C-H C-H C-H C-F

12.04 C-H C-H C-H C-OMe

12.05 C-H C-H C-H N

12.06 C-F C-H C-H N

12.07 C-CN C-H C-H N

12.08 C-CF3 C-H C-H C-H

12.09 C-H C-H C-H C-H

12.10 C-Cl C-H C-H C-H

Table 12a:

Table 12a provides 10 compound of formula (III) wherein Q² is 2-Bromo-6-chloro-4- (l,2,2,2-tetrafluoro-l-trifluoromethyl-ethyl)-phenyl , R² is CH₃ and A¹, A², A³, A⁴ has the values listed in the table 12 above.

Table 12b:

Table 12b provides 10 compound of formula (III) wherein Q² is 2-Bromo-6-chloro-4- (l,2,2,2-tetrafluoro-l-trifluoromethyl-ethyl)-phenyl, R² is CH₂CH₃ and A¹, A², A³, A⁴ has the values listed in the table 12 above.

Table 13:

Table 13 provides 73 specific compounds of formula (la) according to formula (I) wherein A¹ is C-CN, A², A³ and A⁴ are C-H and Q² is 2, 6-dichloro-4-(l,2,2,2-tetrafiuoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 14:

Table 14 provides 73 specific compounds of formula (lb) according to formula (I) wherein A⁴ is C-F, A¹, A² and A³ are C-H and Q² is 2, 6-dichloro-4-(l,2,2,2-tetrafluoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 15:

Table 15 provides 73 specific compounds of formula (Ic) according to formula (I) wherein A⁴ is C-OMe, A¹, A² and A³ are C-H and Q² is 2, 6-dichloro-4-(l,2,2,2-tetrafluoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 16:

Table 16 provides 73 specific compounds of formula (Id) according to formula (I) wherein A¹, A², A³ and A⁴ are C-H and Q² is 2, 6-dichloro-4-(l,2,2,2-tetrafluoro-l-trifluoromethyl- ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in the table 1.

Table 17:

Table 17 provides 73 specific compounds of formula (Ie) according to formula (I) wherein A¹ is C-Cl, A², A³ and A⁴ are C-H and Q² is 2, 6-dichloro-4-(l,2,2,2-tetrafiuoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 18:

Table 18 provides 73 specific compounds of formula (If) according to formula (I) wherein A¹ is C-F, A², A³ and A⁴ are C-H and Q² is 2, 6-dichloro-4-(l,2,2,2-tetrafiuoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 19:

Table 19 provides 73 specific compounds of formula (Ig) according to formula (I) wherein A¹ is C-CF₃, A², A³ and A⁴ are C-H and Q² is 2, 6-dichloro-4-(l,2,2,2-tetrafluoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 20:

Table 20 provides 73 specific compounds of formula (Ih) according to formula (I) wherein A⁴ is N A¹, A² and A³ are C-H and Q² is 2, 6-dichloro-4-(l,2,2,2-tetrafluoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 21 :

Table 21 provides 73 specific compounds of formula (Ii) according to formula (I) wherein A⁴ is N, A¹ is CN, A² and A³ are C-H and Q² is 2, 6-dichloro-4-(l,2,2,2-tetrafluoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 22:

Table 22 provides 73 specific compounds of formula (Ij) according to formula (I) wherein A⁴ is N, A¹ is F, A² and A³ are C-H and Q² is 2, 6-dichloro-4-(l,2,2,2-tetrafiuoro-l- trifluoromethyl-ethyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

The 10 Tables 22B to 22B disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 22 to 22 exept that R¹ is H, R² is CH₂CH₃.

The 10 Tables 22C to 22C disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 22 to 22 exept that R¹ is CH₃, R² is CH₃. The 10 Tables 22D to 22D disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 22 to 22 exept that R¹ is CH₂CH₃, R² is H.

The 10 Tables 22E to 22E disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 22 to 22 exept that R¹ is CH₃, R² is CH₂CH₃.

The 10 Tables 22G to 22G disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 22 to 22 exept that R¹ is CH₂CH₃, R² is CH₃.

The 10 Tables 22F to 22F disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 22 to 22 exept that R¹ is CH₂CH₃, R² is CH₂CH₃.

Table 23:

Table 23 provides 20 specific compounds of formula (Illb) wherein Q² is 2, 6-dichloro-4- (l,2,2,2-tetrafluoro-l-trifluoromethyl-ethyl)-phenyl, R² is H, R and A¹, A², A³, A⁴ has the values listed in the table 11.

Table 23a:

Table 23a provides 20 specific compounds of formula (Illb) wherein Q² is 2, 6-dichloro-4- (l,2,2,2-tetrafiuoro-l-trifluoromethyl-ethyl)-phenyl, R² is CH₃, R and A¹, A², A³, A⁴ has the values listed in the table 11. Table 23b:

Table 23b provides 20 specific compounds of formula (Illb) wherein Q² is 2, 6-dichloro-4- (l,2,2,2-tetrafiuoro-l-trifluoromethyl-ethyl)-phenyl, R² is CH₂CH₃, R and A¹, A², A³, A⁴ has the values listed in the table 11.

Table 24:

Table 24 provides 10 compound of formula (III) wherein Q² is 2, 6-dichloro-4-( 1,2,2,2- tetrafluoro-l-trifluoromethyl-ethyl)-phenyl, R² is H and A¹, A², A³, A⁴ has the values listed in the table 12.

Table 24a:

Table 24a provides 10 compound of formula (III) wherein Q² is 2, 6-dichloro-4-( 1,2,2,2- tetrafluoro-l-trifluoromethyl-ethyl)-phenyl, R² is CH₃ and A¹, A², A³, A⁴ has the values listed in the table 12.

Table 24b:

Table 24b provides 10 compound of formula (III) wherein Q² is 2, 6-dichloro-4-( 1,2,2,2- tetrafluoro-l-trifluoromethyl-ethyl)-phenyl, R² is CH₂CH₃ and A¹, A², A³, A⁴ has the values listed in the table 12.

Table 25:

Table 25 provides 73 specific compounds of formula (la) according to formula (I) wherein A¹ is C-CN, A², A³ and A⁴ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,3,3,3-hexafluoro-l- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 26:

Table 26 provides 73 specific compounds of formula (lb) according to formula (I) wherein A⁴ is C-F, A¹, A² and A³ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,3,3,3-hexafluoro-l- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 27:

Table 27 provides 73 specific compounds of formula (Ic) according to formula (I) wherein A⁴ is C-OMe, A¹, A² and A³ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,3,3,3-hexafiuoro- l-trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 28: Table 28 provides 73 specific compounds of formula (Id) according to formula (I) wherein A¹, A², A³ and A⁴ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,3,3,3-hexafluoro-l- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in the table 1.

Table 29:

Table 29 provides 73 specific compounds of formula (Ie) according to formula (I) wherein A¹ is C-Cl, A², A³ and A⁴ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,3,3,3-hexafluoro-l- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 30:

Table 30 provides 73 specific compounds of formula (If) according to formula (I) wherein A¹ is C-F, A², A³ and A⁴ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,3,3,3-hexafluoro-l- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 31 :

Table 31 provides 73 specific compounds of formula (Ig) according to formula (I) wherein A¹ is C-CF₃, A², A³ and A⁴ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,3,3,3-hexafiuoro- l-trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 32:

Table 32 provides 73 specific compounds of formula (Ih) according to formula (I) wherein A⁴ is N A¹, A² and A³ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,3,3,3-hexafluoro-l- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 33:

Table 33 provides 73 specific compounds of formula (Ii) according to formula (I) wherein A⁴ is N, A¹ is CN, A² and A³ are C-H and Q² is 2-Bromo-6-chloro-4-( 1,2,2,3, 3,3 -hexafluoro-1- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 34:

Table 34 provides 73 specific compounds of formula (Ij) according to formula (I) wherein A⁴ is N, A¹ is F, A² and A³ are C-H and Q² is 2-Bromo-6-chloro-4-(l,2,2,3,3,3-hexafluoro-l- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

The 10 Tables 25B to 34B disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 25 to 34 exept that R¹ is H, R² is CH₂CH₃. The 10 Tables 25C to 34C disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 25 to 34 exept that R¹ is CH₃, R² is CH₃.

The 10 Tables 25D to 34D disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 25 to 34 exept that R¹ is CH₂CH₃, R² is H.

The 10 Tables 25E to 34E disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 25 to 34 exept that R¹ is CH₃, R² is CH₂CH₃.

The 10 Tables 25G to 34G disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 25 to 34 exept that R¹ is CH₂CH₃, R² is CH₃.

The 10 Tables 25F to 34F disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 25 to 34 exept that R¹ is CH₂CH₃, R² is CH₂CH₃. Table 35:

Table 35 provides 20 specific compounds of formula (Illb) wherein Q² is 2-Bromo-6-chloro- 4-(l,2,2,3,3,3-hexafluoro-l-trifluoromethyl-propyl)-phenyl, R² is H, R and A¹, A², A³, A⁴ has the values listed in the table 11.

Table 35a:

Table 35a provides 20 specific compounds of formula (Illb) wherein Q² is 2-Bromo-6- chloro-4-(l,2,2,3,3,3-hexafluoro-l-trifluoromethyl-propyl)-phenyl, R² is CH₃, R and A¹, A², A³, A⁴ has the values listed in the table 11.

Table 35b:

Table 35b provides 20 specific compounds of formula (Illb) wherein Q² is 2-Bromo-6- chloro-4-(l,2,2,3,3,3-hexafluoro-l-trifluoromethyl-propyl)-phenyl, R² is CH₂CH , R and A¹, A², A³, A⁴ has the values listed in the table 11.

Table 36: Table 36 provides 10 compound of formula (III) wherein Q² is 2-Bromo-6-chloro-4-

(1, 2,2,3, 3,3-hexafluoro-l-trifluoromethyl-propyl)-phenyl, R² is H and A¹, A², A³, A⁴ has the values listed in the table 12.

Table 36a:

Table 36a provides 10 compound of formula (III) wherein Q² is 2-Bromo-6-chloro-4-

(1, 2,2,3, 3,3-hexafluoro-l-trifluoromethyl-propyl)-phenyl, R² is CH₃ and A¹, A², A³, A⁴ has the values listed in the table 12.

Table 36b:

Table 36b provides 10 compound of formula (III) wherein Q² is 2-Bromo-6-chloro-4- (l,2,2,3,3,3-hexafluoro-l-trifluoromethyl-propyl)-phenyl, R² is CH₂CH₃ and A¹, A², A³, A⁴ has the values listed in the table 12.

Table 37:

Table 37 provides 73 specific compounds of formula (la) according to formula (I) wherein A¹ is C-CN, A², A³ and A⁴ are C-H and Q² is 2, 6-dichloro-4-( 1,2,2,3, 3,3 -hexafluoro-1- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 38:

Table 38 provides 73 specific compounds of formula (lb) according to formula (I) wherein A⁴ is C-F, A¹, A² and A³ are C-H and Q² is 2, 6-dichloro-4-( 1,2,2,3, 3,3 -hexafluoro-1- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 39:

Table 39 provides 73 specific compounds of formula (Ic) according to formula (I) wherein A⁴ is C-OMe, A¹, A² and A³ are C-H and Q² is 2, 6-dichloro-4-( 1,2,2,3, 3,3 -hexafluoro-1- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 40:

Table 40 provides 73 specific compounds of formula (Id) according to formula (I) wherein A¹, A², A³ and A⁴ are C-H and Q² is 2, 6-dichloro-4-(l,2,2,3,3,3-hexafluoro-l- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in the table 1.

Table 41 : Table 41 provides 73 specific compounds of formula (Ie) according to formula (I) wherein A¹ is C-Cl, A², A³ and A⁴ are C-H and Q² is 2, 6-dichloro-4-( 1,2,2,3, 3,3 -hexafiuoro-1- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 42:

Table 42 provides 73 specific compounds of formula (If) according to formula (I) wherein A¹ is C-F, A², A³ and A⁴ are C-H and Q² is 2, 6-dichloro-4-( 1,2,2,3, 3,3 -hexafluoro-1- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 43:

Table 43 provides 73 specific compounds of formula (Ig) according to formula (I) wherein A¹ is C-CF₃, A², A³ and A⁴ are C-H and Q² is 2, 6-dichloro-4-( 1,2,2,3, 3,3 -hexafluoro-1- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 44:

Table 44 provides 73 specific compounds of formula (Ih) according to formula (I) wherein A⁴ is N A¹, A² and A³ are C-H and Q² is 2, 6-dichloro-4-(l,2,2,3,3,3-hexafhioro-l- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 45:

Table 45 provides 73 specific compounds of formula (Ii) according to formula (I) wherein A⁴ is N, A¹ is CN, A² and A³ are C-H and Q² is 2, 6-dichloro-4-(l,2,2,3,3,3-hexafhioro-l- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

Table 46:

Table 46 provides 73 specific compounds of formula (Ij) according to formula (I) wherein A⁴ is N, A¹ is F, A² and A³ are C-H and Q² is 2, 6-dichloro-4-(l,2,2,3,3,3-hexafluoro-l- trifluoromethyl-propyl)-phenyl, G¹ is O, R¹ is H, R² is H and Q¹ has the values listed in Table 1.

The 10 Tables 37B to 46B disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 37 to 46 exept that R¹ is H, R² is CH₂CH₃.

The 10 Tables 37C to 46C disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 37 to 46 exept that R¹ is CH₃, R² is CH₃.

The 10 Tables 37D to 46D disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 37 to 46 exept that R¹ is CH₂CH₃, R² is H.

The 10 Tables 37E to 46E disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 37 to 46 exept that R¹ is CH₃, R² is CH₂CH .

The 10 Tables 37G to 46G disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 37 to 46 exept that R¹ is CH₂CH₃, R² is CH₃.

The 10 Tables 37F to 46F disclose each 73 specific compounds wherein the meaning of the substituents are given in the Tables 37 to 46 exept that R¹ is CH₂CH₃, R² is CH₂CH₃. Table 47:

Table 47 provides 20 specific compounds of formula (Illb) wherein Q² is 2, 6-dichloro-4- (1, 2,2,3, 3,3-hexafluoro-l-trifluoromethyl-propyl)-phenyl, R² is H, R and A¹, A², A³, A⁴ has the values listed in the table 11.

Table 47a:

Table 47a provides 20 specific compounds of formula (Illb) wherein Q² is 2, 6-dichloro-4- (1, 2,2,3, 3,3-hexafluoro-l-trifluoromethyl-propyl)-phenyl, R² is CH , R and A¹, A², A³, A⁴ has the values listed in the table 11.

Table 47b:

Table 47b provides 20 specific compounds of formula (Illb) wherein Q² is 2, 6-dichloro-4- (l,2,2,3,3,3-hexafluoro-l-trifluoromethyl-propyl)-phenyl, R² is CH₂CH₃, R and A¹, A², A³, A⁴ has the values listed in the table 11.

Table 48:

Table 48 provides 10 compound of formula (III) wherein Q² is 2, 6-dichloro-4-( 1,2,2,3, 3,3 - hexafluoro-l-trifluoromethyl-propyl)-phenyl, R² is H and A¹, A², A³, A⁴ has the values listed in the table 12.

Table 48a: Table 48a provides 10 compound of formula (III) wherein Q² is 2, 6-dichloro-4-(l, 2,2,3, 3,3- hexafluoro-l-trifluoromethyl-propyl)-phenyl, R² is CH₃ and A¹, A², A³, A⁴ has the values listed in the table 12.

Table 48b:

Table 48b provides 10 compound of formula (III) wherein Q² is 2, 6-dichloro-4-( 1,2,2,3, 3,3 - hexafluoro-l-trifluoromethyl-propyl)-phenyl, R² is CH₂CH₃ and A¹, A², A³, A⁴ has the values listed in the table 12.

The compounds of the invention may be made by the following methods.

(1) Compounds of formula (I), wherein G¹ is oxygen, may be prepared by reaction of a compound of formula (V) with an azido derivative, Q²-N₃ (VII), in the presence of copper or a copper catalyst, such as copper sulfate or copper (I) iodide, and optionally in the presence of a base, such as N-ethyldiisopropylamine, in the presence of a solvent or a mixture of solvents, such as t-butanol, water. In the case of a Cu(II) catalyst, a reducing agent, such as sodium ascorbate may be used. In the case of a Cu(0) catalyst, such as an amine salt, an oxidising agent may be used. (See, for example: Angewandte Chemie, International Edition (2009), 48(27), 4900-4908 and cited references, Angew. Chem. Int. Ed. 2008, 47, 2182 - 2184 and cited references, and Eur. J. Org. Chem. 2006, 51-68 and cited references).

(2) Compounds of formula (V) may be prepared by reaction of a compound of formula (VI) , wherein R is OH with a compound of formula (IV), in the presence of a coupling reagent, such as DCC (Ν,Ν'-dicyclohexylcarbodiimide), EDC (l-ethyl-3-[3- dimethylamino-propyl]carbodiimide hydrochloride) or BOP-C1 (bis(2-oxo-3- oxazolidinyl)phosphonic chloride), in the presence of a base, such as pyridine, triethylamine, 4-(dimethylamino)pyridine or diisopropylethylamine, and optionally in the presence of a nucleophilic catalyst, such as hydroxybenzotriazole. Optionally, when R is CI, the reaction may be carried out under basic conditions (for example in the presence of pyridine, triethylamine, 4-(dimethylamino)pyridine or diisopropylethylamine), optionally in the presence of a nucleophilic catalyst. Alternatively, the reaction may be conducted in a biphasic system comprising an organic solvent, preferably ethyl acetate, and an aqueous solvent, preferably a solution of sodium bicarbonate. Optionally, when R is Ci-C₆alkoxy, the amide may be prepared by heating the ester (VI) and amine (IV) together.

(3) Compound of formula (VI) , wherein R is OH may be prepared by reaction of a compound of formula (VI) , wherein R is Ci-C₆alkoxy via hydrolysis. For instance, in the case where R is methoxy or ethoxy, the hydrolysis can be done with water and a base, such as potassium hydroxide or lithium hydroxide, in the absence or in the presence of a solvent, such as, for instance, tetrahydrofurane or methanol. In the case where R is, for example, tert- butoxy, the hydrolysis is done in the presence of acid, such as trifluoroacetic acid or hydrochloric acid. The reaction is carried out at a temperature of from -120°C to +130°C, preferably from -100°C to 100°C.

(4) Compounds of formula (V), wherein R¹ is Ci-C₆alkyl, may be prepared from a compound of formula (V) wherein R¹ is H via alkylation may be achieved by treating the amine with an alkylating agent such as an alkyl halide, optionally in the presence of a base.

(5) Compounds of formula (I), wherein G¹ is oxygen, may be also be prepared by reaction of a compound of formula (III) , wherein R is OH, CI or Ci-C₆alkoxy with a compound of formula (IV) as described in (2).

(IV)

(VI ) (I I I ) (I ) (6) Compounds of formula (III) may be prepared from a compound of formula (VI) using the same conditions as described in (1).

(7) Compounds of formula (III) may be prepared by hydrolysis of a ester compound of formula (Illb) by the method described in (3).

(8) Compounds of formula (I), wherein G¹ is sulfur, may be prepared from a compound of formula (I), wherein G¹ is oxygen, by treatment with a thio-transfer reagent, such as Lawesson's reagent or phosphorus pentasulfide.

(9) Compounds of formula (VIII) may be prepared from a compound of formula (IX), wherein A¹, A² , A³ and A⁴ are each independentely C-LG or C-H, and LG is a leaving group, such as fluorine or chlorine, by reaction with a nucleophile, such as an aliphatic alcohol, sodium cyanide.

(10) Compounds of formula (Illb), wherein A¹, A² , A³ and A⁴ are as described for the compound of formula (I) may be prepared from a compound of formula (Illb), wherein A¹, A² , A³ and A⁴ are each independentely C-LG or C-H, and LG is a leaving group, such as fluorine or chlorine, by reaction with a nucleophile, such as an aliphatic alcohol, sodium cyanide.

(1 M b') (1 M b)

11) Compounds of formula (VII), wherein Q₂ is as described for the compound of formula (I), may be also be prepared by reaction of a compound of formula (II) with sodium nitrite followed by addition of sodium azide. See, for example: Diazo Chemistry I: Aromatic and Heteroaromatic Compounds. Zollinger, H.. Germany. (1994), 380 pp.

Publisher: (VCH, Weinheim, Germany) and cited references.

Q— NH₂ Q— N = N = N

(II) (VII)

13) Alternatively, compounds of formula (NH2Q2) are either known or may be made by methods known to a person skilled in the art.

14) Compounds of formula (VI) , (VIII) or (IX) are either known or may be made by methods known to a person skilled in the art.

The compounds of formula (I) can be used to combat and control infestations of insect pests such as Lepidoptera, Diptera, Hemiptera, Thysanoptera, Orthoptera, Dictyoptera, Coleoptera, Siphonaptera, Hymenoptera and Isoptera and also other invertebrate pests, for example, acarine, nematode and mollusc pests. Insects, acarines, nematodes and molluscs are hereinafter collectively referred to as pests. The pests which may be combated and controlled by the use of the invention compounds include those pests associated with agriculture (which term includes the growing of crops for food and fibre products), horticulture and animal husbandry, companion animals, forestry and the storage of products of vegetable origin (such as fruit, grain and timber); those pests associated with the damage of man-made structures and the transmission of diseases of man and animals; and also nuisance pests (such as flies).

Examples of pest species which may be controlled by the compounds of formula (I) include: Myzus persicae (aphid), Aphis gossypii (aphid), Aphis fabae (aphid), Lygus spp. (capsids), Dysdercus spp. (capsids), Nilaparvata lugens (planthopper), Nephotettixc incticeps (leafhopper), Nezara spp. (stinkbugs), Euschistus spp. (stinkbugs), Leptocorisa spp.

(stinkbugs), Frankliniella occidentalis (thrip), Thrips spp. (thrips), Leptinotarsa

decemlineata (Colorado potato beetle), Anthonomus grandis (boll weevil), Aonidiella spp. (scale insects), Trialeurodes spp. (white flies), Bemisia tabaci (white fly), Ostrinia nubilalis (European corn borer), Spodoptera littoralis (cotton leafworm), Heliothis virescens (tobacco budworm), Helicoverpa armigera (cotton bollworm), Helicoverpa zea (cotton bollworm), Sylepta derogata (cotton leaf roller), Pieris brassicae (white butterfly), Plutella xylostella (diamond back moth), Agrotis spp. (cutworms), Chilo suppressalis (rice stem borer), Locusta_, migratoria (locust), Chortiocetes terminifera (locust), Diabrotica spp. (rootworms),

Panonychus ulmi (European red mite), Panonychus citri (citrus red mite), Tetranychus urticae (two-spotted spider mite), Tetranychus cinnabarinus (carmine spider mite),

Phyllocoptruta oleivora (citrus rust mite), Polyphagotarsonemus latus (broad mite),

Brevipalpus spp. (flat mites), Boophilus microplus (cattle tick), Dermacentor variabilis (American dog tick), Ctenocephalides felis (cat flea), Liriomyza spp. (leafminer), Musca domestica (housefly), Aedes aegypti (mosquito), Anopheles spp. (mosquitoes), Culex spp. (mosquitoes), Lucillia spp. (blowflies), Blattella germanica (cockroach), Periplaneta americana (cockroach), Blatta orientalis (cockroach), termites of the Mastotermitidae (for example Mastotermes spp.), the Kalotermitidae (for example Neotermes spp.), the

Rhinotermitidae (for example Coptotermes formosanus, Reticulitermes flavipes, R. speratu, R. virginicus, R. hesperus, and R. santonensis) and the Termitidae (for example Globitermes sulfureus), Solenopsis geminata (fire ant), Monomorium pharaonis (pharaoh's ant),

Damalinia spp. and Linognathus spp. (biting and sucking lice), Meloidogyne spp. (root knot nematodes), Globodera spp. and Heterodera spp. (cyst nematodes), Pratylenchus spp.

(lesion nematodes), Rhodopholus spp. (banana burrowing nematodes), Tylenchulus spp. (citrus nematodes), Haemonchus contortus (barber pole worm), Caenorhabditis elegans_ (vinegar eelworm), Trichostrongylus spp. (gastro intestinal nematodes) and Deroceras reticulatum (slug).

The invention therefore provides a method of combating and controlling insects, acarines, nematodes or molluscs which comprises applying an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I), or a composition containing a compound of formula (I), to a pest, a locus of pest, preferably a plant, or to a plant susceptible to attack by a pest or a plant propagation material. The compounds of formula (I) are preferably used against insects, acarines or nematodes. As for acari, for example, Tetranychus cinnabarinus, Tetranychus urticae,

Panonychus citri, Aculops pelekassi, Tarsonemus spp..

As for nematodes, for example, Meloidogyne incognita, Bursaphelenchus lignicolus Mamiya et Kiyohara, Aphelenchoides besseyi, Heterodera glycines, Pratylenchus spp..

Additionally, the compounds can be used for controlling animal pests, in particular insects, arachnids, helminths, nematodes and molluscs, which are encountered in agriculture, in horticulture, the field of veterinary medicine, in forests, in gardens and leisure facilities, in the protection of stored products and of materials, and in the hygiene sector. They may preferably be employed as plant protection agents. They may be active against normally sensitive and resistant species and against all or some stages of development.

These pests include inter alia:

From the order of the Anoplura (Phthiraptera), for example, Damalinia spp., Haematopinus spp., Linognathus spp., Pediculus spp., Trichodectes spp..

From the class of the Arachnida, for example, Acarus siro, Aceria sheldoni, Aculops spp., Aculus spp., Amblyomma spp., Argas spp., Boophilus spp., Brevipalpus spp., Bryobia praetiosa, Chorioptes spp., Dermanyssus gallinae, Eotetranychus spp., Epitrimerus pyri, Eutetranychus spp., Eriophyes spp., Hemitarsonemus spp., Hyalomma spp., Ixodes spp., Latrodectus mactans, Metatetranychus spp., Oligonychus spp., Ornithodoros spp.,

Panonychus spp., Phyllocoptruta oleivora, Polyphagotarsonemus latus, Psoroptes spp., Rhipicephalus spp., Rhizoglyphus spp., Sarcoptes spp., Scorpio maurus, Stenotarsonemus spp., Tarsonemus spp., Tetranychus spp., Vasates lycopersici.

From the class of the Bivalva, for example, Dreissena spp..

From the order of the Chilopoda, for example, Geophilus spp., Scutigera spp..

From the order of the Coleoptera, for example, Acanthoscehdes obtectus, Adoretus spp., Agelastica alni, Agriotes spp., Amphimallon solstitialis, Anobium punctatum,

Anoplophora spp., Anthonomus spp., Anthrenus spp., Apogonia spp., Atomaria spp., Attagenus spp., Bruchidius obtectus, Bruchus spp., Ceuthorhynchus spp., Cleonus mendicus, Conoderus spp., Cosmopolites spp., Costelytra zealandica, Curculio spp., Cryptorhynchus lapathi, Dermestes spp., Diabrotica spp., Epilachna spp., Faustinus cubae, Gibbium psylloides, Heteronychus arator, Hylamorpha elegans, Hylotrupes bajulus, Hypera postica, Hypothenemus spp., Lachnosterna consanguinea, Leptinotarsa decemlineata, Lissorhoptrus oryzophilus, Lixus spp., Lyctus spp., Meligethes aeneus, Melolontha melolontha, Migdolus spp., Monochamus spp., Naupactus xanthographus, Niptus hololeucus, Oryctes rhinoceros, Oryzaephilus surinamensis, Otiorrhynchus sulcatus, Oxycetonia jucunda, Phaedon cochleariae, Phyllophaga spp., Popillia japonica, Premnotrypes spp., Psylliodes

chrysocephala, Ptinus spp., Rhizobius ventralis, Rhizopertha dominica, Sitophilus spp., Sphenophorus spp., Sternechus spp., Symphyletes spp., Tenebrio molitor, Tribolium spp., Trogoderma spp., Tychius spp., Xylotrechus spp., Zabrus spp..

From the order of the Collembola, for example, Onychiurus armatus.

From the order of the Dermaptera, for example, Forficula auricularia.

From the order of the Diplopoda, for example, Blaniulus guttulatus.

From the order of the Diptera, for example, Aedes spp., Anopheles spp., 5z^'¾z^'o hortulanus, Calliphora erythrocephala, Ceratitis capitata, Chrysomyia spp., Cochliomyia spp., Cordylobia anthropophaga, Culex spp., Cuterebra spp., Dacus oleae, Dermatobia hominis, Drosophila spp., Fannia spp., Gastrophilus spp., Hylemyia spp., Hyppobosca spp., Hypoderma spp., Liriomyza spp., Lucilia spp., Musca spp., Nezara spp., Oestrus spp., Oscinella frit, Pegomyia hyoscyami, Phorbia spp., Stomoxys spp., Tabanus spp., Tannia spp., Tipula paludosa, Wohlfahrtia spp..

From the class of the Gastropoda, for example, ^non spp., Biomphalaria spp., Bulinus spp., Deroceras spp., Galba spp., Lymnaea spp., Oncomelania spp., Succinea spp..

From the class of the helminths, for example, Ancylostoma duodenale, Ancylostoma ceylanicum, Acylostoma braziliensis, Ancylostoma spp., Ascaris lubricoides, Ascaris spp., Brugia malayi, Brugia timori, Bunostomum spp., Chabertia spp., Clonorchis spp., Cooperia spp., Dicrocoelium spp, Dictyocaulus filaria, Diphyllobothrium latum, Dracunculus medinensis, Echinococcus granulosus, Echinococcus multilocularis, Enterobius

vermicularis, Faciola spp., Haemonchus spp., Heterakis spp., Hymenolepis nana,

Hyostrongulus spp., Zoa Zoa, Nematodirus spp., Oesophagostomum spp., Opisthorchis spp., Onchocerca volvulus, Ostertagia spp., Paragonimus spp., Schistosomen spp., Strongyloides fuelleborni, Strongyloides stercoralis, Stronyloides spp., Taenia saginata, Taenia solium, Trichinella spiralis, Trichinella nativa, Trichinella britovi, Trichinella nelsoni, Trichinella pseudopsiralis, Trichostrongulus spp., Trichuris trichuria, Wuchereria bancrofti.

It may be furthermore possible to control protozoa, such as Eimeria.

From the order of the Heteroptera, for example, Anasa tristis, Antestiopsis spp., Blissus spp., Calocoris spp., Campylomma livida, Cavelerius spp., Cimex spp., Creontiades dilutus, Dasynus piperis, Dichelops furcatus, Diconocoris hewetti, Dysdercus spp.,

Euschistus spp., Eurygaster spp., Heliopeltis spp., Horcias nobilellus, Leptocorisa spp., Leptoglossus phyllopus, Lygus spp., Macropes excavatus, Miridae, Nezara spp., Oebalus spp., Pentomidae, Piesma quadrata, Piezodorus spp., Psallus seriatus, Pseudacysta persea, Rhodnius spp., Sahlbergella singularis, Scotinophora spp., Stephanitis nashi, Tibraca spp., Triatoma spp..

From the order of the Homoptera, for example, Acyrthosipon spp., Aeneolamia spp.,

Agonoscena spp., Aleurodes spp., Aleurolobus barodensis, Aleurothrixus spp., Amrasca spp., Anuraphis cardui, Aonidiella spp., Aphanostigma piri, Aphis spp., Arboridia apicalis, Aspidiella spp., Aspidiotus spp., Atanus spp., Aulacorthum solani, Bemisia spp.,

Brachycaudus helichrysii, Brachycolus spp., Brevicoryne brassicae, Calligypona marginata, Carneocephala fulgida, Ceratovacuna lanigera, Cercopidae, Ceroplastes spp.,

Chaetosiphon fragaefolii, Chionaspis tegalensis, Chlorita onukii, Chromaphis juglandicola, Chrysomphalus ficus, Cicadulina mbila, Coccomytilus halli, Coccus spp., Cryptomyzus ribis, Dalbulus spp., Dialeurodes spp., Diaphorina spp., Diaspis spp., Doralis spp., Drosicha spp., Dysaphis spp., Dysmicoccus spp., Empoasca spp., Eriosoma spp., Erythroneura spp., Euscelis bilobatus, Geococcus cofifieae, Homalodisca coagulata, Hyalopterus arundinis, Icerya spp., Idiocerus spp., Idioscopus spp., Laodelphax striatellus, Lecanium spp.,

Lepidosaphes spp., Lipaphis erysimi, Macrosiphum spp., Mahanarva fimbriolata,

Melanaphis sacchari, Metcalfiella spp., Metopolophium dirhodum, Monellia costalis, Monelliopsis pecanis, Myzus spp., Nasonovia ribisnigri, Nephotettix spp., Nilaparvata lugens, Oncometopia spp., Orthezia praelonga, Parabemisia myricae, Paratrioza spp., Parlatoria spp., Pemphigus spp., Peregrinus maidis, Phenacoccus spp., Phloeomyzus passerinii, Phorodon humuli, Phylloxera spp., Pinnaspis aspidistrae, Planococcus spp., Protopulvinaria pyriformis, Pseudaulacaspis pentagona, Pseudococcus spp., Psylla spp., Pteromalus spp., Pyrilla spp., Quadr aspidiotus spp., Quesada gigas, Rastrococcus spp., Rhopalosiphum spp., Saissetia spp., Scaphoides titanus, Schizaphis graminum, Selenaspidus articulatus, Sogata spp., Sogatella furcifera, Sogatodes spp., Stictocephala festina,

Tenalaphara malayensis, Tinocallis caryaefoliae, Tomaspis spp., Toxoptera spp.,

Trialeurodes vaporariorum, Trioza spp., Typhlocyba spp., Unaspis spp., Viteus vitifolii.

From the order of the Hymenoptera, for example, Diprion spp., Hoplocampa spp., Lasius spp., Mono- morium pharaonis, Vespa spp..

From the order of the Isopoda, for example, Armadillidium vulgare, Oniscus asellus, Porcellio scaber. From the order of the Isoptera, for example, Reticulitermes spp., Odontotermes spp..

From the order of the Lepidoptera, for example, Acronicta major, Aedia

leucomelas, Agrotis spp., Alabama argillacea, Anticarsia spp., Barathra brassicae,

Bucculatrix thurberiella, Bupalus piniarius, Cacoecia podana, Capua reticulana,

Carpocapsa pomonella, Cheimatobia brumata, Chilo spp., Choristoneura fumiferana, Clysia ambiguella, Cnaphalocerus spp., Earias insulana, Ephestia kuehniella, Euproctis

chrysorrhoea, Euxoa spp., Feltia spp., Galleria mellonella, Helicoverpa spp., Heliothis spp., Hofmannophila pseudospretella, Homona magnanima, Hyponomeuta padella, Laphygma spp., Lithocolletis blancardella, Lithophane antennata, Loxagrotis albicosta, Lymantria spp., Malacosoma neustria, Mamestra brassicae, Mods repanda, Mythimna separata, Oria spp., Oulema oryzae, Panolis flammea, Pectinophora gossypiella, Phyllocnistis citrella, Pieris spp., Plutella xylostella, Prodenia spp., Pseudaletia spp., Pseudoplusia includens, Pyrausta nubilalis, Spodoptera spp., Thermesia gemmatalis, Tinea pellionella, Tineola bisselliella, Tortrix viridana, Trichoplusia spp..

From the order of the Orthoptera, for example, Acheta domesticus, Blatta orientalis, Blattella germanica, Gryllotalpa spp., Leucophaea maderae, Locusta spp., Melanoplus spp., Periplaneta americana, Schistocerca gregaria.

From the order of the Siphonaptera, for example, Ceratophyllus spp., Xenopsylla cheopis.

From the order of the Symphyla, for example, Scutigerella immaculata.

From the order of the Thysanoptera, for example, Baliothrips biformis, Enneothrips flavens, Frankliniella spp., Heliothrips spp., Hercinothrips femoralis, Kakothrips spp., Rhipiphorothrips cruentatus, Scirtothrips spp., Taeniothrips cardamoni, Thrips spp.

From the order of the Thysanura, for example, Lepisma saccharina.

The phytoparasitic nematodes include, for example, Anguina spp., Aphelenchoides spp., Belonoaimus spp., Bursaphelenchus spp., Ditylenchus dipsaci, Globodera spp., Heliocotylenchus spp., Heterodera spp., Longidorus spp., Meloidogyne spp., Pratylenchus spp., Radopholus similis, Rotylenchus spp., Trichodorus spp., Tylenchorhynchus spp., Tylenchulus spp., Tylenchulus semipenetrans, Xiphinema spp.. Furthermore, in the field of veterinary medicine, the novel compounds of the present invention can be effectively used against various harmful animal parasitic pests (endoparasites and ectoparasites), for example, insects and helminthes.

Examples of such animal parasitic pests include the pests as described below.

Examples of the insects include Gasterophilus spp., Stomoxys spp., Trichodectes spp., Rhodnius spp., Ctenocephalides canis, Cimx lecturius, Ctenocephalides felis, Lucilia cuprina, and the like.

Examples of acari include Ornithodoros spp., Ixodes spp., Boophilus spp., and the like.

In the veterinary fields, e.g. in the field of veterinary medicine, the active compounds according to the present invention are active against animal parasites, in particular ectoparasites or endoparasites.

The term endoparasites includes in particular helminths, such as cestodes, nematodes or trematodes, and protozoae, such as coccidia.

Ectoparasites are typically and preferably arthropods, in particular insects such as flies (stinging and licking), parasitic fly larvae, lice, hair lice, bird lice, fleas and the like; or acarids, such as ticks, for examples hard ticks or soft ticks, or mites, such as scab mites, harvest mites, bird mites and the like.

These parasites include:

From the order of the Anoplurida, for example Haematopinus spp., Linognathus spp., Pediculus spp., Phtirus spp., Solenopotes spp.; particular examples are: Linognathus setosus, Linognathus vituli, Linognathus ovillus, Linognathus oviformis, Linognathus pedalis, Linognathus stenopsis, Haematopinus asini macrocephalus, Haematopinus eurysternus, Haematopinus suis, Pediculus humanus capitis, Pediculus humanus corporis, Phylloera vastatrix, Phthirus pubis, Solenopotes capillatus; from the order of the

Mallophagida and the suborders Amblycerina and Ischnocerina, for example Trimenopon spp., Menopon spp., Trinoton spp., Bovicola spp., Werneckiella spp., Lepikentron spp., Damalina spp., Trichodectes spp., Felicola spp.; particular examples are: Bovicola bovis, Bovicola ovis, Bovicola limbata, Damalina bovis, Trichodectes canis, Felicola subrostratus, Bovicola caprae, Lepikentron ovis, Werneckiella equi; from the order of the Diptera and the suborders Nematocerina and Brachycerina, for example Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Odagmia spp., Wilhelmia spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomyia spp., Wohlfahrtia spp., Sarcophaga spp., Oestrus spp., Hypoderma spp., Gasterophilus spp., Hippobosca spp., Lipoptena spp., Melophagus spp., Rhinoestrus spp., Tipula spp.; particular examples are: Aedes aegypti, Stegomyia albopicta (Aedes albopictus), Aedes taeniorhynchus, Anopheles gambiae, Anopheles maculipennis, Calliphora

erythrocephala, Chrysozona pluvialis, Culex quinquefasciatus, Culex pipiens, Culex tarsalis, Fannia canicularis, Sarcophaga carnaria, Stomoxys calcitrans, Tipula paludosa, Lucilia cuprina, Lucilia sericata, Simulium reptans, Phlebotomus papatasi, Phlebotomus

longipalpis, Odagmia ornata, Wilhelmia equina, Boophthora erythrocephala, Tabanus bromius, Tabanus spodopterus, Tabanus atratus, Tabanus sudeticus, Hybomitra ciurea, Chrysops caecutiens, Chrysops relictus, Haematopota pluvialis, Haematopota italica, Musca autumnalis, Musca domestica, Haematobia irritans irritans, Haematobia irritans exigua, Haematobia stimulans, Hydrotaea irritans, Hydrotaea albipuncta, Chrysomya chloropyga, Chrysomya bezziana, Oestrus ovis, Hypoderma bovis, Hypoderma lineatum, Przhevalskiana silenus, Dermatobia hominis, Melophagus ovinus, Lipoptena capreoli, Lipoptena cervi, Hippobosca variegata, Hippobosca equina, Gasterophilus intestinalis, Gasterophilus haemorroidalis, Gasterophilus inermis, Gasterophilus nasalis, Gasterophilus nigricornis, Gasterophilus pecorum, Braula coeca; from the order of the Siphonapterida, for example Pulex spp., Ctenocephalides spp., Tunga spp., Xenopsylla spp., Ceratophyllus spp.;

particular examples are: Ctenocephalides canis, Ctenocephalides felis, Pulex irritans, Tunga penetrans, Xenopsylla cheopis; from the order of the Heteropterida, for example Cimex spp., Triatoma spp., Rhodnius spp., Panstrongylus spp..

From the order of the Blattarida, for example Blatta orientalis, Periplaneta americana, Blattela germanica, Supella spp. (e.g. Suppella longipalpa);

From the subclass of the Acari (Acarina) and the orders of the Meta- and

Mesostigmata, for example Argas spp., Ornithodorus spp., Otobius spp., Ixodes spp., Amblyomma spp., Rhipicephalus (Boophilus) spp., Dermacentor spp., Haemophysalis spp., Hyalomma spp., Dermanyssus spp., Rhipicephalus spp. (the original genus of multi host ticks), Ornithonyssus spp., Pneumonyssus spp., Raillietia spp., Pneumonyssus spp.,

Sternostoma spp., Varroa spp., Acarapis spp.; particular examples are: Argas persicus, Argas reflexus, Ornithodorus moubata, Otobius megnini, Rhipicephalus (Boophilus) microplus, Rhipicephalus (Boophilus) decoloratus, Rhipicephalus (Boophilus) annulatus, Rhipicephalus (Boophilus) calceratus, Hyalomma anatolicum, Hyalomma aegypticum, Hyalomma marginatum, Hyalomma transiens, Rhipicephalus evertsi, Ixodes ricinus, Ixodes hexagonus, Ixodes canisuga, Ixodes pilosus, Ixodes rubicundus, Ixodes scapularis, Ixodes holocyclus, Haemaphysalis concinna, Haemaphysalis punctata, Haemaphysalis cinnabarina, Haemaphysalis otophila, Haemaphysalis leachi, Haemaphysalis longicorni, Dermacentor marginatus, Dermacentor reticulatus, Dermacentor pictus, Dermacentor albipictus,

Dermacentor andersoni, Dermacentor variabilis, Hyalomma mauritanicum, Rhipicephalus sanguineus, Rhipicephalus bursa, Rhipicephalus appendiculatus, Rhipicephalus capensis, Rhipicephalus turanicus, Rhipicephalus zambeziensis, Amblyomma americanum,

Amblyomma variegatum, Amblyomma maculatum, Amblyomma hebraeum, Amblyomma cajennense, Dermanyssus gallinae, Ornithonyssus bursa, Ornithonyssus sylviarum, Varroa jacobsoni; from the order of the Actinedida (Prostigmata) and Acaridida (Astigmata) , for example Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergates spp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp.,

Laminosioptes spp.; particular examples are: Cheyletiella yasguri, Cheyletiella blakei, Demodex canis, Demodex bovis, Demodex ovis, Demodex caprae, Demodex equi, Demodex caballi, Demodex suis, Neotrombicula autumnalis, Neotrombicula desaleri, Neoschongastia xerothermobia, Trombicula akamushi, Otodectes cynotis, Notoedres cati, Sarcoptis canis,

Sarcoptes bovis, Sarcoptes ovis, Sarcoptes rupicaprae (S. caprae), Sarcoptes equi, Sarcoptes suis, Psoroptes ovis, Psoroptes cuniculi, Psoroptes equi, Chorioptes bovis, Psoergates ovis, Pneumonyssoidic mange, Pneumonyssoides caninum, Acarapis woodi.

The active compounds according to the invention are also suitable for controlling arthropods, helminths and protozoae, which attack animals.

Animals include agricultural livestock such as, for example, cattle, sheep, goats, horses, pigs, donkeys, camels, buffaloes, rabbits, chickens, turkeys, ducks, geese, cultured fish, honeybees.

Moreover, animals include domestic animals - also referred to as companion animals - such as, for example, dogs, cats, cage birds, aquarium fish and what are known as experimental animals such as, for example, hamsters, guinea pigs, rats and mice.

By controlling these arthropods, helminths and/or protozoae, it is intended to reduce deaths and improve performance (in the case of meat, milk, wool, hides, eggs, honey and the like) and health of the host animal, so that more economical and simpler animal keeping is made possible by the use of the active compounds according to the invention.

For example, it may be desirable to prevent or interrupt the uptake of blood by the parasites from the hosts.

Also, controlling the parasites may help to prevent the transmittance of infectious agents.

The term "controlling" as used herein with regard to the veterinary field, means that the active compounds are effective in reducing the incidence of the respective parasite in an animal infected with such parasites to innocuous levels.

More specifically, "controlling", as used herein, means that the active compound is effective in killing the respective parasite, inhibiting its growth, or inhibiting its proliferation. Generally, when used for the treatment of animals the active compounds according to the invention can be applied directly.

Preferably they are applied as pharmaceutical compositions which may contain pharmaceutically acceptable excipients and/or auxiliaries which are known in the art.

In the veterinary field and in animal keeping, the active compounds are applied (e.g. administered) in the known manner by enteral administration in the form of, for example, tablets, capsules, drinks, drenches, granules, pastes, boluses, the feed-through method, suppositories; by parenteral administration, such as, for example, by injections

(intramuscular, subcutaneous, intravenous, intraperitoneal and the like), implants, by nasal application, by dermal application in the form of, for example, bathing or dipping, spraying, pouring-on and spotting-on, washing, dusting, and with the aid of active-compound- comprising shaped articles such as collars, ear tags, tail tags, limb bands, halters, marking devices and the like.

The active compounds may be formulated as shampoo or as suitable formulations usable in aerosols, unpressurized sprays, for example pump sprays and atomizer sprays.

When used for livestock, poultry, domestic animals and the like, the active compounds according to the invention can be applied as formulations (for example powders, wettable powders ["WP"], emulsions, emulsifiable concentrates ["EC"], flowables, homogeneous solutions, and suspension concentrates ["SC"]) which comprise the active compounds in an amount of from 1 to 80 percent by weight, either directly or after dilution (e.g. 100- to 10 000-fold dilution), or else as a chemical bath. When used in the veterinary field the active compounds according to the invention may be used in combination with suitable synergists or other active compounds, such as for example, acaricides, insecticides, anthelmintics, anti-protozoal drugs.

In the present invention, a substance having an insecticidal action against pests including all of these is referred to as an insecticide.

An active compound of the present invention can be prepared in conventional formulation forms, when used as an insecticide.

Examples of the formulation forms include solutions, emulsions, wettable powders, water dispersible granules, suspensions, powders, foams, pastes, tablets, granules, aerosols, active compound-infiltrated natural and synthetic materials, microcapsules, seed coating agents, formulations used with a combustion apparatus (for example, fumigation and smoking cartridges, cans, coils or the like as the combustion apparatus), ULV (cold mist, warm mist), and the like.

These formulations can be produced by methods that are known per se.

For example, a formulation can be produced by mixing the active compound with a developer, that is, a liquid diluent or carrier; a liquefied gas diluent or carrier; a solid diluent or carrier, and optionally with a surfactant, that is, an emulsifier and/or dispersant and/or foaming agent.

In the case where water is used as the developer, for example, an organic solvent can also be used as an auxiliary solvent.

Examples of the liquid diluent or carrier include aromatic hydrocarbons (for example, xylene, toluene, alkylnaphthalene and the like), chlorinated aromatic or chlorinated aliphatic hydrocarbons (for example, chlorobenzenes, ethylene chlorides, methylene chlorides), aliphatic hydrocarbons (for example, cyclohexanes), paraffins (for example, mineral oil fractions), alcohols (for example, butanol, glycols and their ethers, esters and the like), ketones (for example, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone and the like), strongly polar solvents (for example, dimethylformamide, dimethylsulfoxide and the like), water and the like. The liquefied gas diluent or carrier may be those which are gaseous at normal temperature and normal pressure, for example, aerosol propellants such as butane, propane, nitrogen gas, carbon dioxide and halogenated hydrocarbons. Examples of the solid diluent include pulverized natural minerals (for example, kaolin, clay, talc, chalk, quartz, attapulgite, montmorillonite, diatomaceous earth, and the like), pulverized synthetic minerals (for example, highly dispersed silicic acid, alumina, silicates and the like), and the like. Examples of the solid carrier for granules include pulverized and screened rocks (for example, calcite, marble, pumice, sepiolite, dolomite and the like), synthetic granules of inorganic and organic powder, fine particles of organic materials (for example, sawdust, coconut shells, maize cobs, tobacco stalk and the like), and the like. Examples of the emulsifier and/or foaming agent include nonionic and anionic emulsifiers [for example, polyoxyethylene fatty acid esters, polyoxyethylene fatty acid alcohol ethers (for example, alkylaryl polyglycol ether), alkylsulfonates, alkylsulfates, arylsulfonates and the like], albumin hydro lyzate, and the like. Examples of the dispersant include lignin sulfite waste liquor and methylcellulose.

Fixing agents can also be used in the formulations (powders, granules, emulsions), and examples of the fixing agent include carboxymethylcellulose, natural and synthetic polymers (for example, gum arabic, polyvinyl alcohol, polyvinyl acetate, and the like) and the like. Colorants can also be used, and examples of the colorants include inorganic pigments (for example, iron oxide, titanium oxide, Prussian Blue and the like), organic dyes such as alizarin dyes, azo dyes or metal phthalocyanine dyes, and in addition, trace elements such as the salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc. The formulations in general can contain the active ingredient in an amount ranging from 0.1 to 95 percent by weight, and preferably 0.5 to 90 percent> by weight. The compound according to the present invention can also exist as an admixture with other active compounds, for example, insecticides, poisonous baits, bactericides, miticides, nematicides, fungicides, growth regulators, herbicides and the like, in the form of their commercially useful formulation forms and in the application forms prepared from those formulations.

The content of the compound according to the present invention in a commercially useful application form can be varied within a wide range.

The concentration of the active compound according to the present invention in actual usage can be, for example, in the range of 0.0000001 to 100 percent by weight, and preferably 0.00001 to 1 percent by weight.

The compounds according to the present invention can be used through

conventional methods that are appropriate for the usage form.

The active compound of the present invention have, when used against hygiene pests and pests associated with stored products, stability effective against alkali on lime materials, and also shows excellent residual effectiveness on wood and soil. The compounds of the invention may have favourable properties with respect to amount appled, residue formulation, selectivity, toxicity, production methodology, high activity, wide spectrum of control, safety, control of resistant organisms, e.g. pests that are resistant to organic phosphorus agents and/or carbamate agents.

Further embodiments of the invention are described below.

The compounds of formula (I) can be used to combat and control infestations of insect pests such as Lepidoptera, Diptera, Hemiptera, Thysanoptera, Orthoptera, Dictyoptera, Coleoptera, Siphonaptera, Hymenoptera and Isoptera and also other invertebrate pests, for example, acarine, nematode and mollusc pests. Insects, acarines, nematodes and molluscs are hereinafter collectively referred to as pests. The pests which may be combated and controlled by the use of the invention compounds include those pests associated with agriculture (which term includes the growing of crops for food and fiber products), horticulture and animal husbandry, companion animals, forestry and the storage of products of vegetable origin (such as fruit, grain and timber); those pests associated with the damage of man-made structures and the transmission of diseases of man and animals; and also nuisance pests (such as flies).

The compounds of the invention may be used for example on turf, ornamentals, such as flowers, shrubs, broad-leaved trees or evergreens, for example conifers, as well as for tree injection, pest management and the like.

The compounds of the invention may be used to control animal housing pests including: Ants, Bedbugs (adult), Bees, Beetles, Boxelder Bugs, Carpenter Bees, Carpet Beetles, Centipedes, Cigarette, Beetles, Clover Mites, Cockroaches, Confused Flour Beetle, Crickets, Earwigs, Firebrats, Fleas, Flies, Lesser Grain Borers, Millipedes, Mosquitoes, Red Flour Beetles, Rice Weevils, Saw-toothed Grain Beetles, Silverfish, Sowbugs, Spiders, Termites, Ticks, Wasps, Cockroaches, Crickets, Flies, Litter Beetles (such as Darkling, Hide, and Carrion), Mosquitoes, Pillbugs, Scorpions, Spiders, Spider Mites (Twospotted, Spruce), Ticks.

The compounds of the invention may be used to control ornamental pests including: Ants (Including Imported fire ants), Armyworms, Azalea caterpillars, Aphids, Bagworms, Black vine weevils (adult), Boxelder bugs, Budworms, California oakworms, Cankerworms, Cockroaches, Crickets, Cutworms, Eastern tent caterpillars, Elm leaf beetles, European sawflies, Fall webworms, Flea beetles, Forest tent caterpillars, Gypsy moth larvae, Japanese beetles (adults), June beetles (adults), Lace bugs, Leaf-feeding caterpillars, Leafhoppers, Leafminers (adults), Leaf rollers, Leaf skeletonizers, Midges, Mosquitoes, Oleander moth larvae, Pillbugs, Pine sawflies, Pine shoot beetles, Pinetip moths, Plant bugs, Root weevils, Sawflies, Scale insects (crawlers), Spiders, Spittlebugs, Striped beetles, Striped oakworms, Thrips, Tip moths, Tussock moth larvae, Wasps, Broadmites, Brown softscales, California redscales (crawlers), Clover mites, Mealybugs, Pineneedlescales (crawlers), Spider mites, Whiteflies

The compounds of the invention may be used to control turf pests including: Ants

(Including Imported fire ants, Armyworms, Centipedes, Crickets, Cutworms, Earwigs, Fleas (adult), Grasshoppers, Japanese beetles (adult), Millipedes, Mites, Mosquitoes (adult), Pillbugs, Sod webworms, Sow bugs, Ticks (including species which transmit Lyme disease), Bluegrass billbugs (adult), Black turfgrass ataenius (adult), Chiggers, Fleas (adult), Grubs (suppression), Hyperodes weevils (adult), Mole crickets (nymphs and young adults), Mole Crickets (mature adults), Chinch Bugs

decemlineata (Colorado potato beetle), Anthonomus grandis (boll weevil), Aonidiella spp. (scale insects), Trialeurodes spp. (white flies), Bemisia tabaci (white fly), Ostrinia nubilalis (European corn borer), Spodoptera littoralis (cotton leafworm), Heliothis virescens (tobacco budworm), Helicoverpa armigera (cotton bollworm), Helicoverpa zea (cotton bollworm), Sylepta derogata (cotton leaf roller), Pieris brassicae (white butterfly), Plutella xylostella (diamond back moth), Agrotis spp. (cutworms), Chilo suppressalis (rice stem borer), Locusta_ migratoria (locust), Chortiocetes terminifera (locust), Diabrotica spp. (rootworms),

Brevipalpus spp. (flat mites), Boophilus microplus (cattle tick), Dermacentor variabilis (American dog tick), Ctenocephalides felis (cat flea), Liriomyza spp. (leafminer), Musca domestica (housefly), Aedes aegypti (mosquito), Anopheles spp. (mosquitoes), Culex spp. (mosquitoes), Lucillia spp. (blowflies), Blattella germanica (cockroach), Periplaneta americana (cockroach), Blatta orientalis (cockroach), termites of the Mastotermitidae (for example Mastotermes spp.), the Kalotermitidae (for example Neotermes spp.), the R inotermitidae (for example Coptotermes formosanus, Reticulitermes flavipes, R. speratu, R. virginicus, R. hesperus, and R. santonensis) and the Termitidae (for example Globitermes sulfureus), Solenopsis geminata (fire ant), Monomorium pharaonis (pharaoh's ant),

The compounds of the invention may be used for pest control on various plants, including soybean (e.g. in some cases 10-70g/ha), corn (e.g. in some cases 10-70g/ha), sugarcane (e.g. in some cases 20-200g/ha), alfalfa (e.g. in some cases 10-70g/ha), brassicas (e.g. in some cases 10-50g/ha), oilseed rape (e.g. canola) (e.g. in some cases 20-70g/ha), potatoes (including sweet potatoes) (e.g. in some cases 10-70g/ha), cotton (e.g. in some cases 10-70g/ha), rice (e.g. in some cases 10-70g/ha), coffee (e.g. in some cases 30-150g/ha), citrus (e.g. in some cases 60-200g/ha), almonds (e.g. in some cases 40-180g/ha), fruiting vegetables (e.g. tomatoes, pepper, chili, eggplant, cucumber, squash etc.) (e.g. in some cases 10-80g/ha), tea (e.g. in some cases 20-150g/ha), bulb vegetables (e.g. onion, leek etc.) (e.g. in some cases 30-90g/ha), grapes (e.g. in some cases 30-180g/ha), pome fruit (e.g. apples, pears etc.) (e.g. in some cases 30-180g/ha), and stone fruit (e.g. pears, plums etc.) (e.g. in some cases 30-180g/ha).

The compounds of the invention may be used on soybean to control, for example, Elasmopalpus lignosellus, Diloboderus abderus, Diabrotica speciosa, Sternechus subsignatus, Formicidae, Agrotis ypsilon, Julus ssp., Anticarsia gemmatalis, Megascelis ssp., Procornitermes ssp., Gryllotalpidae, Nezara viridula, Piezodorus spp., Aero sternum spp., Neomegalotomus spp., Cerotoma trifurcata, Popillia japonica, Edessa spp., Liogenys fuscus, Euchistus heros, stalk borer, Scaptocoris castanea, phyllophaga spp., Pseudoplusia includens, Spodoptera spp., Bemisia tabaci, Agriotes spp. The compounds of the invention are preferably used on soybean to control Diloboderus abderus, Diabrotica speciosa, Nezara viridula, Piezodorus spp., Aero sternum spp., Cerotoma trifurcata, Popillia japonica, Euchistus heros, Phyllophaga spp., Agriotes spp..

The compounds of the invention may be used on corn to control, for example, Euchistus heros, Dichelops furcatus, Diloboderus abderus, Elasmopalpus lignosellus, Spodoptera frugiperda, Nezara viridula, Cerotoma trifurcata, Popillia japonica, Agrotis ypsilon, Diabrotica speciosa, Heteroptera, Procornitermes ssp., Scaptocoris castanea, Formicidae, Julus ssp., Dalbulus maidis, Diabrotica virgifera, Mods latipes, Bemisia tabaci, heliothis spp., Tetranychus spp., Thrips spp., phyllophaga spp., scaptocoris spp., Liogenys fuscus, Spodoptera spp., Ostrinia spp., Sesamia spp., Agriotes spp.. The compounds of the invention are preferably used on corn to control Euchistus heros, Dichelops furcatus, Diloboderus abderus, Nezara viridula, Cerotoma trifurcata, Popillia japonica, Diabrotica speciosa, Diabrotica virgifera, Tetranychus spp., Thrips spp., Phyllophaga spp., Scaptocoris spp., Agriotes spp..

The compounds of the invention may be used on sugar cane to control, for example,

Sphenophorus spp., termites, Mahanarva spp.. The compounds of the invention are preferably used on sugar cane to control termites, Mahanarva spp..

The compounds of the invention may be used on alfalfa to control, for example, Hypera brunneipennis, Hypera postica, Colias eurytheme, Collops spp., Empoasca solana, Epitrix, Geocoris spp., Lygus hesperus, Lygus lineolaris, Spissistilus spp, Spodoptera spp., Trichoplusia ni. The compounds of the invention are preferably used on alfalfa to control Hypera brunneipennis, Hypera postica, Empoasca solana, Epitrix, Lygus hesperus, Lygus lineolaris, Trichoplusia ni.

The compounds of the invention may be used on brassicas to control, for example, Plutella xylostella, Pieris spp., Mamestra spp., Plusia spp., Trichoplusia ni, Phyllotreta spp., Spodoptera spp., Empoasca solana, Thrips spp., Spodoptera spp., Delia spp.. The

compounds of the invention are preferably used on brassicas to control Plutella xylostella Pieris spp., Plusia spp., Trichoplusia ni, Phyllotreta spp., Thrips spp..

The compounds of the invention may be used on oil seed rape, e.g. canola, to control, for example, Meligethes spp., Ceutorhynchus napi, Psylloides spp.

The compounds of the invention may be used on potatoes, including sweet potatoes, to control, for example, Empoasca spp., Leptinotarsa spp., Diabrotica speciosa,

Phthorimaea spp., Paratrioza spp., Maladera matrida, Agriotes spp. The compounds of the invention are preferably used on potatoes, including sweet potatoes, to control Empoasca spp., Leptinotarsa spp., Diabrotica speciosa, Phthorimaea spp., Paratrioza spp., Agriotes spp.

The compounds of the invention may be used on cotton to control, for example, Anthonomus grandis, Pectinophora spp., Heliothis spp., Spodoptera spp., Tetranychus spp., Empoasca spp., Thrips spp., Bemisia tabaci, Lygus spp., Phyllophaga spp., Scaptocoris spp. The compounds of the invention are preferably used on cotton to control Anthonomus grandis, Tetranychus spp., Empoasca spp., Thrips spp., Lygus spp., phyllophaga spp., Scaptocoris spp.

The compounds of the invention may be used on rice to control, for example, Leptocorisa spp., Cnaphalocrosis spp., Chilo spp., Scirpophaga spp., Lissorhoptrus spp., Oebalus pugnax. The compounds of the invention are preferably used on rice to control Leptocorisa spp., Lissorhoptrus spp., Oebalus pugnax.

The compounds of the invention may be used on coffee to control, for example, Hypothenemus Hampei, Perileucoptera Coffeella, Tetranychus spp. The compounds of the invention are preferably used on coffee to control Hypothenemus Hampei, Perileucoptera coffeella.

The compounds of the invention may be used on citrus to control, for example, Panonychus citri, Phyllocoptruta oleivora, Brevipalpus spp., Diaphorina citri, Scirtothrips spp., Thrips spp., Unaspis spp., Ceratitis capitata, Phyllocnistis spp. The compounds of the invention are preferably used on citrus to control Panonychus citri, Phyllocoptruta oleivora, Brevipalpus spp., Diaphorina citri, Scirtothrips spp., Thrips spp., Phyllocnistis spp..

The compounds of the invention may be used on almonds to control, for example, Amyelois transitella, Tetranychus spp..

The compounds of the invention may be used on fruiting vegetable, including tomatoes, pepper, chili, eggplant, cucumber, squash etc, to control Thrips spp., Tetranychus spp., Polyphagotarsonemus spp., Aculops spp., Empoasca spp., Spodoptera spp., Heliothis spp., Tuta absoluta, Liriomyza spp., Bemisia tabaci, Trialeurodes spp., Paratrioza spp., Frankliniella occidentalis, Frankliniella spp., Anthonomus spp., Phyllotreta spp., Amrasca spp., Epilachna spp., Halyomorpha spp., Scirtothrips spp., Leucinodes spp., Neoleucinodes spp.. The compounds of the invention are preferably used on fruiting vegetable, including tomatoes, pepper, chili, eggplant, cucumber, squash etc, to control, for example, Thrips spp., Tetranychus spp., Polyphagotarsonemus spp., Aculops spp., Empoasca spp., Spodoptera spp., Heliothis spp., Tuta absoluta, Liriomyza spp., Paratrioza spp., Frankliniella occidentalis, Frankliniella spp., Amrasca spp., Scirtothrips spp., Leucinodes spp.,

Neoleucinodes spp.. The compounds of the invention may be used on tea to control, for example, Pseudaulacaspis spp., Empoasca spp., Scirtothrips spp., Caloptilia theivora. The compounds of the invention are prefrerably used on tea to control Empoasca spp., Scirtothrips spp.

The compounds of the invention may be used on bulb vegetables, including onion, leek etc to control, for example, Thrips spp., Spodoptera spp., Heliothis spp.. The compounds of the invention are preferably used on bulb vegetables, including onion, leek etc to control Thrips spp..

The compounds of the invention may be used on grapes to control, for example, Empoasca spp., Lobesia spp., Frankliniella spp., Thrips spp., Tetranychus spp.,

Rhipiphorothrips Cruentatus, Eotetranychus Willamettei, Erythroneura Elegantula,

Scaphoides spp.. The compounds of the invention are preferably used on grapes to control Frankliniella spp., Thrips spp., Tetranychus spp., Rhipiphorothrips Cruentatus, Scaphoides spp..

The compounds of the invention may be used on pome fruit, including apples, pairs etc, to control, for example, Cacopsylla spp., Psylla spp., Panonychus ulmi, Cydia pomonella. The compounds of the invention are preferably used on pome fruit, including apples, pairs etc, to control Cacopsylla spp., Psylla spp., Panonychus ulmi.

The compounds of the invention may be used on stone fruit to control, for example, Grapholita molesta, Scirtothrips spp., Thrips spp., Frankliniella spp., Tetranychus spp. The compounds of the invention are preferably used on stone fruit to control Scirtothrips spp., Thrips spp., Frankliniella spp., Tetranychus spp..The invention therefore provides a method of combating and/or controlling an animal pest, e.g. an invertebrate animal pest, which comprises applying to the pest, to a locus of the pest, or to a plant susceptible to attack by the pest a pesticidally effective amount of a compound of formula (I). In particular, the invention provides a method of combating and/or controlling insects, acarines, nematodes or molluscs which comprises applying an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I), or a composition containing a compound of formula (I), to a pest, a locus of pest, preferably a plant, or to a plant susceptible to attack by a pest, The compounds of formula (I) are preferably used against insects, acarines or nematodes.

The term "plant" as used herein includes seedlings, bushes and trees. Crops are to be understood as also including those crops which have been rendered tolerant to herbicides or classes of herbicides (e.g. ALS-, GS-, EPSPS-, PPO- and HPPD -inhibitors) by conventional methods of breeding or by genetic engineering. An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding is

Clearfield® summer rape (canola). Examples of crops that have been rendered tolerant to herbicides by genetic engineering methods include e.g. glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® and

LibertyLink®.

Crops are also to be understood as being those which have been rendered resistant to harmful insects by genetic engineering methods, for example Bt maize (resistant to European corn borer), Bt cotton (resistant to cotton boll weevil) and also Bt potatoes (resistant to Colorado beetle). Examples of Bt maize are the Bt 176 maize hybrids of NK® (Syngenta Seeds). Examples of transgenic plants comprising one or more genes that code for an insecticidal resistance and express one or more toxins are KnockOut® (maize), Yield Gard® (maize), NuCOTIN33B® (cotton), Bollgard® (cotton), NewLeaf® (potatoes), NatureGard® and Protexcta®. Plant crops or seed material thereof can be both resistant to herbicides and, at the same time, resistant to insect feeding ("stacked" transgenic events). For example, seed can have the ability to express an insecticidal Cry3 protein while at the same time being tolerant to glyphosate.

Crops are also to be understood as being those which are obtained by conventional methods of breeding or genetic engineering and contain so-called output traits (e.g. improved storage stability, higher nutritional value and improved flavor).

In order to apply a compound of formula (I) as an insecticide, acaricide, nematicide or molluscicide to a pest, a locus of pest, or to a plant susceptible to attack by a pest, a compound of formula (I) is usually formulated into a composition which includes, in addition to the compound of formula (I), a suitable inert diluent or carrier and, optionally, a surface active agent (SFA). SFAs are chemicals which are able to modify the properties of an interface (for example, liquid/solid, liquid/air or liquid/liquid interfaces) by lowering the interfacial tension and thereby leading to changes in other properties (for example dispersion, emulsification and wetting). It is preferred that all compositions (both solid and liquid formulations) comprise, by weight, 0.0001 to 95%, more preferably 1 to 85%, for example 5 to 60%, of a compound of formula (I). The composition is generally used for the control of pests such that a compound of formula (I) is applied at a rate of from 0. lg to 10kg per hectare, preferably from lg to 6kg per hectare, more preferably from lg to 1kg per hectare. When used in a seed dressing, a compound of formula (I) is generally used at a rate of 0.000 lg to lOg (for example 0.00 lg or 0.05g), preferably 0.005g to lOg, more preferably 0.005g to 4g, per kilogram of seed.

In another aspect the present invention provides a composition comprising a pesticidally effective amount of a compound of formula (I), in particular an insecticidal, acaricidal, nematicidal or molluscicidal composition comprising an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I) and a suitable carrier or diluent therefor. The composition is preferably an insecticidal, acaricidal, nematicidal or molluscicidal composition.

The compositions can be chosen from a number of formulation types, including dustable powders (DP), soluble powders (SP), water soluble granules (SG), water dispersible granules (WG), wettable powders (WP), granules (GR) (slow or fast release), soluble concentrates (SL), oil miscible liquids (OL), ultra low volume liquids (UL), emulsifiable concentrates (EC), dispersible concentrates (DC), emulsions (both oil in water (EW) and water in oil (EO)), micro-emulsions (ME), suspension concentrates (SC), aerosols, fogging/smoke formulations, capsule suspensions (CS) and seed treatment formulations. The formulation type chosen in any instance will depend upon the particular purpose envisaged and the physical, chemical and biological properties of the compound of formula (I).

Dustable powders (DP) may be prepared by mixing a compound of formula (I) with one or more solid diluents (for example natural clays, kaolin, pyrophyllite, bentonite, alumina, montmorillonite, kieselguhr, chalk, diatomaceous earths, calcium phosphates, calcium and magnesium carbonates, sulfur, lime, flours, talc and other organic and inorganic solid carriers) and mechanically grinding the mixture to a fine powder.

Soluble powders (SP) may be prepared by mixing a compound of formula (I) with one or more water-soluble inorganic salts (such as sodium bicarbonate, sodium carbonate or magnesium sulfate) or one or more water-soluble organic solids (such as a polysaccharide) and, optionally, one or more wetting agents, one or more dispersing agents or a mixture of said agents to improve water dispersibility/solubility. The mixture is then ground to a fine powder. Similar compositions may also be granulated to form water soluble granules (SG).

Wettable powders (WP) may be prepared by mixing a compound of formula (I) with one or more solid diluents or carriers, one or more wetting agents and, preferably, one or more dispersing agents and, optionally, one or more suspending agents to facilitate the dispersion in liquids. The mixture is then ground to a fine powder. Similar compositions may also be granulated to form water dispersible granules (WG).

Granules (GR) may be formed either by granulating a mixture of a compound of formula (I) and one or more powdered solid diluents or carriers, or from pre-formed blank granules by absorbing a compound of formula (I) (or a solution thereof, in a suitable agent) in a porous granular material (such as pumice, attapulgite clays, fuller's earth, kieselguhr, diatomaceous earths or ground corn cobs) or by adsorbing a compound of formula (I) (or a solution thereof, in a suitable agent) on to a hard core material (such as sands, silicates, mineral carbonates, sulfates or phosphates) and drying if necessary. Agents which are commonly used to aid absorption or adsorption include solvents (such as aliphatic and aromatic petroleum solvents, alcohols, ethers, ketones and esters) and sticking agents (such as polyvinyl acetates, polyvinyl alcohols, dextrins, sugars and vegetable oils). One or more other additives may also be included in granules (for example an emulsifying agent, wetting agent or dispersing agent).

Dispersible Concentrates (DC) may be prepared by dissolving a compound of formula (I) in water or an organic solvent, such as a ketone, alcohol or glycol ether. These solutions may contain a surface active agent (for example to improve water dilution or prevent crystallization in a spray tank).

Emulsifiable concentrates (EC) or oil-in- water emulsions (EW) may be prepared by dissolving a compound of formula (I) in an organic solvent (optionally containing one or more wetting agents, one or more emulsifying agents or a mixture of said agents). Suitable organic solvents for use in ECs include aromatic hydrocarbons (such as alkylbenzenes or alkylnaphthalenes, exemplified by SOLVESSO 100, SOLVESSO 150 and SOLVESSO 200; SOLVESSO is a Registered Trade Mark), ketones (such as cyclohexanone or

methylcyclohexanone) and alcohols (such as benzyl alcohol, furfuryl alcohol or butanol), N- alkylpyrrolidones (such as N-methylpyrrolidone or N-octylpyrrolidone), dimethyl amides of fatty acids (such as Cs-Cio fatty acid dimethylamide) and chlorinated hydrocarbons. An EC product may spontaneously emulsify on addition to water, to produce an emulsion with sufficient stability to allow spray application through appropriate equipment. Preparation of an EW involves obtaining a compound of formula (I) either as a liquid (if it is not a liquid at room temperature, it may be melted at a reasonable temperature, typically below 70°C) or in solution (by dissolving it in an appropriate solvent) and then emulsifiying the resultant liquid or solution into water containing one or more SFAs, under high shear, to produce an emulsion. Suitable solvents for use in EWs include vegetable oils, chlorinated hydrocarbons (such as chlorobenzenes), aromatic solvents (such as alkylbenzenes or alkylnaphthalenes) and other appropriate organic solvents which have a low solubility in water.

Microemulsions (ME) may be prepared by mixing water with a blend of one or more solvents with one or more SFAs, to produce spontaneously a thermodynamically stable isotropic liquid formulation. A compound of formula (I) is present initially in either the water or the solvent/SFA blend. Suitable solvents for use in MEs include those hereinbefore described for use in ECs or in EWs. An ME may be either an oil-in-water or a water-in-oil system (which system is present may be determined by conductivity measurements) and may be suitable for mixing water-soluble and oil-soluble pesticides in the same formulation. An ME is suitable for dilution into water, either remaining as a microemulsion or forming a conventional oil-in-water emulsion.

Suspension concentrates (SC) may comprise aqueous or non-aqueous suspensions of finely divided insoluble solid particles of a compound of formula (I). SCs may be prepared by ball or bead milling the solid compound of formula (I) in a suitable medium, optionally with one or more dispersing agents, to produce a fine particle suspension of the compound. One or more wetting agents may be included in the composition and a suspending agent may be included to reduce the rate at which the particles settle.

Alternatively, a compound of formula (I) may be dry milled and added to water, containing agents hereinbefore described, to produce the desired end product.

Aerosol formulations comprise a compound of formula (I) and a suitable propellant (for example /? -butane). A compound of formula (I) may also be dissolved or dispersed in a suitable medium (for example water or a water miscible liquid, such as n-propanol) to provide compositions for use in non-pressurized, hand-actuated spray pumps.

A compound of formula (I) may be mixed in the dry state with a pyrotechnic mixture to form a composition suitable for generating, in an enclosed space, a smoke containing the compound.

Capsule suspensions (CS) may be prepared in a manner similar to the preparation of EW formulations but with an additional polymerization stage such that an aqueous dispersion of oil droplets is obtained, in which each oil droplet is encapsulated by a polymeric shell and contains a compound of formula (I) and, optionally, a carrier or diluent therefor. The polymeric shell may be produced by either an interfacial polycondensation reaction or by a coacervation procedure. The compositions may provide for controlled release of the compound of formula (I) and they may be used for seed treatment. A compound of formula (I) may also be formulated in a biodegradable polymeric matrix to provide a slow, controlled release of the compound.

A composition may include one or more additives to improve the biological performance of the composition (for example by improving wetting, retention or distribution on surfaces; resistance to rain on treated surfaces; or uptake or mobility of a compound of formula (I)). Such additives include surface active agents, spray additives based on oils, for example certain mineral oils or natural plant oils (such as soy bean and rape seed oil), and blends of these with other bio-enhancing adjuvants (ingredients which may aid or modify the action of a compound of formula (I)).

A compound of formula (I) may also be formulated for use as a seed treatment, for example as a powder composition, including a powder for dry seed treatment (DS), a water soluble powder (SS) or a water dispersible powder for slurry treatment (WS), or as a liquid composition, including a flowable concentrate (FS), a solution (LS) or a capsule suspension (CS). The preparations of DS, SS, WS, FS and LS compositions are very similar to those of, respectively, DP, SP, WP, SC and DC compositions described above. Compositions for treating seed may include an agent for assisting the adhesion of the composition to the seed (for example a mineral oil or a film- forming barrier).

Wetting agents, dispersing agents and emulsifying agents may be surface SFAs of the cationic, anionic, amphoteric or non-ionic type.

Suitable SFAs of the cationic type include quaternary ammonium compounds (for example cetyltrimethyl ammonium bromide), imidazolines and amine salts.

Suitable anionic SFAs include alkali metals salts of fatty acids, salts of aliphatic monoesters of sulfuric acid (for example sodium lauryl sulfate), salts of sulfonated aromatic compounds (for example sodium dodecylbenzenesulfonate, calcium

dodecylbenzenesulfonate, butylnaphthalene sulfonate and mixtures of sodium di- z^'sopropyl- and tri-z^'sopropyl-naphthalene sulfonates), ether sulfates, alcohol ether sulfates (for example sodium laureth-3-sulfate), ether carboxylates (for example sodium laureth-3- carboxylate), phosphate esters (products from the reaction between one or more fatty alcohols and phosphoric acid (predominately mono-esters) or phosphorus pentoxide

(predominately di-esters), for example the reaction between lauryl alcohol and

tetraphosphoric acid; additionally these products may be ethoxylated), sulfosuccinamates, paraffin or olefine sulfonates, taurates and lignosulfonates. Suitable SFAs of the amphoteric type include betaines, propionates and glycinates. Suitable SFAs of the non-ionic type include condensation products of alkylene oxides, such as ethylene oxide, propylene oxide, butylene oxide or mixtures thereof, with fatty alcohols (such as oleyl alcohol or cetyl alcohol) or with alkylphenols (such as octylphenol, nonylphenol or octylcresol); partial esters derived from long chain fatty acids or hexitol anhydrides; condensation products of said partial esters with ethylene oxide; block polymers (comprising ethylene oxide and propylene oxide); alkanolamides; simple esters (for example fatty acid polyethylene glycol esters); amine oxides (for example lauryl dimethyl amine oxide); and lecithins.

Suitable suspending agents include hydrophilic colloids (such as polysaccharides, polyvinylpyrrolidone or sodium carboxymethylcellulose) and swelling clays (such as bentonite or attapulgite).

A compound of formula (I) may be applied by any of the known means of applying pesticidal compounds. For example, it may be applied, formulated or unformulated, to the pests or to a locus of the pests (such as a habitat of the pests, or a growing plant liable to infestation by the pests) or to any part of the plant, including the foliage, stems, branches or roots, to the seed before it is planted or to other media in which plants are growing or are to be planted (such as soil surrounding the roots, the soil generally, paddy water or hydroponic culture systems), directly or it may be sprayed on, dusted on, applied by dipping, applied as a cream or paste formulation, applied as a vapor or applied through distribution or

incorporation of a composition (such as a granular composition or a composition packed in a water-soluble bag) in soil or an aqueous environment.

A compound of formula (I) may also be injected into plants or sprayed onto vegetation using electrodynamic spraying techniques or other low volume methods, or applied by land or aerial irrigation systems.

Compositions for use as aqueous preparations (aqueous solutions or dispersions) are generally supplied in the form of a concentrate containing a high proportion of the active ingredient, the concentrate being added to water before use. These concentrates, which may include DCs, SCs, ECs, EWs, MEs, SGs, SPs, WPs, WGs and CSs, are often required to withstand storage for prolonged periods and, after such storage, to be capable of addition to water to form aqueous preparations which remain homogeneous for a sufficient time to enable them to be applied by conventional spray equipment. Such aqueous preparations may contain varying amounts of a compound of formula (I) (for example 0.0001 to 10%, by weight) depending upon the purpose for which they are to be used.

A compound of formula (I) may be used in mixtures with fertilizers (for example nitrogen-, potassium- or phosphorus-containing fertilizers). Suitable formulation types include granules of fertilizer. The mixtures preferably contain up to 25% by weight of the compound of formula (I).

The invention therefore also provides a fertilizer composition comprising a fertilizer and a compound of formula (I).

The compositions of this invention may contain other compounds having biological activity, for example micronutrients or compounds having fungicidal activity or which possess plant growth regulating, herbicidal, insecticidal, nematicidal or acaricidal activity.

The compound of formula (I) may be the sole active ingredient of the composition or it may be admixed with one or more additional active ingredients such as a pesticide, e.g. a insecticide, fungicide or herbicide, or a synergist or plant growth regulator where appropriate. An additional active ingredient may provide a composition having a broader spectrum of activity or increased persistence at a locus; synergize the activity or complement the activity (for example by increasing the speed of effect or overcoming repellency) of the compound of formula (I); or help to overcome or prevent the development of resistance to individual components. The particular additional active ingredient will depend upon the intended utility of the composition.

The compounds of the invention are also useful in the field of animal health, e.g. they may be used against parasitic invertebrate pests, more preferably against parasitic invertebrate pests in or on an animal. Examples of pests include nematodes, trematodes, cestodes, flies, mites, tricks, lice, fleas, true bugs and maggots. The animal may be a non- human animal, e.g. an animal associated with agriculture, e.g. a cow, a pig, a sheep, a goat, a horse, or a donkey, or a companion animal, e.g. a dog or a cat.

In a further aspect the invention provides a compound of the invention for use in a method of therapeutic treatment.

In a further aspect the invention relates to a method of controlling parasitic invertebrate pests in or on an animal comprising administering a pesticidally effective amount of a compound of the invention. The administration may be for example oral administration, parenteral administration or external administration, e.g. to the surface of the animal body. In a further aspect the invention relates to a compound of the invention for controlling parasitic invertebrate pests in or on an animal. In a further aspect the invention relates to use of a compound of the invention in the manufacture of a medicament for controlling parasitic invertebrate pests in or on an animal

In a further aspect, the invention relates to a method of controlling parasitic invertebrate pests comprising administering a pesticidally effective amount of a compound of the invention to the environment in which an animal resides.

In a further aspect the invention relates to a method of protecting an animal from a parasitic invertebrate pest comprising administering to the animal a pesticidally effective amount of a compound of the invention. In a further aspect the invention relates to a compound of the invention for use in protecting an animal from a parasitic invertebrate pest. In a further aspect the invention relates to use of a compound of the invention in the manufacture of a medicament for protecting an animal from a parasitic invertebrate pest.

In a further aspect the invention provides a method of treating an animal suffering from a parasitic invertebrate pest comprising administering to the animal a pesticidally effective amount of a compound of the invention. In a further aspect the invention relates to a compound of the invention for use in treating an animal suffering from a parasitic invertebrate pest. In a further aspect the invention relates to use of a compound of the invention in the manufacture of a medicament for treating an animal suffering from a parasitic invertebrate pest.

In a further aspect, the invention provides a pharmaceutical composition comprising a compound of the invention and a pharmaceutically suitable excipient.

The compounds of the invention may be used alone or in combination with one or more other biologically active ingredients.

In one aspect the invention provides a combination product comprising a pesticidally effective amount of a component A and a pesticidally effective amount of component B wherein component A is a compound of the invention and component B is a compound as described below.

The compounds of the invention may be used in combination with anthelmintic agents. Such anthelmintic agents include, compounds selected from the macrocyclic lactone class of compounds such as ivermectin, avermectin, abamectin, emamectin, eprinomectin, doramectin, selamectin, moxidectin, nemadectin and milbemycin derivatives as described in EP- 357460, EP -444964 and EP-594291. Additional anthelmintic agents include semisynthetic and biosynthetic avermectin/milbemycin derivatives such as those described in US-5015630, WO-9415944 and WO-9522552. Additional anthelmintic agents include the benzimidazoles such as albendazole, cambendazole, fenbendazole, flubendazole,

mebendazole, oxfendazole, oxibendazole, parbendazole, and other members of the class. Additional anthelmintic agents include imidazothiazoles and tetrahydropyrimidines such as tetramisole, levamisole, pyrantel pamoate, oxantel or morantel. Additional anthelmintic agents include flukicides, such as triclabendazole and clorsulon and the cestocides, such as praziquantel and epsiprantel.

The compounds of the invention may be used in combination with derivatives and analogues of the paraherquamide/marcfortine class of anthelmintic agents, as well as the antiparasitic oxazolines such as those disclosed in US-5478855, US- 4639771 and DE- 19520936.

The compounds of the invention may be used in combination with derivatives and analogues of the general class of dioxomorpholine antiparasitic agents as described in WO- 9615121 and also with anthelmintic active cyclic depsipeptides such as those described in WO-9611945, WO-9319053, WO- 9325543, EP-626375, EP-382173, WO-9419334, EP- 382173, and EP-503538.

The compounds of the invention may be used in combination with other

ectoparasiticides; for example, fipronil; pyrethroids; organophosphates; insect growth regulators such as lufenuron; ecdysone agonists such as tebufenozide and the like;

neonicotinoids such as imidacloprid and the like.

The compounds of the invention may be used in combination with terpene alkaloids, for example those described in International Patent Application Publication Numbers W095/19363 or WO04/72086, particularly the compounds disclosed therein.

Other examples of such biologically active compounds that the compounds of the invention may be used in combination with include but are not restricted to the following:

Organophosphates: acephate, azamethiphos, azinphos-ethyl, azinphos- methyl, bromophos, bromophos-ethyl, cadusafos, chlorethoxyphos, chlorpyrifos, chlorfenvinphos, chlormephos, demeton, demeton-S-methyl, demeton-S-methyl sulphone, dialifos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fensulfothion, fenthion, flupyrazofos, fonofos, formothion, fosthiazate, heptenophos, isazophos, isothioate, isoxathion, malathion, methacriphos, methamidophos, methidathion, methyl- parathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, paraoxon, parathion, parathion-methyl, phenthoate, phosalone, phosfolan, phosphocarb, phosmet, phosphamidon, phorate, phoxim, pirimiphos, pirimiphos- methyl, profenofos, propaphos, proetamphos, prothiofos, pyraclofos,

pyridapenthion, quinalphos, sulprophos, temephos, terbufos, tebupirimfos, tetrachlorvinphos, thimeton, triazophos, trichlorfon, vamidothion.

Carbamates: alanycarb, aldicarb, 2-sec-butylphenyl methylcarbamate, benfuracarb, carbaryl, carbofuran, carbosulfan, cloethocarb, ethiofencarb, fenoxycarb, fenthiocarb, furathiocarb, HCN-801, isoprocarb, indoxacarb, methiocarb, methomyl, 5-methyl-m- cumenylbutyryl(methyl)carbamate, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, UC-51717.

Pyrethroids: acrinathin, allethrin, alphametrin, 5-benzyl-3-furylmethyl (E) -

(1 R)-cis-2,2-dimethyl-3-(2-oxothiolan-3-ylidenemethyl)cyclopropanecarboxylate, bifenthrin, beta -cyfluthrin, cyfluthrin, a-cypermethrin, beta -cypermethrin, bioallethrin, bioallethrin((S)-cyclopentylisomer), bioresmethrin, bifenthrin, NCI-85193, cycloprothrin, cyhalothrin, cythithrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, ethofenprox, fenfluthrin, fenpropathrin, fenvalerate, flucythrinate, flumethrin, fluvalinate (D isomer), imiprothrin, cyhalothrin, lambda-cyhalothrin, permethrin, phenothrin, prallethrin, pyrethrins (natural products), resmethrin, tetramethrin, transfluthrin, theta-cypermethrin, silafluofen, t- fluvalinate, tefluthrin, tralomethrin, Zeta-cypermethrin.

Arthropod growth regulators: a) chitin synthesis inhibitors: benzoylureas:

chlorfluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron, buprofezin, diofenolan, hexythiazox, etoxazole, chlorfentazine; b) ecdysone antagonists: halofenozide, methoxyfenozide, tebufenozide; c) juvenoids: pyriproxyfen, methoprene (including S-methoprene),

fenoxycarb; d) lipid biosynthesis inhibitors: spirodiclofen.

Other antiparasitics: acequinocyl, amitraz, AKD-1022, ANS-118, azadirachtin,

Bacillus thuringiensis, bensultap, bifenazate, binapacryl, bromopropylate, BTG-504, BTG- 505, camphechlor, cartap, chlorobenzilate, chlordimeform, chlorfenapyr, chromafenozide, clothianidine, cyromazine, diacloden, diafenthiuron, DBI-3204, dinactin,

dihydroxymethyldihydroxypyrrolidine, dinobuton, dinocap, endosulfan, ethiprole, ethofenprox, fenazaquin, flumite, MTI- 800, fenpyroximate, fluacrypyrim, flubenzimine, flubrocythrinate, flufenzine, flufenprox, fluproxyfen, halofenprox, hydramethylnon, IKI-220, kanemite, NC-196, neem guard, nidinorterfuran, nitenpyram, SD-35651, WL- 108477, pirydaryl, propargite, protrifenbute, pymethrozine, pyridaben, pyrimidifen, NC-1111, R- 195,RH-0345, RH-2485, RYI-210, S-1283, S-1833, SI-8601, silafluofen, silomadine, spinosad, tebufenpyrad, tetradifon, tetranactin, thiacloprid, thiocyclam, thiamethoxam, tolfenpyrad, triazamate, triethoxyspinosyn, trinactin, verbutin, vertalec, YI-5301.

Fungicides: acibenzolar, aldimorph, ampropylfos, andoprim, azaconazole, azoxystrobin, benalaxyl, benomyl, bialaphos, blasticidin-S, Bordeaux mixture,

bromuconazole, bupirimate, carpropamid, captafol, captan, carbendazim, chlorfenazole, chloroneb, chloropicrin, chlorothalonil, chlozolinate, copper oxychloride, copper salts, cyflufenamid, cymoxanil, cyproconazole, cyprodinil, cyprofuram, RH-7281, diclocymet, diclobutrazole, diclomezine, dicloran, difenoconazole, RP-407213, dimethomorph, domoxystrobin, diniconazole, diniconazole-M, dodine, edifenphos, epoxiconazole, famoxadone, fenamidone, fenarimol, fenbuconazole, fencaramid, fenpiclonil, fenpropidin, fenpropimorph, fentin acetate, fiuazinam, fludioxonil, flumetover, flumorf/fiumorlin, fentin hydroxide, fluoxastrobin, fiuquinconazole, flusilazole, flutolanil, flutriafol, folpet, fosetyl- aluminium, furalaxyl, furametapyr, hexaconazole, ipconazole, iprobenfos, iprodione, isoprothiolane, kasugamycin, krsoxim-methyl, mancozeb, maneb, mefenoxam, mepronil, metalaxyl, metconazole, metominostrobin/fenominostrobin, metrafenone, myclobutanil, neo- asozin, nicobifen, orysastrobin, oxadixyl, penconazole, pencycuron, probenazole, prochloraz, propamocarb, propioconazole, proquinazid, prothioconazole, pyrifenox, pyraclostrobin, pyrimethanil, pyroquilon, quinoxyfen, spiroxamine, sulfur, tebuconazole, tetrconazole, thiabendazole, thifluzamide, thiophanate-methyl, thiram, tiadinil, triadimefon, triadimenol, tricyclazole, trifloxystrobin, triticonazole, validamycin, vinclozin.

Biological agents: Bacillus thuringiensis ssp aizawai, kurstaki, Bacillus

thuringiensis delta endotoxin, baculovirus, entomopathogenic bacteria, virus and fungi.

Bactericides: chlortetracycline, oxytetracycline, streptomycin.

Other biological agents: enrofloxacin, febantel, penethamate, moloxicam, cefalexin, kanamycin, pimobendan, clenbuterol, omeprazole, tiamulin, benazepril, pyriprole, cefquinome, florfenicol, buserelin, cefovecin, tulathromycin, ceftiour, carprofen,

metaflumizone, praziquarantel, triclabendazole.

When used in combination with other active ingredients, the compounds of the invention are preferably used in combination with the following (where "Tx" means a compound of formula (I), and in particular a compound selected from Tables 1 to Table 120, which may result in a synergistic combination with the given active ingredient): imidacloprid + Tx, enrofloxacin + Tx, praziquantel + Tx, pyrantel embonate + Tx, febantel + Tx, penethamate + Tx, moloxicam + Tx, cefalexin + Tx, kanamycin + Tx, pimobendan + Tx, clenbuterol + Tx, fipronil + Tx, ivermectin + Tx, omeprazole + Tx, tiamulin + Tx, benazepril + Tx, milbemycin + Tx, cyromazine + Tx, thiamethoxam + Tx, pyriprole + Tx, deltamethrin + Tx, cefquinome + Tx, florfenicol + Tx, buserelin + Tx, cefovecin + Tx, tulathromycin + Tx, ceftiour + Tx, selamectin + Tx, carprofen + Tx, metaflumizone + Tx, moxidectin + Tx, methoprene (including S-methoprene) + Tx, clorsulon + Tx, pyrantel + Tx, amitraz + Tx, triclabendazole + Tx, avermectin + Tx, abamectin + Tx, emamectin + Tx, eprinomectin + Tx, doramectin + Tx, selamectin + Tx, nemadectin + Tx, albendazole + Tx, cambendazole + Tx, fenbendazole + Tx, flubendazole + Tx, mebendazole + Tx, oxfendazole + Tx, oxibendazole + Tx, parbendazole + Tx, tetramisole + Tx, levamisole + Tx, pyrantel pamoate + Tx, oxantel + Tx, morantel + Tx, triclabendazole + Tx, epsiprantel + Tx, fipronil + Tx, lufenuron + Tx, ecdysone + Tx or tebufenozide + Tx; more preferably, enrofloxacin + Tx, praziquantel + Tx, pyrantel embonate + Tx, febantel + Tx, penethamate + Tx, moloxicam + Tx, cefalexin + Tx, kanamycin + Tx, pimobendan + Tx, clenbuterol + Tx, omeprazole + Tx, tiamulin + Tx, benazepril + Tx, pyriprole + Tx, cefquinome + Tx, florfenicol + Tx, buserelin + Tx, cefovecin + Tx, tulathromycin + Tx, ceftiour + Tx, selamectin + Tx, carprofen + Tx, moxidectin + Tx, clorsulon + Tx, pyrantel + Tx, eprinomectin + Tx, doramectin + Tx, selamectin + Tx, nemadectin + Tx, albendazole + Tx, cambendazole + Tx, fenbendazole + Tx, flubendazole + Tx, mebendazole + Tx, oxfendazole + Tx, oxibendazole + Tx, parbendazole + Tx, tetramisole + Tx, levamisole + Tx, pyrantel pamoate + Tx, oxantel + Tx, morantel + Tx, triclabendazole + Tx, epsiprantel + Tx, lufenuron + Tx or ecdysone + Tx; even more preferably enrofloxacin + Tx, praziquantel + Tx, pyrantel embonate + Tx, febantel + Tx, penethamate + Tx, moloxicam + Tx, cefalexin + Tx, kanamycin + Tx, pimobendan + Tx, clenbuterol + Tx, omeprazole + Tx, tiamulin + Tx, benazepril + Tx, pyriprole + Tx, cefquinome + Tx, florfenicol + Tx, buserelin + Tx, cefovecin + Tx, tulathromycin + Tx, ceftiour + Tx, selamectin + Tx, carprofen + Tx, moxidectin + Tx, clorsulon + Tx or pyrantel + Tx.

Examples of ratios include 100: 1 to 1 :6000, 50:1 to 1 :50, 20: 1 to 1 :20, even more especially from 10: 1 to 1 : 10, 5: 1 to 1 :5, 2: 1 to 1 :2, 4: 1 to 2: 1, 1 : 1, or 5: 1, or 5:2, or 5:3, or 5:4, or 4: 1, or 4:2, or 4:3, or 3: 1, or 3:2, or 2: 1, or 1 :5, or 2:5, or 3:5, or 4:5, or 1 :4, or 2:4, or 3:4, or 1 :3, or 2:3, or 1 :2, or 1 :600, or 1 :300, or 1 : 150, or 1 :35, or 2:35, or 4:35, or 1 :75, or 2:75, or 4:75, or 1 :6000, or 1 :3000, or 1 : 1500, or 1 :350, or 2:350, or 4:350, or 1 :750, or 2:750, or 4:750. Those mixing ratios are understood to include, on the one hand, ratios by weight and also, on other hand, molar ratios.

Of particular note is a combination where the additional active ingredient has a different site of action from the compound of formula I. In certain instances, a combination with at least one other parasitic invertebrate pest control active ingredient having a similar spectrum of control but a different site of action will be particularly advantageous for resistance management. Thus, a combination product of the invention may comprise a pesticidally effective amount of a compound of formula I and pesticidally effective amount of at least one additional parasitic invertebrate pest control active ingredient having a similar spectrum of control but a different site of action.

One skilled in the art recognizes that because in the environment and under physiological conditions salts of chemical compounds are in equilibrium with their corresponding non salt forms, salts share the biological utility of the non salt forms.

Thus a wide variety of salts of compounds of the invention (and active ingredients used in combination with the active ingredients of the invention) may be useful for control of invertebrate pests and animal parasites. Salts include acid-addition salts with inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids. The compounds of the invention also include N-oxides. Accordingly, the invention comprises combinations of compounds of the invention including N-oxides and salts thereof and an additional active ingredient including N-oxides and salts thereof.

The compositions for use in animal health may also contain formulation auxiliaries and additives, known to those skilled in the art as formulation aids (some of which may be considered to also function as solid diluents, liquid diluents or surfactants). Such formulation auxiliaries and additives may control: pH (buffers), foaming during processing (antifoams such polyorganosiloxanes), sedimentation of active ingredients (suspending agents), viscosity (thixotropic thickeners), in-container microbial growth (antimicrobials), product freezing (antifreezes), color (dyes/pigment dispersions), wash-off (film formers or stickers), evaporation (evaporation retardants), and other formulation attributes. Film formers include, for example, polyvinyl acetates, polyvinyl acetate copolymers, polyvinylpyrrolidone-vinyl acetate copolymer, polyvinyl alcohols, polyvinyl alcohol copolymers and waxes. Examples of formulation auxiliaries and additives include those listed in McCutcheon 's Volume 2: Functional Materials, annual International and North American editions published by McCutcheon's Division, The Manufacturing Confectioner Publishing Co.; and PCT

Publication WO 03/024222.

The compounds of the invention can be applied without other adjuvants, but most often application will be of a formulation comprising one or more active ingredients with suitable carriers, diluents, and surfactants and possibly in combination with a food depending on the contemplated end use. One method of application involves spraying a water dispersion or refined oil solution of the combination products. Compositions with spray oils, spray oil concentrations, spreader stickers, adjuvants, other solvents, and synergists such as piperonyl butoxide often enhance compound efficacy. Such sprays can be applied from spray containers such as a can, a bottle or other container, either by means of a pump or by releasing it from a pressurized container, e.g., a pressurized aerosol spray can. Such spray compositions can take various forms, for example, sprays, mists, foams, fumes or fog. Such spray compositions thus can further comprise propellants, foaming agents, etc. as the case may be. Of note is a spray composition comprising a pesticidally effective amount of a compound of the invention and a carrier. One embodiment of such a spray composition comprises a pesticidally effective amount of a compound of the invention and a propellant. Representative propellants include, but are not limited to, methane, ethane, propane, butane, isobutane, butene, pentane, isopentane, neopentane, pentene, hydrofluorocarbons, chlorofluorocarbons, dimethyl ether, and mixtures of the foregoing. Of note is a spray composition (and a method utilizing such a spray composition dispensed from a spray container) used to control at least one parasitic invertebrate pest selected from the group consisting of mosquitoes, black flies, stable flies, deer flies, horse flies, wasps, yellow jackets, hornets, ticks, spiders, ants, gnats, and the like, including individually or in combinations.

The controlling of animal parasites includes controlling external parasites that are parasitic to the surface of the body of the host animal (e.g., shoulders, armpits, abdomen, inner part of the thighs) and internal parasites that are parasitic to the inside of the body of the host animal (e.g., stomach, intestine, lung, veins, under the skin, lymphatic tissue).

External parasitic or disease transmitting pests include, for example, chiggers, ticks, lice, mosquitoes, flies, mites and fleas. Internal parasites include heartworms, hookworms and helminths. The compounds of the invention may be particularly suitable for combating external parasitic pests. The compounds of the invention may be suitable for systemic and/or non-systemic control of infestation or infection by parasites on animals. The compounds of the invention may be suitable for combating parasitic

invertebrate pests that infest animal subjects including those in the wild, livestock and agricultural working animals. Livestock is the term used to refer (singularly or plurally) to a domesticated animal intentionally reared in an agricultural setting to make produce such as food or fiber, or for its labor; examples of livestock include cattle, sheep, goats, horses, pigs, donkeys, camels, buffalo, rabbits, hens, turkeys, ducks and geese (e.g., raised for meat, milk, butter, eggs, fur, leather, feathers and/or wool). By combating parasites, fatalities and performance reduction (in terms of meat, milk, wool, skins, eggs, etc.) are reduced, so that applying the compounds of the invention allows more economic and simple husbandry of animals.

The compounds of the invention may be suitable for combating parasitic

invertebrate pests that infest companion animals and pets (e.g., dogs, cats, pet birds and aquarium fish), research and experimental animals (e.g., hamsters, guinea pigs, rats and mice), as well as animals raised for/in zoos, wild habitats and/or circuses.

In an embodiment of this invention, the animal is preferably a vertebrate, and more preferably a mammal, avian or fish. In a particular embodiment, the animal subject is a mammal (including great apes, such as humans). Other mammalian subjects include primates (e.g., monkeys), bovine (e.g., cattle or dairy cows), porcine (e.g., hogs or pigs), ovine (e.g., goats or sheep), equine (e.g., horses), canine (e.g., dogs), feline (e.g., house cats), camels, deer, donkeys, buffalos, antelopes, rabbits, and rodents (e.g., guinea pigs, squirrels, rats, mice, gerbils, and hamsters). Avians include Anatidae (swans, ducks and geese), Columbidae (e.g., doves and pigeons), Phasianidae (e.g., partridges, grouse and turkeys), Thesienidae (e.g., domestic chickens), Psittacines (e.g., parakeets, macaws, and parrots), game birds, and ratites (e.g., ostriches).

Birds treated or protected by the compounds of the invention can be associated with either commercial or noncommercial aviculture. These include Anatidae, such as swans, geese, and ducks, Columbidae, such as doves and domestic pigeons, Phasianidae, such as partridge, grouse and turkeys, Thesienidae, such as domestic chickens, and Psittacines, such as parakeets, macaws and parrots raised for the pet or collector market, among others.

For purposes of the present invention, the term "fish" is understood to include without limitation, the Teleosti grouping of fish, i.e., teleosts. Both the Salmoniformes order (which includes the Salmonidae family) and the Perciformes order (which includes the Centrarchidae family) are contained within the Teleosti grouping. Examples of potential fish recipients include the Salmonidae, Serranidae, Sparidae, Cichlidae, and Centrarchidae, among others.

Other animals are also contemplated to benefit from the inventive methods, including marsupials (such as kangaroos), reptiles (such as farmed turtles), and other economically important domestic animals for which the inventive methods are safe and effective in treating or preventing parasite infection or infestation.

Examples of parasitic invertebrate pests controlled by administering a pesticidally effective amount of the compounds of the invention to an animal to be protected include ectoparasites (arthropods, acarines, etc.) and endoparasites (helminths, e.g., nematodes, trematodes, cestodes, acanthocephalans, etc.).

The disease or group of diseases described generally as helminthiasis is due to infection of an animal host with parasitic worms known as helminths. The term 'helminths' is meant to include nematodes, trematodes, cestodes and acanthocephalans. Helminthiasis is a prevalent and serious economic problem with domesticated animals such as swine, sheep, horses, cattle, goats, dogs, cats and poultry.

Among the helminths, the group of worms described as nematodes causes widespread and at times serious infection in various species of animals.

Nematodes that are contemplated to be treated by the compounds of the invention include, without limitation, the following genera: Acanthocheilonema, Aelurostrongylus, Ancylo stoma, Angiostrongylus, Ascaridia, Ascaris, Brugia, Bunostomum, Capillaria, Chabertia, Cooperia, Crenosoma, Dictyocaulus, Dioctophyme, Dipetalonema,

Diphyllobothrium, Dirofilaria, Dracunculus, Enterobius, Filaroides, Haemonchus,

Heterakis, Lagochilascaris, Loa, Mansonella, Muellerius, Necator, Nematodirus,

Oesophagostomum, Ostertagia, Oxyuris, Parafilaria, Parascaris, Physaloptera,

Protostrongylus, Setaria, Spirocerca, Stephanofilaria, Strongyloides, Strongylus, Thelazia, Toxascaris, Toxocara, Trichinella, Trichonema, Trichostrongylus, Trichuris, Uncinaria and Wuchereria.

Of the above, the most common genera of nematodes infecting the animals referred to above are Haemonchus, Trichostrongylus, Ostertagia, Nematodirus, Cooperia, Ascaris, Bunostomum, Oesophagostomum, Chabertia, Trichuris, Strongylus, Trichonema,

Dictyocaulus, Capillaria, Heterakis, Toxocara, Ascaridia, Oxyuris, Ancylostoma, Uncinaria, Toxascaris and Parascaris. Certain of these, such as Nematodirus, Cooperia and

Oesophagostomum attack primarily the intestinal tract while others, such as Haemonchus and Ostertagia, are more prevalent in the stomach while others such as Dictyocaulus are found in the lungs. Still other parasites may be located in other tissues such as the heart and blood vessels, subcutaneous and lymphatic tissue and the like.

Trematodes that are contemplated to be treated by the invention and by the inventive methods include, without limitation, the following genera: Alaria, Fasciola, Nanophyetus, Opisthorchis, Paragonimus and Schistosoma.

Cestodes that are contemplated to be treated by the invention and by the inventive methods include, without limitation, the following genera: Diphyllobothrium, Diplydium, Spirometra and Taenia.

The most common genera of parasites of the gastrointestinal tract of humans are

Ancylostoma, Necator, Ascaris, Strongy hides, Trichinella, Capillaria, Trichuris and Enterobius. Other medically important genera of parasites which are found in the blood or other tissues and organs outside the gastrointestinal tract are the filarial worms such as Wuchereria, Brugia, Onchocerca and Loa, as well as Dracunculus and extra intestinal stages of the intestinal worms Strongyloides and Trichinella.

Numerous other helminth genera and species are known to the art, and are also contemplated to be treated by the compounds of the invention. These are enumerated in great detail in Textbook of Veterinary Clinical Parasitology, Volume 1, Helminths, E. J. L.

Soulsby, F. A. Davis Co., Philadelphia, Pa.; Helminths, Arthropods and Protozoa, (6^thEdition of Monnig's Veterinary Helminthology and Entomology), E. J. L. Soulsby, Williams and Wilkins Co., Baltimore, Md.

The compounds of the invention may be effective against a number of animal ectoparasites (e.g., arthropod ectoparasites of mammals and birds).

Insect and acarine pests include, e.g., biting insects such as flies and mosquitoes, mites, ticks, lice, fleas, true bugs, parasitic maggots, and the like.

Adult flies include, e.g., the horn fly or Haematobia irritans, the horse fly or Tabanus spp., the stable fly or Stomoxys calcitrans, the black fly or Simulium spp., the deer fly or Chrysops spp., the louse fly or Melophagus ovinus, and the tsetse fly or Glossina spp. Parasitic fly maggots include, e.g., the bot fly {Oestrus ovis and Cuterebra spp.), the blow fly or Phaenicia spp., the screwworm or Cochliomyia hominivorax, the cattle grub or

Hypoderma spp., the fleeceworm and the Gastrophilus of horses. Mosquitoes include, for example, Culex spp., Anopheles spp. and Aedes spp.. Mites include Mesostigmalphatalpha spp., e.g. mesostigmatids such as the chicken mite, Dermalphanyssus galphallinalphae; itch or scab mites such as Sarcoptidae spp. for example, Salpharcoptes scalphabiei; mange mites such as Psoroptidae spp. including Chorioptes bovis and Psoroptes ovis; chiggers, e.g. Trombiculidae spp. for example the North American chigger, Trombicula alfreddugesi.

Ticks include, e.g., soft-bodied ticks including Argasidae spp. for example

Argalphas spp. and Ornithodoros spp.; hard-bodied ticks including Ixodidae spp., for example Rhipicephalphalus sanguineus, Dermacentor variabilis, Dermacentor andersoni, Amblyomma americanum, Ixodes scapularis and other Rhipicephalus spp. (including the former Boophilus genera).

Lice include, e.g., sucking lice, e.g., Menopon spp.

and Bovicola spp.; biting lice, e.g., Haematopinus spp., Linognathus spp. and Solenopotes spp.

Fleas include, e.g., Ctenocephalides spp., such as dog flea (Ctenocephalides canis) and cat flea {Ctenocephalides felis); Xenopsylla spp. such as oriental rat flea (Xenopsylla cheopis); and Pulex spp. such as human flea (Pulex irritans).

True bugs include, e.g., Cimicidae or e.g., the common bed bug (Cimex lectularius);

Triatominae spp. including triatomid bugs also known as kissing bugs; for example

Rhodnius prolixus and Triatoma spp..

Generally, flies, fleas, lice, mosquitoes, gnats, mites, ticks and helminths cause tremendous losses to the livestock and companion animal sectors. Arthropod parasites also are a nuisance to humans and can vector disease-causing organisms in humans and animals.

Numerous other parasitic invertebrate pests are known to the art, and are also contemplated to be treated by the compounds of the invention. These are enumerated in great detail in Medical and Veterinary Entomology, D. S. Kettle, John Wiley AND Sons, New

York and Toronto; Control of Arthropod Pests of Livestock: A Review of Technology, R. O.

Drummand, J. E. George, and S. E. Kunz, CRC Press, Boca Raton, Fla.

The present invention also provides a method for controlling pests (such as mosquitoes and other disease vectors; see also http://www.who.int/malaria/vector_control/irs/en/). In one embodiment, the method for controlling pests comprises applying the compositions of the invention to the target pests, to their locus or to a surface or substrate by brushing, rolling, spraying, spreading or dipping. By way of example, an IRS (indoor residual spraying) application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention. In another embodiment, it is contemplated to apply such compositions to a substrate such as non- woven or a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents. In one embodiment, the method for controlling such pests comprises applying a pesticidally effective amount of the compositions of the invention to the target pests, to their locus, or to a surface or substrate so as to provide effective residual pesticidal activity on the surface or substrate. Such application may be made by brushing, rolling, spraying, spreading or dipping the pesticidal composition of the invention. By way of example, an IRS application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention so as to provide effective residual pesticidal activity on the surface. In another embodiment, it is contemplated to apply such compositions for residual control of pests on a substrate such as a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents.

Substrates including non- woven, fabrics or netting to be treated may be made of natural fibres such as cotton, raffia, jute, flax, sisal, hessian, or wool, or synthetic fibres such as polyamide, polyester, polypropylene, polyacrylonitrile or the like. The polyesters are particularly suitable. The methods of textile treatment are know, e.g. from Handbuch

Textilveredlung: Band 1 : Ausrustung, Band 2: Farbgebung, Band 3: Beschichtung, Band 4: Umwelttechnik; Verlag: Deutscher Fachverlag; Auflage: 15., uberarbeitete Ausgabe (17. April 2006); ISBN-10: 3866410123; ISBN-13: 978-3866410121, see especially Band 1 : Ausrustung pages 27-198, more preferably on page 118; or WO2008151984 or

WO2003034823 or US5631072 or WO200564072 or WO2006128870 or EP1724392 or WO2005064072 or WO2005113886 or WO2007090739.

The compounds of the invention may also be effective against ectoparasites including: flies such as Haematobia (Lyperosia) irritans (horn fly), Simulium spp. (blackfly), Glossina spp. (tsetse flies), Hydrotaea irritans (head fly), Musca autumnalis (face fly), Musca domestica (house fly), Morellia simplex (sweat fly), Tabanus spp. (horse fly), Hypoderma bovis, Hypoderma lineatum, Lucilia sericata, Lucilia cuprina (green blowfly), Calliphora spp. (blowfly), Protophormia spp., Oestrus ovis (nasal botfly), Culicoides spp. (midges), Hippobosca equine, Gastrophilus intestinalis, Gastrophilus haemorrhoidalis and Gastrophilus nasalis; lice such as Bovicola (Damalinia) bovis, Bovicola equi, Haematopinus asini, Felicola subrostratus, Heterodoxus spiniger, Lignonathus setosus and Trichodectes canis; keds such as Melophagus ovinus; and mites such as Psoroptes spp., Sarcoptes scabei, Chorioptes bovis, Demodex equi, Cheyletiella spp., Notoedres cati, Trombicula spp. and Otodectes cyanotis (ear mites).

Treatments of the invention are by conventional means such as by enteral administration in the form of, for example, tablets, capsules, drinks, drenching preparations, granulates, pastes, boli, feed-through procedures, or suppositories; or by parenteral administration, such as, for example, by injection (including intramuscular, subcutaneous, intravenous, intraperitoneal) or implants; or by nasal administration.

When compounds of the invention are applied in combination with an additional biologically active ingredient, they may be administered separately e.g. as separate compositions. In this case, the biologically active ingredients may be administered simultaneously or sequentially. Alternatively, the biologically active ingredients may be components of one composition.

The compounds of the invention may be administered in a controlled release form, for example in subcutaneous or orally adminstered slow release formulations.

Typically a parasiticidal composition according to the present invention comprises a compound of the invention, optionally in combination with an additional biologically active ingredient, or N-oxides or salts thereof, with one or more pharmaceutically or veterinarily acceptable carriers comprising excipients and auxiliaries selected with regard to the intended route of administration (e.g., oral or parenteral administration such as injection) and in accordance with standard practice. In addition, a suitable carrier is selected on the basis of compatibility with the one or more active ingredients in the composition, including such considerations as stability relative to pH and moisture content. Therefore of note are compounds of the invention for protecting an animal from an invertebrate parasitic pest comprising a parasitically effective amount of a compound of the invention, optionally in combination with an additional biologically active ingredient and at least one carrier.

For parenteral administration including intravenous, intramuscular and

subcutaneous injection, the compounds of the invention can be formulated in suspension, solution or emulsion in oily or aqueous vehicles, and may contain adjuncts such as suspending, stabilizing and/or dispersing agents.

The compounds of the invention may also be formulated for bolus injection or continuous infusion. Pharmaceutical compositions for injection include aqueous solutions of water-soluble forms of active ingredients (e.g., a salt of an active compound), preferably in physiologically compatible buffers containing other excipients or auxiliaries as are known in the art of pharmaceutical formulation. Additionally, suspensions of the active compounds may be prepared in a lipophilic vehicle. Suitable lipophilic vehicles include fatty oils such as sesame oil, synthetic fatty acid esters such as ethyl oleate and triglycerides, or materials such as liposomes.

Aqueous injection suspensions may contain substances that increase the viscosity of the suspension, such as sodium carboxymethyl cellulose, sorbitol, or dextran. Formulations for injection may be presented in unit dosage form, e.g., in ampoules or in multi-dose containers. Alternatively, the active ingredient may be in powder form for constitution with a suitable vehicle, e.g., sterile, pyrogen-free water, before use.

In addition to the formulations described supra, the compounds of the invention may also be formulated as a depot preparation. Such long acting formulations may be

administered by implantation (for example, subcutaneously or intramuscularly) or by intramuscular or subcutaneous injection.

The compounds of the invention may be formulated for this route of administration with suitable polymeric or hydrophobic materials (for instance, in an emulsion with a pharmacologically acceptable oil), with ion exchange resins, or as a sparingly soluble derivative such as, without limitation, a sparingly soluble salt.

For administration by inhalation, the compounds of the invention can be delivered in the form of an aerosol spray using a pressurized pack or a nebulizer and a suitable propellant, e.g., without limitation, dichlorodifluoromethane, trichlorofluoromethane, dichlorotetrafluoroethane or carbon dioxide. In the case of a pressurized aerosol, the dosage unit may be controlled by providing a valve to deliver a metered amount.

Capsules and cartridges of, for example, gelatin for use in an inhaler or insufflator may be formulated containing a powder mix of the compound and a suitable powder base such as lactose or starch.

The compounds of the invention may have favourable pharmacokinetic and pharmacodynamic properties providing systemic availability from oral administration and ingestion. Therefore after ingestion by the animal to be protected, parasiticidally effective concentrations of a compound of the invention in the bloodstream may protect the treated animal from blood-sucking pests such as fleas, ticks and lice. Therefore of note is a composition for protecting an animal from an invertebrate parasite pest in a form for oral administration (i.e. comprising, in addition to a parasiticidally effective amount of a compound of the invention, one or more carriers selected from binders and fillers suitable for oral administration and feed concentrate carriers).

For oral administration in the form of solutions (the most readily available form for absorption), emulsions, suspensions, pastes, gels, capsules, tablets, boluses, powders, granules, rumen-retention and feed/water/lick blocks, the compounds of the invention can be formulated with binders/fillers known in the art to be suitable for oral administration compositions, such as sugars and sugar derivatives (e.g., lactose, sucrose, mannitol, sorbitol), starch (e.g., maize starch, wheat starch, rice starch, potato starch), cellulose and derivatives (e.g., methylcellulose, carboxymethylcellulose, ethylhydroxycellulose), protein derivatives (e.g., zein, gelatin), and synthetic polymers (e.g., polyvinyl alcohol, polyvinylpyrrolidone). If desired, lubricants (e.g., magnesium stearate), disintegrating agents (e.g., cross-linked polyvinylpyrrolidinone, agar, alginic acid) and dyes or pigments can be added. Pastes and gels often also contain adhesives (e.g., acacia, alginic acid, bentonite, cellulose, xanthan gum, colloidal magnesium aluminum silicate) to aid in keeping the composition in contact with the oral cavity and not being easily ejected.

In one embodiment a composition of the present invention is formulated into a chewable and/or edible product (e.g., a chewable treat or edible tablet). Such a product would ideally have a taste, texture and/or aroma favored by the animal to be protected so as to facilitate oral administration of the compounds of the invention.

If the parasiticidal compositions are in the form of feed concentrates, the carrier is typically selected from high-performance feed, feed cereals or protein concentrates.

Such feed concentrate-containing compositions can, in addition to the parasiticidal active ingredients, comprise additives promoting animal health or growth, improving quality of meat from animals for slaughter or otherwise useful to animal husbandry.

These additives can include, for example, vitamins, antibiotics, chemotherapeutics, bacteriostats, fungistats, coccidiostats and hormones.

The compound of the invention may also be formulated in rectal compositions such as suppositories or retention enemas, using, e.g., conventional suppository bases such as cocoa butter or other glycerides.

The formulations for the method of this invention may include an antioxidant, such asBHT (butylated hydroxytoluene). The antioxidant is generally present in amounts of at 0.1- 5 percent (wt/vol). Some of the formulations require a solubilizer, such as oleic acid, to dissolve the active agent, particularly if spinosad is included. Common spreading agents used in these pour-on formulations include isopropyl myristate, isopropyl palmitate,

caprylic/capric acid esters of saturated C₁₂-C₁₈ fatty alcohols, oleic acid, oleyl ester, ethyl oleate, triglycerides, silicone oils and dipropylene glycol methyl ether. The pour-on formulations for the method of this invention are prepared according to known techniques. Where the pour-on is a solution, the parasiticide/insecticide is mixed with the carrier or vehicle, using heat and stirring if required. Auxiliary or additional ingredients can be added to the mixture of active agent and carrier, or they can be mixed with the active agent prior to the addition of the carrier. Pour-on formulations in the form of emulsions or suspensions are similarly prepared using known techniques.

Other delivery systems for relatively hydrophobic pharmaceutical compounds may be employed. Liposomes and emulsions are well-known examples of delivery vehicles or carriers for hydrophobic drugs. In addition, organic solvents such as dimethylsulfoxide may be used, if needed.

The rate of application required for effective parasitic invertebrate pest control (e.g.

"pesticidally effective amount") will depend on such factors as the species of parasitic invertebrate pest to be controlled, the pest's life cycle, life stage, its size, location, time of year, host crop or animal, feeding behavior, mating behavior, ambient moisture, temperature, and the like. One skilled in the art can easily determine the pesticidally effective amount necessary for the desired level of parasitic invertebrate pest control.

In general for veterinary use, the compounds of the invention are administered in a pesticidally effective amount to an animal, particularly a homeothermic animal, to be protected from parasitic invertebrate pests.

A pesticidally effective amount is the amount of active ingredient needed to achieve an observable effect diminishing the occurrence or activity of the target parasitic invertebrate pest. One skilled in the art will appreciate that the pesticidally effective dose can vary for the various compounds and compositions useful for the method of the present invention, the desired pesticidal effect and duration, the target parasitic invertebrate pest species, the animal to be protected, the mode of application and the like, and the amount needed to achieve a particular result can be determined through simple experimentation.

For oral or parenteral administration to animals, a dose of the compositions of the present invention administered at suitable intervals typically ranges from about 0.01 mg/kg to aboutlOO mg/kg, and preferably from about 0.01 mg/kg to about 30 mg/kg of animal body weight.

Suitable intervals for the administration of the compositions of the present invention to animals range from about daily to about yearly. Of note are administration intervals ranging from about weekly to about once every 6 months. Of particular note are monthly adminstration intervals (i.e. administering the compounds to the animal once every month).

The term "plant" as used herein includes seedlings, bushes and trees.

The term "crops" is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.

Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins, from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis, such as δ-endotoxins, e.g. CrylAb, CrylAc, CrylF, CrylFa2, Cry2Ab, Cry3A, Cry3Bbl or Cry9C, or vegetative insecticidal proteins (Vip), e.g. Vipl, Vip2, Vip3 or Vip3A; or insecticidal proteins of bacteria colonising nematodes, for example Photorhabdus spp. or Xenorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus nematophilus; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins; toxins produced by fungi, such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors; ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroidoxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors, HMG- COA-reductase, ion channel blockers, such as blockers of sodium or calcium channels, juvenile hormone esterase, diuretic hormone receptors, stilbene synthase, bibenzyl synthase, chitinases and glucanases.

In the context of the present invention there are to be understood by δ-endotoxins, for example CrylAb, CrylAc, CrylF, CrylFa2, Cry2Ab, Cry3A, Cry3Bbl or Cry9C, or vegetative insecticidal proteins (Vip), for example Vipl, Vip2, Vip3 or Vip3A, expressly also hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701). Truncated toxins, for example a truncated CrylAb, are known. In the case of modified toxins, one or more amino acids of the naturally occurring toxin are replaced. In such amino acid replacements, preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G-recognition sequence is inserted into a Cry3A toxin (see WO 03/018810).

Examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0 374 753, WO 93/07278, WO 95/34656, EP-A-0 427 529, EP-A-451 878 and WO 03/052073. The processes for the preparation of such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. Cryl- type deoxyribonucleic acids and their preparation are known, for example, from WO

95/34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90/13651. The toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects. Such insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and butterflies (Lepidoptera).

Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available.

Examples of such plants are: YieldGard® (maize variety that expresses a CrylAb toxin); YieldGard Rootworm® (maize variety that expresses a Cry3Bbl toxin); YieldGard Plus® (maize variety that expresses a CrylAb and a Cry3Bbl toxin); Starlink® (maize variety that expresses a Cry9C toxin); Herculex I® (maize variety that expresses a CrylFa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a Cryl Ac toxin); Bollgard I® (cotton variety that expresses a Cryl Ac toxin); Bollgard II® (cotton variety that expresses a Cryl Ac and a Cry2Ab toxin); VipCot® (cotton variety that expresses a Vip3A and a Cryl Ab toxin); NewLeaf® (potato variety that expresses a Cry3A toxin); NatureGard ®, Agrisure® GT Advantage (GA21 glyphosate -tolerant trait), Agrisure® CB Advantage (Btl 1 corn borer (CB) trait) and Protecta®. Further examples of such transgenic crops are:

1. Btll Maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer {Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated Cryl Ab toxin. Btl 1 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.

2. Btl76 Maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer {Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a CrylAb toxin. Btl 76 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium. 3. MIR604 Maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-G-protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810.

4. MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-l 150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a Cry3Bbl toxin and has resistance to certain Coleoptera insects. 5. IPC 531 Cotton from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-l 150 Brussels, Belgium, registration number C/ES/96/02. 6. 1507 Maize from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-l 160 Brussels, Belgium, registration number C/NL/00/10. Genetically modified maize for the expression of the protein Cry IF for achieving resistance to certain Lepidoptera insects and of the PAT protein for achieving tolerance to the herbicide glufosinate ammonium.

7. NK603 x MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-l 150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810. NK603 x MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a Cryl Ab toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain Lepidoptera, include the European corn borer. Crops are also to be understood as being those which are obtained by conventional methods of breeding or genetic engineering and contain so-called output traits (e.g. improved storage stability, higher nutritional value and improved flavour).

In order to apply a compound of formula (I) as an insecticide, acaricide, nematicide or molluscicide to a pest, a locus of pest, or to a plant susceptible to attack by a pest, a compound of formula (I) is usually formulated into a composition which includes, in addition to the compound of formula (I), a suitable inert diluent or carrier and, optionally, a surface active agent (SFA). SFAs are chemicals which are able to modify the properties of an interface (for example, liquid/solid, liquid/air or liquid/liquid interfaces) by lowering the interfacial tension and thereby leading to changes in other properties (for example dispersion, emulsification and wetting). It is preferred that all compositions (both solid and liquid formulations) comprise, by weight, 0.0001 to 95%, more preferably 1 to 85%, for example 5 to 60%, of a compound of formula (I). The composition is generally used for the control of pests such that a compound of formula (I) is applied at a rate of from 0. lg to 10kg per hectare, preferably from lg to 6kg per hectare, more preferably from lg to 1kg per hectare.

When used in a seed dressing, a compound of formula (I) is used at a rate of 0.000 lg to lOg (for example 0.00 lg or 0.05g), preferably 0.005g to lOg, more preferably 0.005g to 4g, per kilogram of seed. In another aspect the present invention provides an insecticidal, acaricidal, nematicidal or molluscicidal composition comprising an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I) and a suitable carrier or diluent therefor. The composition is preferably an insecticidal, acaricidal, nematicidal or molluscicidal composition.

Dispersible Concentrates (DC) may be prepared by dissolving a compound of formula (I) in water or an organic solvent, such as a ketone, alcohol or glycol ether. These solutions may contain a surface active agent (for example to improve water dilution or prevent crystallisation in a spray tank).

Emulsifiable concentrates (EC) or oil-in-water emulsions (EW) may be prepared by dissolving a compound of formula (I) in an organic solvent (optionally containing one or more wetting agents, one or more emulsifying agents or a mixture of said agents). Suitable organic solvents for use in ECs include aromatic hydrocarbons (such as alkylbenzenes or alkylnaphthalenes, exemplified by SOLVESSO 100, SOLVESSO 150 and SOLVESSO 200; SOLVESSO is a Registered Trade Mark), ketones (such as cyclohexanone or

methylcyclohexanone) and alcohols (such as benzyl alcohol, furfuryl alcohol or butanol), N-alkylpyrrolidones (such as N-methylpyrrolidone or N-octylpyrrolidone), dimethyl amides of fatty acids (such as Cs-Cio fatty acid dimethylamide) and chlorinated hydrocarbons. An EC product may spontaneously emulsify on addition to water, to produce an emulsion with sufficient stability to allow spray application through appropriate equipment. Preparation of an EW involves obtaining a compound of formula (I) either as a liquid (if it is not a liquid at room temperature, it may be melted at a reasonable temperature, typically below 70°C) or in solution (by dissolving it in an appropriate solvent) and then emulsifiying the resultant liquid or solution into water containing one or more SFAs, under high shear, to produce an emulsion. Suitable solvents for use in EWs include vegetable oils, chlorinated hydrocarbons (such as chlorobenzenes), aromatic solvents (such as alkylbenzenes or alkylnaphthalenes) and other appropriate organic solvents which have a low solubility in water.

Suspension concentrates (SC) may comprise aqueous or non-aqueous suspensions of finely divided insoluble solid particles of a compound of formula (I). SCs may be prepared by ball or bead milling the solid compound of formula (I) in a suitable medium, optionally with one or more dispersing agents, to produce a fine particle suspension of the compound. One or more wetting agents may be included in the composition and a suspending agent may be included to reduce the rate at which the particles settle. Alternatively, a compound of formula (I) may be dry milled and added to water, containing agents hereinbefore described, to produce the desired end product.

Aerosol formulations comprise a compound of formula (I) and a suitable propellant (for example /? -butane). A compound of formula (I) may also be dissolved or dispersed in a suitable medium (for example water or a water miscible liquid, such as n-propanol) to provide compositions for use in non-pressurised, hand-actuated spray pumps.

Capsule suspensions (CS) may be prepared in a manner similar to the preparation of EW formulations but with an additional polymerisation stage such that an aqueous dispersion of oil droplets is obtained, in which each oil droplet is encapsulated by a polymeric shell and contains a compound of formula (I) and, optionally, a carrier or diluent therefor. The polymeric shell may be produced by either an interfacial polycondensation reaction or by a coacervation procedure. The compositions may provide for controlled release of the compound of formula (I) and they may be used for seed treatment. A compound of formula (I) may also be formulated in a biodegradable polymeric matrix to provide a slow, controlled release of the compound.

(predominately di-esters), for example the reaction between lauryl alcohol and

tetraphosphoric acid; additionally these products may be ethoxylated), sulfosuccinamates, paraffin or olefine sulfonates, taurates and lignosulfonates.

Suitable SFAs of the amphoteric type include betaines, propionates and glycinates. Suitable SFAs of the non-ionic type include condensation products of alkylene oxides, such as ethylene oxide, propylene oxide, butylene oxide or mixtures thereof, with fatty alcohols (such as oleyl alcohol or cetyl alcohol) or with alkylphenols (such as octylphenol, nonylphenol or octylcresol); partial esters derived from long chain fatty acids or hexitol anhydrides; condensation products of said partial esters with ethylene oxide; block polymers (comprising ethylene oxide and propylene oxide); alkanolamides; simple esters (for example fatty acid polyethylene glycol esters); amine oxides (for example lauryl dimethyl amine oxide); and lecithins.

A compound of formula (I) may be applied by any of the known means of applying pesticidal compounds. For example, it may be applied, formulated or unformulated, to the pests or to a locus of the pests (such as a habitat of the pests, or a growing plant liable to infestation by the pests) or to any part of the plant, including the foliage, stems, branches or roots, to the seed before it is planted or to other media in which plants are growing or are to be planted (such as soil surrounding the roots, the soil generally, paddy water or hydroponic culture systems), directly or it may be sprayed on, dusted on, applied by dipping, applied as a cream or paste formulation, applied as a vapour or applied through distribution or

A compound of formula (I) may be used in mixtures with fertilisers (for example nitrogen-, potassium- or phosphorus-containing fertilisers). Suitable formulation types include granules of fertiliser. The mixtures preferably contain up to 25% by weight of the compound of formula (I). The invention therefore also provides a fertiliser composition comprising a fertiliser and a compound of formula (I).

The compound of formula I (herein after abbreviated by the term "TX" thus means a compound encompassed by the compounds of formula I, or preferably the term "TX" refers to a compound selected from the Tables 1 to 12 and A) may be the sole active ingredient of the composition or it may be admixed with one or more additional active ingredients such as a pesticide (insect, acarine, mollusc and nematode pesticide), fungicide, synergist, herbicide, safener or plant growth regulator where appropriate. The activity of the compositions according to the invention may thereby be broadened considerably and may have surprising advantages which can also be described, in a wider sense, as synergistic activity. An additional active ingredient may: provide a composition having a broader spectrum of activity or increased persistence at a locus; provide a composition demonstrating better plant/crop tolerance by reducing phytotoxicity; provide a composition controlling insects in their different development stages; synergise the activity or complement the activity (for example by increasing the speed of effect or overcoming repellency) of the TX; or help to overcome or prevent the development of resistance to individual components. The particular additional active ingredient will depend upon the intended utility of the composition.

Examples of suitable pesticides include the following:

a) Pyrethroids, such as permethrin, cypermethrin, fenvalerate, esfenvalerate, deltamethrin, cyhalothrin (in particular lambda-cyhalothrin), bifenthrin, fenpropathrin, cyfluthrin, tefluthrin, fish safe pyrethroids (for example ethofenprox), natural pyrethrin, tetramethrin, s-bioallethrin, fenfluthrin, prallethrin or

5-benzyl-3-furylmethyl-(E)-(lR,3S)-2,2-dimethyl- 3-(2-oxothiolan-3-ylidenemethyl)cyclopr opane carboxylate;

b) Organophosphates, such as, profenofos, sulprofos, acephate, methyl parathion, azinphos-methyl, demeton-s-methyl, heptenophos, thiometon, fenamiphos, monocrotophos, profenofos, triazophos, methamidophos, dimethoate, phosphamidon, malathion, chlorpyrifos, phosalone, terbufos, fensulfothion, fonofos, phorate, phoxim, pirimiphos-methyl,

pirimiphos-ethyl, fenitrothion, fosthiazate or diazinon; c) Carbamates (including aryl carbamates), such as pirimicarb, triazamate, cloethocarb, carbofuran, furathiocarb, ethiofencarb, aldicarb, thiofurox, carbosulfan, bendiocarb, fenobucarb, propoxur, methomyl or oxamyl;

d) Benzoyl ureas, such as diflubenzuron, triflumuron, hexaflumuron, flufenoxuron or chlorfluazuron;

e) Organic tin compounds, such as cyhexatin, fenbutatin oxide or azocyclotin;

f) Pyrazoles, such as tebufenpyrad and fenpyroximate;

g) Macrolides, such as avermectins or milbemycins, for example abamectin, emamectin benzoate, ivermectin, milbemycin, or spinosad, spinetoram or azadirachtin;

h) Hormones or pheromones;

i) Organochlorine compounds such as endosulfan, benzene hexachloride, DDT, chlordane or dieldrin;

j) Amidines, such as chlordimeform or amitraz;

k) Fumigant agents, such as chloropicrin, dichloropropane, methyl bromide or metam;

1) Neonicotinoid compounds such as imidacloprid, thiacloprid, acetamiprid, clothianidin, nitenpyram, dinotefuran or thiamethoxam;

m) Diacylhydrazines, such as tebufenozide, chromafenozide or methoxyfenozide;

n) Diphenyl ethers, such as diofenolan or pyriproxifen;

o) Indoxacarb;

p) Chlorfenapyr;

q) Pymetrozine or pyrifluquinazon;

r) Spirotetramat, spirodiclofen or spiromesifen;

s) Flubendiamide, chloranthraliniprole, or cyanthraniliprole;

t) Cyenopyrafen or cyflumetofen; or

u) Sulfoxaflor.

In addition to the major chemical classes of pesticide listed above, other pesticides having particular targets may be employed in the composition, if appropriate for the intended utility of the composition. For instance, selective insecticides for particular crops, for example stemborer specific insecticides (such as cartap) or hopper specific insecticides (such as buprofezin) for use in rice may be employed. Alternatively insecticides or acaricides specific for particular insect species/stages may also be included in the compositions (for example acaricidal ovo-larvicides, such as clofentezine, flubenzimine, hexythiazox or tetradifon; acaricidal motilicides, such as dicofol or propargite; acaricides, such as bromopropylate or chlorobenzilate; or growth regulators, such as hydramethylnon, cyromazine, methoprene, chlorfluazuron or diflubenzuron). The following mixtures of the compounds of formula I with active ingredients are preferred, wherein, preferably, the term "TX" refers to a compound covered by the compounds of formula I or preferably the term "TX" refers to a compound selected from the Tables 1 to 48 and A and B and C:

an adjuvant selected from the group of substances consisting of petroleum oils (alternative name) (628) + TX,

an acaricide selected from the group of substances consisting of l,l-bis(4-chlorophenyl)-2- ethoxyethanol (IUPAC name) (910) + TX, 2,4-dichlorophenyl benzenesulfonate

(IUPAC/Chemical Abstracts name) (1059) + TX, 2-fluoro-N-methyl-N-l-naphthylacetamide (IUPAC name) (1295) + TX, 4-chlorophenyl phenyl sulfone (IUPAC name) (981) + TX, abamectin (1) + TX, acequinocyl (3) + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, alpha-cypermethrin (202) + TX, amidithion (870) + TX, amidoflumet [CCN] + TX, amidothioate (872) + TX, amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX, aramite (881) + TX, arsenous oxide (882) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) + TX, azinphos- ethyl (44) + TX, azinphos-methyl (45) + TX, azobenzene (IUPAC name) (888) + TX, azocyclotin (46) + TX, azothoate (889) + TX, benomyl (62) + TX, benoxafos (alternative name) [CCN] + TX, benzoximate (71) + TX, benzyl benzoate (IUPAC name) [CCN] + TX, bifenazate (74) + TX, bifenthrin (76) + TX, binapacryl (907) + TX, brofenvalerate

(alternative name) + TX, bromocyclen (918) + TX, bromophos (920) + TX, bromophos-ethyl (921) + TX, bromopropylate (94) + TX, buprofezin (99) + TX, butocarboxim (103) + TX, butoxycarboxim (104) + TX, butylpyridaben (alternative name) + TX, calcium polysulfide (IUPAC name) (111) + TX, camphechlor (941) + TX, carbanolate (943) + TX, carbaryl (115) + TX, carbofuran (118) + TX, carbophenothion (947) + TX, CGA 50'439

(development code) (125) + TX, chinomethionat (126) + TX, chlorbenside (959) + TX, chlordimeform (964) + TX, chlordimeform hydrochloride (964) + TX, chlorfenapyr (130) + TX, chlorfenethol (968) + TX, chlorfenson (970) + TX, chlorfensulphide (971) + TX, chlorfenvinphos (131) + TX, chlorobenzilate (975) + TX, chloromebuform (977) + TX, chloromethiuron (978) + TX, chloropropylate (983) + TX, chlorpyrifos (145) + TX, chlorpyrifos-methyl (146) + TX, chlorthiophos (994) + TX, cinerin I (696) + TX, cinerin II (696) + TX, cinerins (696) + TX, clofentezine (158) + TX, closantel (alternative name)

[CCN] + TX, coumaphos (174) + TX, crotamiton (alternative name) [CCN] + TX, crotoxyphos (1010) + TX, cufraneb (1013) + TX, cyanthoate (1020) + TX, cyflumetofen (CAS Reg. No.: 400882-07-7) + TX, cyhalothrin (196) + TX, cyhexatin (199) + TX, cypermethrin (201) + TX, DCPM (1032) + TX, DDT (219) + TX, demephion (1037) + TX, demephion-0 (1037) + TX, demephion-S (1037) + TX, demeton (1038) + TX, demeton- methyl (224) + TX, demeton-0 (1038) + TX, demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton-S-methyl (224) + TX, demeton- S-methylsulphon (1039) + TX, diafenthiuron (226) + TX, dialifos (1042) + TX, diazinon (227) + TX, dichlofluanid (230) + TX, dichlorvos (236) + TX, dicliphos (alternative name) + TX, dicofol (242) + TX, dicrotophos (243) + TX, dienochlor (1071) + TX, dimefox (1081) + TX, dimethoate (262) + TX, dinactin (alternative name) (653) + TX, dinex (1089) + TX, dinex-diclexine (1089) + TX, dinobuton (269) + TX, dinocap (270) + TX, dinocap-4 [CCN] + TX, dinocap-6 [CCN] + TX, dinocton (1090) + TX, dinopenton (1092) + TX, dinosulfon (1097) + TX, dinoterbon (1098) + TX, dioxathion (1102) + TX, diphenyl sulfone (IUPAC name) (1103) + TX, disulfiram (alternative name) [CCN] + TX, disulfoton (278) + TX, DNOC (282) + TX, dofenapyn (1113) + TX, doramectin (alternative name) [CCN] + TX, endosulfan (294) + TX, endothion (1121) + TX, EPN (297) + TX, eprinomectin (alternative name) [CCN] + TX, ethion (309) + TX, ethoate-methyl (1134) + TX, etoxazole (320) + TX, etrimfos (1142) + TX, fenazaflor (1147) + TX, fenazaquin (328) + TX, fenbutatin oxide (330) + TX, fenothiocarb (337) + TX, fenpropathrin (342) + TX, fenpyrad (alternative name) + TX, fen- pyroximate (345) + TX, fenson (1157) + TX, fentrifanil (1161) + TX, fenvalerate (349) + TX, fipronil (354) + TX, fluacrypyrim (360) + TX, fluazuron (1166) + TX, flubenzimine (1167) + TX, flucycloxuron (366) + TX, flucythrinate (367) + TX, fluenetil (1169) + TX, flufenoxuron (370) + TX, flumethrin (372) + TX, fluorbenside (1174) + TX, fluvalinate (1184) + TX, FMC 1137 (development code) (1185) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1192) + TX, formparanate (1193) + TX, gamma-HCH (430) + TX, glyodin (1205) + TX, halfenprox (424) + TX, heptenophos (432) + TX, hexadecyl cyclopropanecarboxylate (IUPAC/Chemical Abstracts name) (1216) + TX, hexythiazox (441) + TX, iodomethane (IUPAC name) (542) + TX, isocarbophos (alternative name) (473) + TX, isopropyl O-(methoxyaminothiophosphoryl)salicylate (IUPAC name) (473) + TX, ivermectin (alternative name) [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenphos (1248) + TX, lindane (430) + TX, lufenuron (490) + TX, malathion (492) + TX, malonoben (1254) + TX, mecarbam (502) + TX, mephosfolan (1261) + TX, mesulfen (alternative name) [CCN] + TX, methacrifos (1266) + TX, methamidophos (527) + TX, methidathion (529) + TX, methiocarb (530) + TX, methomyl (531) + TX, methyl bromide (537) + TX, metolcarb (550) + TX, mevinphos (556) + TX, mexacarbate (1290) + TX, milbemectin (557) + TX, milbemycin oxime (alternative name) [CCN] + TX, mipafox (1293) + TX, monocrotophos (561) + TX, morphothion (1300) + TX, moxidectin (alternative name) [CCN] + TX, naled (567) + TX, NC-184 (compound code) + TX, NC-512 (compound code) + TX, nifluridide (1309) + TX, nikkomycins (alternative name) [CCN] + TX, nitrilacarb (1313) + TX, nitrilacarb 1 : 1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (compound code) + TX, omethoate (594) + TX, oxamyl (602) + TX, oxydeprofos (1324) + TX, oxydisulfoton (1325) + TX, pp'-DDT (219) + TX, parathion (615) + TX, permethrin (626) + TX, petroleum oils (alternative name) (628) + TX, phenkapton (1330) + TX, phenthoate (631) + TX, phorate (636) + TX, phosalone (637) + TX, phosfolan (1338) + TX, phosmet (638) + TX, phosphamidon (639) + TX, phoxim (642) + TX, pirimiphos-methyl (652) + TX, polychloroterpenes (traditional name) (1347) + TX, polynactins (alternative name) (653) + TX, proclonol (1350) + TX, profenofos (662) + TX, promacyl (1354) + TX, propargite (671) + TX, propetamphos (673) + TX, propoxur (678) + TX, prothidathion (1360) + TX, prothoate (1362) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridaphenthion (701) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, quinalphos (711) + TX, quintiofos (1381) + TX, R-1492 (development code) (1382) + TX, RA-17 (development code) (1383) + TX, rotenone (722) + TX, schradan (1389) + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, SI-0009 (compound code) + TX, sophamide (1402) + TX, spirodiclofen (738) + TX, spiromesifen (739) + TX, SSI-121 (development code) (1404) + TX, sulfiram (alternative name) [CCN] + TX, sulfiuramid (750) + TX, sulfotep (753) + TX, sulphur (754) + TX, SZI-121 (development code) (757) + TX, tau-fiuvalinate (398) + TX, tebufenpyrad (763) + TX, TEPP (1417) + TX, terbam (alternative name) + TX,

tetrachlorvinphos (777) + TX, tetradifon (786) + TX, tetranactin (alternative name) (653) + TX, tetrasul (1425) + TX, thiafenox (alternative name) + TX, thiocarboxime (1431) + TX, thiofanox (800) + TX, thiometon (801) + TX, thioquinox (1436) + TX, thuringiensin (alternative name) [CCN] + TX, triamiphos (1441) + TX, triarathene (1443) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, trichlorfon (824) + TX, trifenofos (1455) + TX, trinactin (alternative name) (653) + TX, vamidothion (847) + TX, vaniliprole [CCN] and YI-5302 (compound code) + TX,

an algicide selected from the group of substances consisting of bethoxazin [CCN] + TX, copper dioctanoate (IUPAC name) (170) + TX, copper sulfate (172) + TX, cybutryne [CCN] + TX, dichlone (1052) + TX, dichlorophen (232) + TX, endothal (295) + TX, fentin (347) + TX, hydrated lime [CCN] + TX, nabam (566) + TX, quinoclamine (714) + TX, quinonamid (1379) + TX, simazine (730) + TX, triphenyltin acetate (IUPAC name) (347) and

triphenyltin hydroxide (IUPAC name) (347) + TX,

an anthelmintic selected from the group of substances consisting of abamectin (1) + TX, crufomate (1011) + TX, doramectin (alternative name) [CCN] + TX, emamectin (291) + TX, emamectin benzoate (291) + TX, eprinomectin (alternative name) [CCN] + TX, ivermectin

(alternative name) [CCN] + TX, milbemycin oxime (alternative name) [CCN] + TX, moxidectin (alternative name) [CCN] + TX, piperazine [CCN] + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) and thiophanate (1435) + TX,

an avicide selected from the group of substances consisting of chloralose (127) + TX, endrin

(1122) + TX, fenthion (346) + TX, pyridin-4 -amine (IUPAC name) (23) and strychnine

(745) + TX,

a bactericide selected from the group of substances consisting of 1 -hydroxy- lH-pyridine-2- thione (IUPAC name) (1222) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748) + TX, 8-hydroxyquinoline sulfate (446) + TX, bronopol (97) + TX, copper dioctanoate (IUPAC name) (170) + TX, copper hydroxide (IUPAC name) (169) + TX, cresol [CCN] + TX, dichlorophen (232) + TX, dipyrithione (1105) + TX, dodicin (1112) + TX, fenaminosulf (1144) + TX, formaldehyde (404) + TX, hydrargaphen (alternative name) [CCN] + TX, kasugamycin (483) + TX, kasugamycin hydrochloride hydrate (483) + TX, nickel bis(dimethyldithiocarbamate) (IUPAC name) (1308) + TX, nitrapyrin (580) + TX, octhilinone (590) + TX, oxolinic acid (606) + TX, oxytetracycline (611) + TX, potassium hydroxyquinoline sulfate (446) + TX, probenazole (658) + TX, streptomycin (744) + TX, streptomycin sesquisulfate (744) + TX, tecloftalam (766) + TX, and thiomersal (alternative name) [CCN] + TX,

a biological agent selected from the group of substances consisting of Adoxophyes orana GV (alternative name) (12) + TX, Agrobacterium radiobacter (alternative name) (13) + TX, Amblyseius spp. (alternative name) (19) + TX, Anagrapha falcifera NPV (alternative name) (28) + TX, Anagrus atomus (alternative name) (29) + TX, Aphelinus abdominalis (alternative name) (33) + TX, Aphidius colemani (alternative name) (34) + TX, Aphidoletes aphidimyza (alternative name) (35) + TX, Autographa californica NPV (alternative name) (38) + TX, Bacillus firmus (alternative name) (48) + TX, Bacillus sphaericus Neide

(scientific name) (49) + TX, Bacillus thuringiensis Berliner (scientific name) (51) + TX, Bacillus thuringiensis subsp. aizawai (scientific name) (51) + TX, Bacillus thuringiensis subsp. israelensis (scientific name) (51) + TX, Bacillus thuringiensis subsp. japonensis (scientific name) (51) + TX, Bacillus thuringiensis subsp. kurstaki (scientific name) (51) + TX, Bacillus thuringiensis subsp. tenebrionis (scientific name) (51) + TX, Beauveria bassiana (alternative name) (53) + TX, Beauveria brongniartii (alternative name) (54) + TX, Chrysoperla carnea (alternative name) (151) + TX, Cryptolaemus montrouzieri (alternative name) (178) + TX, Cydia pomonella GV (alternative name) (191) + TX, Dacnusa sibirica (alternative name) (212) + TX, Diglyphus isaea (alternative name) (254) + TX, Encarsia formosa (scientific name) (293) + TX, Eretmocerus eremicus (alternative name) (300) + TX, Helicoverpa zea NPV (alternative name) (431) + TX, Heterorhabditis bacteriophora and H. megidis (alternative name) (433) + TX, Hippodamia convergens (alternative name) (442) + TX, Leptomastix dactylopii (alternative name) (488) + TX, Macrolophus caliginosus (alternative name) (491) + TX, Mamestra brassicae NPV (alternative name) (494) + TX, Metaphycus helvolus (alternative name) (522) + TX, Metarhizium anisopliae var. acridum (scientific name) (523) + TX, Metarhizium anisopliae var. anisopliae (scientific name) (523) + TX, Neodiprion sertifer NPV and N. lecontei NPV (alternative name) (575) + TX, Orius spp. (alternative name) (596) + TX, Paecilomyces fumosoroseus (alternative name) (613) + TX, Phytoseiulus persimilis (alternative name) (644) + TX, Spodoptera exigua multicapsid nuclear polyhedrosis virus (scientific name) (741) + TX, Steinernema bibionis (alternative name) (742) + TX, Steinernema carpocapsae (alternative name) (742) + TX, Steinernema feltiae (alternative name) (742) + TX, Steinernema glaseri (alternative name) (742) + TX, Steinernema riobrave (alternative name) (742) + TX, Steinernema riobravis (alternative name) (742) + TX, Steinernema scapterisci (alternative name) (742) + TX, Steinernema spp. (alternative name) (742) + TX, Trichogramma spp. (alternative name) (826) + TX,

Typhlodromus occidentalis (alternative name) (844) and Verticillium lecanii (alternative name) (848) + TX,

a soil sterilant selected from the group of substances consisting of iodomethane (IUPAC name) (542) and methyl bromide (537) + TX, a chemosterilant selected from the group of substances consisting of apholate [CCN] + TX, bisazir (alternative name) [CCN] + TX, busulfan (alternative name) [CCN] + TX, diflubenzuron (250) + TX, dimatif (alternative name) [CCN] + TX, hemel [CCN] + TX, hempa [CCN] + TX, metepa [CCN] + TX, methiotepa [CCN] + TX, methyl apholate [CCN] + TX, morzid [CCN] + TX, penfluron (alternative name) [CCN] + TX, tepa [CCN] + TX, thiohempa (alternative name) [CCN] + TX, thiotepa (alternative name) [CCN] + TX, tretamine (alternative name) [CCN] and uredepa (alternative name) [CCN] + TX,

an insect pheromone selected from the group of substances consisting of (E)-dec-5-en-l-yl acetate with (E)-dec-5-en-l-ol (IUPAC name) (222) + TX, (E)-tridec-4-en-l-yl acetate (IUPAC name) (829) + TX, (E)-6-methylhept-2-en-4-ol (IUPAC name) (541) + TX, (E,Z)- tetradeca-4,10-dien-l-yl acetate (IUPAC name) (779) + TX, (Z)-dodec-7-en-l-yl acetate (IUPAC name) (285) + TX, (Z)-hexadec-l 1-enal (IUPAC name) (436) + TX, (Z)-hexadec- 1 1-en-l-yl acetate (IUPAC name) (437) + TX, (Z)-hexadec-13-en-l 1-yn-l-yl acetate

(IUPAC name) (438) + TX, (Z)-icos-13-en-10-one (IUPAC name) (448) + TX, (Z)-tetradec- 7-en-l-al (IUPAC name) (782) + TX, (Z)-tetradec-9-en-l -ol (IUPAC name) (783) + TX, (Z)- tetradec-9-en-l-yl acetate (IUPAC name) (784) + TX, (7E,9Z)-dodeca-7,9-dien-l-yl acetate (IUPAC name) (283) + TX, (9Z,1 lE)-tetradeca-9, l 1-dien-l-yl acetate (IUPAC name) (780) + TX, (9Z, 12E)-tetradeca-9,12-dien-l-yl acetate (IUPAC name) (781) + TX, 14- methyloctadec-l -ene (IUPAC name) (545) + TX, 4-methylnonan-5-ol with 4-methylnonan- 5-one (IUPAC name) (544) + TX, alpha-multistriatin (alternative name) [CCN] + TX, brevicomin (alternative name) [CCN] + TX, codlelure (alternative name) [CCN] + TX, codlemone (alternative name) (167) + TX, cuelure (alternative name) (179) + TX, disparlure (277) + TX, dodec-8-en-l-yl acetate (IUPAC name) (286) + TX, dodec-9-en-l-yl acetate (IUPAC name) (287) + TX, dodeca-8 + TX, 10-dien-l-yl acetate (IUPAC name) (284) + TX, dominicalure (alternative name) [CCN] + TX, ethyl 4-methyloctanoate (IUPAC name) (317) + TX, eugenol (alternative name) [CCN] + TX, frontalin (alternative name) [CCN] + TX, gossyplure (alternative name) (420) + TX, grandlure (421) + TX, grandlure I (alternative name) (421) + TX, grandlure II (alternative name) (421) + TX, grandlure III (alternative name) (421) + TX, grandlure IV (alternative name) (421) + TX, hexalure [CCN] + TX, ipsdienol (alternative name) [CCN] + TX, ipsenol (alternative name) [CCN] + TX, japonilure (alternative name) (481) + TX, lineatin (alternative name) [CCN] + TX, litlure (alternative name) [CCN] + TX, looplure (alternative name) [CCN] + TX, medlure [CCN] + TX, megatomoic acid (alternative name) [CCN] + TX, methyl eugenol (alternative name) (540) + TX, muscalure (563) + TX, octadeca-2, 13-dien-l-yl acetate (IUPAC name) (588) + TX, octadeca-3,13-dien-l-yl acetate (IUPAC name) (589) + TX, orfralure (alternative name) [CCN] + TX, oryctalure (alternative name) (317) + TX, ostramone (alternative name) [CCN] + TX, siglure [CCN] + TX, sordidin (alternative name) (736) + TX, sulcatol (alternative name) [CCN] + TX, tetradec-1 1-en-l-yl acetate (IUPAC name) (785) + TX, trimedlure (839) + TX, trimedlure A (alternative name) (839) + TX, trimedlure Bi (alternative name) (839) + TX, trimedlure B₂ (alternative name) (839) + TX, trimedlure C (alternative name) (839) and trunc-call (alternative name) [CCN] + TX,

an insect repellent selected from the group of substances consisting of 2-(octylthio)ethanol (IUPAC name) (591) + TX, butopyronoxyl (933) + TX, butoxy(polypropylene glycol) (936) + TX, dibutyl adipate (IUPAC name) (1046) + TX, dibutyl phthalate (1047) + TX, dibutyl succinate (IUPAC name) (1048) + TX, diethyltoluamide [CCN] + TX, dimethyl carbate [CCN] + TX, dimethyl phthalate [CCN] + TX, ethyl hexanediol (1 137) + TX, hexamide [CCN] + TX, methoquin-butyl (1276) + TX, methylneodecanamide [CCN] + TX, oxamate [CCN] and picaridin [CCN] + TX,

an insecticide selected from the group of substances consisting of 1-dichloro-l-nitroethane (IUPAC/Chemical Abstracts name) (1058) + TX, l ,l-dichloro-2,2-bis(4-ethylphenyl)ethane (IUPAC name) (1056), + TX, 1 ,2-dichloropropane (IUPAC/Chemical Abstracts name) (1062) + TX, 1 ,2-dichloropropane with 1 ,3-dichloropropene (IUPAC name) (1063) + TX, 1- bromo-2-chloroethane (IUPAC/Chemical Abstracts name) (916) + TX, 2,2,2-trichloro-l- (3,4-dichlorophenyl)ethyl acetate (IUPAC name) (1451) + TX, 2,2-dichlorovinyl 2- ethylsulphinylethyl methyl phosphate (IUPAC name) (1066) + TX, 2-(l ,3-dithiolan-2- yl)phenyl dimethylcarbamate (IUPAC/ Chemical Abstracts name) (1 109) + TX, 2-(2- butoxyethoxy)ethyl thiocyanate (IUPAC/Chemical Abstracts name) (935) + TX, 2-(4,5- dimethyl-l ,3-dioxolan-2-yl)phenyl methylcarbamate (IUPAC/ Chemical Abstracts name) (1084) + TX, 2-(4-chloro-3,5-xylyloxy)ethanol (IUPAC name) (986) + TX, 2-chlorovinyl diethyl phosphate (IUPAC name) (984) + TX, 2-imidazolidone (IUPAC name) (1225) + TX, 2-isovalerylindan-l ,3-dione (IUPAC name) (1246) + TX, 2-methyl(prop-2- ynyl)aminophenyl methylcarbamate (IUPAC name) (1284) + TX, 2-thiocyanatoethyl laurate (IUPAC name) (1433) + TX, 3-bromo-l-chloroprop-l-ene (IUPAC name) (917) + TX, 3- methyl-l-phenylpyrazol-5-yl dimethylcarbamate (IUPAC name) (1283) + TX, 4- methyl(prop-2-ynyl)amino-3,5-xylyl methylcarbamate (IUPAC name) (1285) + TX, 5,5- dimethyl-3-oxocyclohex-l-enyl dimethylcarbamate (IUPAC name) (1085) + TX, abamectin (1) + TX, acephate (2) + TX, acetamiprid (4) + TX, acethion (alternative name) [CCN] + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, acrylonitrile (IUPAC name) (861) + TX, alanycarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, aldrin (864) + TX, allethrin (17) + TX, allosamidin (alternative name) [CCN] + TX, allyxycarb (866) + TX, alpha-cypermethrin (202) + TX, alpha-ecdysone (alternative name) [CCN] + TX, aluminium phosphide (640) + TX, amidithion (870) + TX, amidothioate (872) + TX, aminocarb (873) + TX, amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX, anabasine (877) + TX, athidathion (883) + TX, AVI 382 (compound code) + TX, AZ 60541

(compound code) + TX, azadirachtin (alternative name) (41) + TX, azamethiphos (42) + TX, azinphos-ethyl (44) + TX, azinphos-methyl (45) + TX, azothoate (889) + TX, Bacillus thuringiensis delta endotoxins (alternative name) (52) + TX, barium hexafluorosilicate (alternative name) [CCN] + TX, barium polysulfide (IUPAC/Chemical Abstracts name) (892) + TX, barthrin [CCN] + TX, Bayer 22/190 (development code) (893) + TX, Bayer 22408 (development code) (894) + TX, bendiocarb (58) + TX, benfuracarb (60) + TX, bensultap (66) + TX, beta-cyfiuthrin (194) + TX, beta-cypermethrin (203) + TX, bifenthrin (76) + TX, bioallethrin (78) + TX, bioallethrin S-cyclopentenyl isomer (alternative name) (79) + TX, bioethanomethrin [CCN] + TX, biopermethrin (908) + TX, bioresmethrin (80) + TX, bis(2-chloroethyl) ether (IUPAC name) (909) + TX, bistrifluron (83) + TX, borax (86) + TX, brofenvalerate (alternative name) + TX, bromfenvinfos (914) + TX, bromocyclen (918) + TX, bromo-DDT (alternative name) [CCN] + TX, bromophos (920) + TX, bromophos- ethyl (921) + TX, bufencarb (924) + TX, buprofezin (99) + TX, butacarb (926) + TX, butathiofos (927) + TX, butocarboxim (103) + TX, butonate (932) + TX, butoxycarboxim (104) + TX, butylpyridaben (alternative name) + TX, cadusafos (109) + TX, calcium arsenate [CCN] + TX, calcium cyanide (444) + TX, calcium polysulfide (IUPAC name) ( 111 ) + TX, camphechlor (941 ) + TX, carbanolate (943) + TX, carbaryl ( 115) + TX, carbofuran (118) + TX, carbon disulfide (IUPAC/Chemical Abstracts name) (945) + TX, carbon tetrachloride (IUPAC name) (946) + TX, carbophenothion (947) + TX, carbosulfan (119) + TX, cartap (123) + TX, cartap hydrochloride (123) + TX, cevadine (alternative name) (725) + TX, chlorbicyclen (960) + TX, chlordane (128) + TX, chlordecone (963) + TX, chlordimeform (964) + TX, chlordimeform hydrochloride (964) + TX, chlorethoxyfos (129) + TX, chlorfenapyr (130) + TX, chlorfenvinphos (131) + TX, chlorfluazuron (132) + TX, chlormephos (136) + TX, chloroform [CCN] + TX, chloropicrin (141) + TX, chlorphoxim (989) + TX, chlorprazophos (990) + TX, chlorpyrifos (145) + TX, chlorpyrifos- methyl (146) + TX, chlorthiophos (994) + TX, chromafenozide (150) + TX, cinerin I (696) + TX, cinerin II (696) + TX, cinerins (696) + TX, cis-resmethrin (alternative name) + TX, cismethrin (80) + TX, clocythrin (alternative name) + TX, cloethocarb (999) + TX, closantel (alternative name) [CCN] + TX, clothianidin (165) + TX, copper acetoarsenite [CCN] + TX, copper arsenate [CCN] + TX, copper oleate [CCN] + TX, coumaphos (174) + TX, coumithoate (1006) + TX, crotamiton (alternative name) [CCN] + TX, crotoxyphos (1010) + TX, crufomate (1011) + TX, cryolite (alternative name) (177) + TX, CS 708 (development code) (1012) + TX, cyanofenphos (1019) + TX, cyanophos (184) + TX, cyanthoate (1020) + TX, cyclethrin [CCN] + TX, cycloprothrin (188) + TX, cyfhithrin (193) + TX, cyhalothrin (196) + TX, cypermethrin (201) + TX, cyphenothrin (206) + TX, cyromazine (209) + TX, cythioate (alternative name) [CCN] + TX, <i-limonene (alternative name) [CCN] + TX, d- tetramethrin (alternative name) (788) + TX, DAEP (1031) + TX, dazomet (216) + TX, DDT (219) + TX, decarbofuran (1034) + TX, deltamethrin (223) + TX, demephion (1037) + TX, demephion-0 (1037) + TX, demephion-S (1037) + TX, demeton (1038) + TX, demeton- methyl (224) + TX, demeton-0 (1038) + TX, demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton-S-methyl (224) + TX, demeton- S-methylsulphon (1039) + TX, diafenthiuron (226) + TX, dialifos (1042) + TX, diamidafos (1044) + TX, diazinon (227) + TX, dicapthon (1050) + TX, dichlofenthion (1051) + TX, dichlorvos (236) + TX, dicliphos (alternative name) + TX, dicresyl (alternative name) [CCN] + TX, dicrotophos (243) + TX, dicyclanil (244) + TX, dieldrin (1070) + TX, diethyl 5-methylpyrazol-3-yl phosphate

(IUPAC name) (1076) + TX, diflubenzuron (250) + TX, dilor (alternative name) [CCN] + TX, dimefluthrin [CCN] + TX, dimefox (1081) + TX, dimetan (1085) + TX, dimethoate (262) + TX, dimethrin (1083) + TX, dimethylvinphos (265) + TX, dimetilan (1086) + TX, dinex (1089) + TX, dinex-diclexine (1089) + TX, dinoprop (1093) + TX, dinosam (1094) + TX, dinoseb (1095) + TX, dinotefuran (271) + TX, diofenolan (1099) + TX, dioxabenzofos (1100) + TX, dioxacarb (1101) + TX, dioxathion (1102) + TX, disulfoton (278) + TX, dithicrofos (1108) + TX, DNOC (282) + TX, doramectin (alternative name) [CCN] + TX, DSP (1115) + TX, ecdysterone (alternative name) [CCN] + TX, EI 1642 (development code) (1118) + TX, emamectin (291) + TX, emamectin benzoate (291) + TX, EMPC (1120) + TX, empenthrin (292) + TX, endosulfan (294) + TX, endothion ( 1121 ) + TX, endrin ( 1122) + TX, EPBP (1123) + TX, EPN (297) + TX, epofenonane (1124) + TX, eprinomectin

(alternative name) [CCN] + TX, esfenvalerate (302) + TX, etaphos (alternative name) [CCN] + TX, ethiofencarb (308) + TX, ethion (309) + TX, ethiprole (310) + TX, ethoate-methyl (1134) + TX, ethoprophos (312) + TX, ethyl formate (IUPAC name) [CCN] + TX, ethyl- DDD (alternative name) (1056) + TX, ethylene dibromide (316) + TX, ethylene dichloride (chemical name) (1136) + TX, ethylene oxide [CCN] + TX, etofenprox (319) + TX, etrimfos (1142) + TX, EXD (1143) + TX, famphur (323) + TX, fenamiphos (326) + TX, fenazaflor (1147) + TX, fenchlorphos (1148) + TX, fenethacarb (1149) + TX, fenfhithrin (1150) + TX, fenitrothion (335) + TX, fenobucarb (336) + TX, fenoxacrim (1153) + TX, fenoxycarb (340) + TX, fenpirithrin (1155) + TX, fenpropathrin (342) + TX, fenpyrad (alternative name) + TX, fensulfothion (1158) + TX, fenthion (346) + TX, fenthion-ethyl [CCN] + TX, fenvalerate (349) + TX, fipronil (354) + TX, fionicamid (358) + TX, fiubendiamide (CAS. Reg. No.: 272451-65-7) + TX, flucofuron (1168) + TX, fiucycloxuron (366) + TX, flucythrinate (367) + TX, fluenetil (1169) + TX, flufenerim [CCN] + TX, flufenoxuron (370) + TX, flufenprox (1171) + TX, flumethrin (372) + TX, f uvalinate (1184) + TX, FMC 1137 (development code) (1185) + TX, fonofos (1191) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1192) + TX, formparanate (1193) + TX, fosmethilan (1194) + TX, fospirate (1195) + TX, fosthiazate (408) + TX, fosthietan (1196) + TX, furathiocarb (412) + TX, furethrin (1200) + TX, gamma-cyhalothrin (197) + TX, gamma-HCH (430) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, GY-81 (development code) (423) + TX, halfenprox (424) + TX, halofenozide (425) + TX, HCH (430) + TX, HEOD (1070) + TX, heptachlor (1211) + TX, heptenophos (432) + TX, heterophos [CCN] + TX, hexaflumuron (439) + TX, HHDN (864) + TX, hydramethylnon (443) + TX, hydrogen cyanide (444) + TX, hydroprene (445) + TX, hyquincarb (1223) + TX, imidacloprid (458) + TX, imiprothrin (460) + TX, indoxacarb (465) + TX, iodomethane (IUPAC name) (542) + TX, IPSP (1229) + TX, isazofos (1231) + TX, isobenzan (1232) + TX, isocarbophos (alternative name) (473) + TX, isodrin (1235) + TX, isofenphos (1236) + TX, isolane (1237) + TX, isoprocarb (472) + TX, isopropyl 0-(methoxy- aminothiophosphoryl)salicylate (IUPAC name) (473) + TX, isoprothiolane (474) + TX, isothioate (1244) + TX, isoxathion (480) + TX, ivermectin (alternative name) [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenphos (1248) + TX, juvenile hormone I (alternative name) [CCN] + TX, juvenile hormone II (alternative name) [CCN] + TX, juvenile hormone III (alternative name) [CCN] + TX, kelevan (1249) + TX, kinoprene (484) + TX, lambda-cyhalothrin (198) + TX, lead arsenate [CCN] + TX, lepimectin (CCN) + TX, leptophos (1250) + TX, lindane (430) + TX, lirimfos (1251) + TX, lufenuron (490) + TX, lythidathion (1253) + TX, m-cumenyl methylcarbamate (IUPAC name) (1014) + TX, magnesium phosphide (IUPAC name) (640) + TX, malathion (492) + TX, malonoben (1254) + TX, mazidox (1255) + TX, mecarbam (502) + TX, mecarphon (1258) + TX, menazon (1260) + TX, mephosfolan (1261) + TX, mercurous chloride (513) + TX, mesulfenfos (1263) + TX, metaflumizone (CCN) + TX, metam (519) + TX, metam-potassium (alternative name) (519) + TX, metam-sodium (519) + TX, methacrifos (1266) + TX, methamidophos (527) + TX, methanesulphonyl fluoride (IUPAC/Chemical Abstracts name) (1268) + TX, methidathion (529) + TX, methiocarb (530) + TX, methocrotophos (1273) + TX, methomyl (531) + TX, methoprene (532) + TX, methoquin-butyl (1276) + TX, methothrin (alternative name) (533) + TX, methoxychlor (534) + TX, methoxyfenozide (535) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, methylchloroform (alternative name) [CCN] + TX, methylene chloride [CCN] + TX, metofluthrin [CCN] + TX, metolcarb (550) + TX, metoxadiazone (1288) + TX, mevinphos (556) + TX, mexacarbate (1290) + TX,

milbemectin (557) + TX, milbemycin oxime (alternative name) [CCN] + TX, mipafox (1293) + TX, mirex (1294) + TX, monocrotophos (561) + TX, morphothion (1300) + TX, moxidectin (alternative name) [CCN] + TX, naftalofos (alternative name) [CCN] + TX, naled (567) + TX, naphthalene (IUPAC/Chemical Abstracts name) (1303) + TX, NC-170 (development code) (1306) + TX, NC-184 (compound code) + TX, nicotine (578) + TX, nicotine sulfate (578) + TX, nifiuridide (1309) + TX, nitenpyram (579) + TX, nithiazine (1311) + TX, nitrilacarb (1313) + TX, nitrilacarb 1 : 1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (compound code) + TX, nornicotine

(traditional name) (1319) + TX, novaluron (585) + TX, novifiumuron (586) + TX, 0-5- dichloro-4-iodophenyl O-ethyl ethylphosphonothioate (IUPAC name) (1057) + TX, Ο,Ο- diethyl 0-4-methyl-2-oxo-2H-chromen-7-yl phosphorothioate (IUPAC name) (1074) + TX, 0,0-diethyl 0-6-methyl-2-propylpyrimidin-4-yl phosphorothioate (IUPAC name) (1075) + TX, O, Ο,Ο', O'-tetrapropyl dithiopyrophosphate (IUPAC name) (1424) + TX, oleic acid (IUPAC name) (593) + TX, omethoate (594) + TX, oxamyl (602) + TX, oxydemeton-methyl (609) + TX, oxydeprofos (1324) + TX, oxydisulfoton (1325) + TX, pp'-DDT (219) + TX, para-dichlorobenzene [CCN] + TX, parathion (615) + TX, parathion-methyl (616) + TX, penfiuron (alternative name) [CCN] + TX, pentachlorophenol (623) + TX,

pentachlorophenyl laurate (IUPAC name) (623) + TX, permethrin (626) + TX, petroleum oils (alternative name) (628) + TX, PH 60-38 (development code) (1328) + TX, phenkapton (1330) + TX, phenothrin (630) + TX, phenthoate (631) + TX, phorate (636) + TX, phosalone (637) + TX, phosfolan (1338) + TX, phosmet (638) + TX, phosnichlor (1339) + TX, phosphamidon (639) + TX, phosphine (IUPAC name) (640) + TX, phoxim (642) + TX, phoxim-methyl (1340) + TX, pirimetaphos (1344) + TX, pirimicarb (651) + TX, pirimiphos- ethyl (1345) + TX, pirimiphos-methyl (652) + TX, polychlorodicyclopentadiene isomers (IUPAC name) (1346) + TX, polychloroterpenes (traditional name) (1347) + TX, potassium arsenite [CCN] + TX, potassium thiocyanate [CCN] + TX, prallethrin (655) + TX, precocene I (alternative name) [CCN] + TX, precocene II (alternative name) [CCN] + TX, precocene III (alternative name) [CCN] + TX, primidophos (1349) + TX, profenofos (662) + TX, profluthrin [CCN] + TX, promacyl (1354) + TX, promecarb (1355) + TX, propaphos (1356) + TX, propetamphos (673) + TX, propoxur (678) + TX, prothidathion (1360) + TX, prothiofos (686) + TX, prothoate (1362) + TX, protrifenbute [CCN] + TX, pymetrozine (688) + TX, pyraclofos (689) + TX, pyrazophos (693) + TX, pyresmethrin (1367) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridalyl (700) + TX, pyridaphenthion (701) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, pyriproxyfen (708) + TX, quassia (alternative name) [CCN] + TX, quinalphos (711) + TX, quinalphos-methyl (1376) + TX, quinothion (1380) + TX, quintiofos (1381) + TX, R-1492 (development code) (1382) + TX, rafoxanide (alternative name) [CCN] + TX, resmethrin (719) + TX, rotenone (722) + TX, RU 15525 (development code) (723) + TX, RU 25475 (development code) (1386) + TX, ryania (alternative name) (1387) + TX, ryanodine (traditional name) (1387) + TX, sabadilla (alternative name) (725) + TX, schradan (1389) + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, SI-0009 (compound code) + TX, SI-0205 (compound code) + TX, SI-0404 (compound code) + TX, SI-0405 (compound code) + TX, silafluofen (728) + TX, SN 72129 (development code) (1397) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoride (IUPAC/Chemical Abstracts name) (1399) + TX, sodium hexafiuorosilicate (1400) + TX, sodium pentachlorophenoxide (623) + TX, sodium selenate (IUPAC name) (1401) + TX, sodium thiocyanate [CCN] + TX, sophamide (1402) + TX, spinosad (737) + TX, spiromesifen (739) + TX, spirotetrmat (CCN) + TX, sulcofuron (746) + TX, sulcofuron- sodium (746) + TX, sulfluramid (750) + TX, sulfotep (753) + TX, sulphuryl fluoride (756) + TX, sulprofos (1408) + TX, tar oils (alternative name) (758) + TX, tau-fluvalinate (398) + TX, tazimcarb (1412) + TX, TDE (1414) + TX, tebufenozide (762) + TX, tebufenpyrad (763) + TX, tebupirimfos (764) + TX, teflubenzuron (768) + TX, tefluthrin (769) + TX, temephos (770) + TX, TEPP (1417) + TX, terallethrin (1418) + TX, terbam (alternative name) + TX, terbufos (773) + TX, tetrachloroethane [CCN] + TX, tetrachlorvinphos (777) + TX, tetramethrin (787) + TX, theta-cypermethrin (204) + TX, thiacloprid (791) + TX, thiafenox (alternative name) + TX, thiamethoxam (792) + TX, thicrofos (1428) + TX, thiocarboxime (1431) + TX, thiocyclam (798) + TX, thiocyclam hydrogen oxalate (798) + TX, thiodicarb (799) + TX, thiofanox (800) + TX, thiometon (801) + TX, thionazin (1434) + TX, thiosultap (803) + TX, thiosultap-sodium (803) + TX, thuringiensin (alternative name) [CCN] + TX, tolfenpyrad (809) + TX, tralomethrin (812) + TX, transfhithrin (813) + TX, transpermethrin (1440) + TX, triamiphos (1441) + TX, triazamate (818) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, trichlorfon (824) + TX, trichlormetaphos-3 (alternative name) [CCN] + TX, trichloronat (1452) + TX, trifenofos (1455) + TX, triflumuron (835) + TX, trimethacarb (840) + TX, triprene (1459) + TX, vamidothion (847) + TX, vaniliprole [CCN] + TX, veratridine (alternative name) (725) + TX, veratrine

(alternative name) (725) + TX, XMC (853) + TX, xylylcarb (854) + TX, YI-5302

(compound code) + TX, zeta-cypermethrin (205) + TX, zetamethrin (alternative name) + TX, zinc phosphide (640) + TX, zolaprofos (1469) and ZXI 8901 (development code) (858) + TX, cyantraniliprole [736994-63-19] + TX, chlorantraniliprole [500008-45-7] + TX, cyenopyrafen [560121-52-0] + TX, cyflumetofen [400882-07-7] + TX, pyrifluquinazon

[337458-27-2] + TX, spinetoram [187166-40-1 + 187166-15-0] + TX, spirotetramat

[203313-25-1] + TX, sulfoxaflor [946578-00-3] + TX, flufiprole [704886-18-0] + TX, meperfluthrin [915288-13-0] + TX, tetramethylfluthrin [84937-88-2] + TX,

a molluscicide selected from the group of substances consisting of bis(tributyltin) oxide (IUPAC name) (913) + TX, bromoacetamide [CCN] + TX, calcium arsenate [CCN] + TX, cloethocarb (999) + TX, copper acetoarsenite [CCN] + TX, copper sulfate (172) + TX, fentin (347) + TX, ferric phosphate (IUPAC name) (352) + TX, metaldehyde (518) + TX, methiocarb (530) + TX, niclosamide (576) + TX, niclosamide-olamine (576) + TX, pentachlorophenol (623) + TX, sodium pentachlorophenoxide (623) + TX, tazimcarb (1412) + TX, thiodicarb (799) + TX, tributyltin oxide (913) + TX, trifenmorph (1454) + TX, trimethacarb (840) + TX, triphenyltin acetate (IUPAC name) (347) and triphenyltin hydroxide (IUPAC name) (347) + TX, pyriprole [394730-71-3] + TX,

a nematicide selected from the group of substances consisting of AKD-3088 (compound code) + TX, l,2-dibromo-3-chloropropane (IUPAC/Chemical Abstracts name) (1045) + TX, 1 ,2-dichloropropane (IUPAC/ Chemical Abstracts name) (1062) + TX, 1,2-dichloropropane with 1,3-dichloropropene (IUPAC name) (1063) + TX, 1,3-dichloropropene (233) + TX, 3,4- dichlorotetrahydrothiophene 1,1-dioxide (IUPAC/Chemical Abstracts name) (1065) + TX, 3- (4-chlorophenyl)-5-methylrhodanine (IUPAC name) (980) + TX, 5-methyl-6-thioxo-l,3,5- thiadiazinan-3-ylacetic acid (IUPAC name) (1286) + TX, 6-isopentenylaminopurine

(alternative name) (210) + TX, abamectin (1) + TX, acetoprole [CCN] + TX, alanycarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, AZ 60541 (compound code) + TX, benclothiaz [CCN] + TX, benomyl (62) + TX, butylpyridaben (alternative name) + TX, cadusafos (109) + TX, carbofuran (118) + TX, carbon disulfide (945) + TX, carbosulfan (119) + TX, chloropicrin (141) + TX, chlorpyrifos (145) + TX, cloethocarb (999) + TX, cytokinins (alternative name) (210) + TX, dazomet (216) + TX, DBCP (1045) + TX, DCIP (218) + TX, diamidafos (1044) + TX, dichlofenthion (1051) + TX, dicliphos (alternative name) + TX, dimethoate (262) + TX, doramectin (alternative name) [CCN] + TX, emamectin (291) + TX, emamectin benzoate (291) + TX, eprinomectin (alternative name) [CCN] + TX, ethoprophos (312) + TX, ethylene dibromide (316) + TX, fenamiphos (326) + TX, fenpyrad (alternative name) + TX, fensulfothion (1158) + TX, fosthiazate (408) + TX, fosthietan (1196) + TX, furfural (alternative name) [CCN] + TX, GY-81 (development code) (423) + TX, heterophos [CCN] + TX, iodomethane (IUPAC name) (542) + TX, isamidofos (1230) + TX, isazofos (1231) + TX, ivermectin (alternative name) [CCN] + TX, kinetin (alternative name) (210) + TX, mecarphon (1258) + TX, metam (519) + TX, metam- potassium (alternative name) (519) + TX, metam-sodium (519) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, milbemycin oxime (alternative name) [CCN] + TX, moxidectin (alternative name) [CCN] + TX, Myrothecium verrucaria composition

(alternative name) (565) + TX, NC-184 (compound code) + TX, oxamyl (602) + TX, phorate (636) + TX, phosphamidon (639) + TX, phosphocarb [CCN] + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) + TX, terbam (alternative name) + TX, terbufos (773) + TX, tetrachlorothiophene (IUPAC/ Chemical Abstracts name) (1422) + TX, thiafenox (alternative name) + TX, thionazin (1434) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, xylenols [CCN] + TX, YI-5302 (compound code) and zeatin (alternative name) (210) + TX, fluensulfone [318290-98-1] + TX,

a nitrification inhibitor selected from the group of substances consisting of potassium ethylxanthate [CCN] and nitrapyrin (580) + TX,

a plant activator selected from the group of substances consisting of acibenzolar (6) + TX, acibenzolar-S-methyl (6) + TX, probenazole (658) and Reynoutria sachalinensis extract (alternative name) (720) + TX, a rodenticide selected from the group of substances consisting of 2-isovalerylindan-l,3-dione (IUPAC name) (1246) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748) + TX, alpha-chlorohydrin [CCN] + TX, aluminium phosphide (640) + TX, antu (880) + TX, arsenous oxide (882) + TX, barium carbonate (891) + TX, bisthiosemi (912) + TX, brodifacoum (89) + TX, bromadiolone (91) + TX, bromethalin (92) + TX, calcium cyanide (444) + TX, chloralose (127) + TX, chlorophacinone (140) + TX, cholecalciferol (alternative name) (850) + TX, coumachlor (1004) + TX, coumafuryl (1005) + TX, coumatetralyl (175) + TX, crimidine (1009) + TX, difenacoum (246) + TX, difethialone (249) + TX, diphacinone (273) + TX, ergocalciferol (301) + TX, flocoumafen (357) + TX, fluoroacetamide (379) + TX, fiupropadine (1183) + TX, fiupropadine hydrochloride (1183) + TX, gamma-HCH (430) + TX, HCH (430) + TX, hydrogen cyanide (444) + TX, iodomethane (IUPAC name) (542) + TX, lindane (430) + TX, magnesium phosphide (IUPAC name) (640) + TX, methyl bromide (537) + TX, norbormide (1318) + TX, phosacetim (1336) + TX, phosphine (IUPAC name) (640) + TX, phosphorus [CCN] + TX, pindone (1341) + TX, potassium arsenite [CCN] + TX, pyrinuron (1371) + TX, scilliroside (1390) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoroacetate (735) + TX, strychnine (745) + TX, thallium sulfate [CCN] + TX, warfarin (851) and zinc phosphide (640) + TX,

a synergist selected from the group of substances consisting of 2-(2-butoxyethoxy)ethyl piperonylate (IUPAC name) (934) + TX, 5-(l,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone (IUPAC name) (903) + TX, farnesol with nerolidol (alternative name) (324) + TX, MB-599 (development code) (498) + TX, MGK 264 (development code) (296) + TX, piperonyl butoxide (649) + TX, piprotal (1343) + TX, propyl isomer (1358) + TX, S421 (development code) (724) + TX, sesamex (1393) + TX, sesasmolin (1394) and sulfoxide (1406) + TX, an animal repellent selected from the group of substances consisting of anthraquinone (32) + TX, chloralose (127) + TX, copper naphthenate [CCN] + TX, copper oxy chloride (171) + TX, diazinon (227) + TX, dicyclopentadiene (chemical name) (1069) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, methiocarb (530) + TX, pyridin-4 -amine (IUPAC name) (23) + TX, thiram (804) + TX, trimethacarb (840) + TX, zinc naphthenate [CCN] and ziram (856) + TX,

a virucide selected from the group of substances consisting of imanin (alternative name) [CCN] and ribavirin (alternative name) [CCN] + TX,

a wound protectant selected from the group of substances consisting of mercuric oxide (512) + TX, octhilinone (590) and thiophanate-methyl (802) + TX, and biologically active compounds selected from the group consisting of azaconazole (60207-31-0] + TX, bitertanol [70585-36-3] + TX, bromuconazole [116255-48-2] + TX, cyproconazole [94361-06-5] + TX, difenoconazole [119446-68-3] + TX, diniconazole

[83657-24-3] + TX, epoxiconazole [106325-08-0] + TX, fenbuconazole [114369-43-6] + TX, fluquinconazole [136426-54-5] + TX, flusilazole [85509-19-9] + TX, flutriafol [76674- 21-0] + TX, hexaconazole [79983-71-4] + TX, imazalil [35554-44-0] + TX, imibenconazole [86598-92-7] + TX, ipconazole [125225-28-7] + TX, metconazole [125116-23-6] + TX, myclobutanil [88671-89-0] + TX, pefurazoate [101903-30-4] + TX, penconazole [66246-88- 6] + TX, prothioconazole [178928-70-6] + TX, pyrifenox [88283-41-4] + TX, prochloraz [67747-09-5] + TX, propiconazole [60207-90-1] + TX, simeconazole [149508-90-7] + TX, tebuconazole [107534-96-3] + TX, tetraconazole [112281-77-3] + TX, triadimefon [43121- 43-3] + TX, triadimenol [55219-65-3] + TX, triflumizole [99387-89-0] + TX, triticonazole [131983-72-7] + TX, ancymidol [12771-68-5] + TX, fenarimol [60168-88-9] + TX, nuarimol [63284-71-9] + TX, bupirimate [41483-43-6] + TX, dimethirimol [5221-53-4] + TX, ethirimol [23947-60-6] + TX, dodemorph [1593-77-7] + TX, fenpropidine [67306-00-7] + TX, fenpropimorph [67564-91-4] + TX, spiroxamine [118134-30-8] + TX, tridemorph [81412-43-3] + TX, cyprodinil [121552-61-2] + TX, mepanipyrim [110235-47-7] + TX, pyrimethanil [53112-28-0] + TX, fenpiclonil [74738-17-3] + TX, fludioxonil [131341-86-1] + TX, benalaxyl [71626-11-4] + TX, furalaxyl [57646-30-7] + TX, metalaxyl [57837-19-1] + TX, R-metalaxyl [70630-17-0] + TX, ofurace [58810-48-3] + TX, oxadixyl [77732-09-3] + TX, benomyl [17804-35-2] + TX, carbendazim [10605-21-7] + TX, debacarb [62732-91- 6] + TX, fuberidazole [3878-19-1] + TX, thiabendazole [148-79-8] + TX, chlozolinate

[84332-86-5] + TX, dichlozoline [24201-58-9] + TX, iprodione [36734-19-7] + TX, myclozoline [54864-61-8] + TX, procymidone [32809-16-8] + TX, vinclozoline [50471-44- 8] + TX, boscalid [188425-85-6] + TX, carboxin [5234-68-4] + TX, fenfuram [24691-80-3] + TX, flutolanil [66332-96-5] + TX, mepronil [55814-41-0] + TX, oxycarboxin [5259-88-1] + TX, penthiopyrad [183675-82-3] + TX, thifluzamide [130000-40-7] + TX, guazatine

[108173-90-6] + TX, dodine [2439-10-3] [112-65-2] (free base) + TX, iminoctadine [13516- 27-3] + TX, azoxystrobin [131860-33-8] + TX, dimoxystrobin [149961-52-4] + TX, enestroburin {Proc. BCPC, Int. Congr., Glasgow, 2003, 1, 93} + TX, fluoxastrobin [361377- 29-9] + TX, kresoxim-methyl [143390-89-0] + TX, metominostrobin [133408-50-1] + TX, trifloxystrobin [141517-21-7] + TX, orysastrobin [248593-16-0] + TX, picoxystrobin

[117428-22-5] + TX, pyraclostrobin [175013-18-0] + TX, ferbam [14484-64-1] + TX, mancozeb [8018-01-7] + TX, maneb [12427-38-2] + TX, metiram [9006-42-2] + TX, propineb [12071-83-9] + TX, thiram [137-26-8] + TX, zineb [12122-67-7] + TX, ziram

[137-30-4] + TX, captafol [2425-06-1] + TX, captan [133-06-2] + TX, dichlofluanid [1085- 98-9] + TX, fluoroimide [41205-21-4] + TX, folpet [133-07-3 ] + TX, tolylfluanid [731-27- 1 ] + TX, bordeaux mixture [8011 -63-0] + TX, copperhydroxid [20427-59-2] + TX, copperoxychlorid [1332-40-7] + TX, coppersulfat [7758-98-7] + TX, copperoxid [1317-39- 1] + TX, mancopper [53988-93-5] + TX, oxine-copper [10380-28-6] + TX, dinocap [131-72- 6] + TX, nitrothal-isopropyl [10552-74-6] + TX, edifenphos [17109-49-8] + TX,

iprobenphos [26087-47-8] + TX, isoprothiolane [50512-35-1] + TX, phosdiphen [36519-00- 3] + TX, pyrazophos [13457-18-6] + TX, tolclofos-methyl [57018-04-9] + TX, acibenzolar- S-methyl [135158-54-2] + TX, anilazine [101-05-3] + TX, benthiavalicarb [413615-35-7] + TX, blasticidin-S [2079-00-7] + TX, chinomethionat [2439-01-2] + TX, chloroneb [2675-77- 6] + TX, chlorothalonil [1897-45-6] + TX, cyflufenamid [180409-60-3] + TX, cymoxanil [57966-95-7] + TX, dichlone [117-80-6] + TX, diclocymet [139920-32-4] + TX, diclomezine [62865-36-5] + TX, dicloran [99-30-9] + TX, diethofencarb [87130-20-9] + TX, dimethomorph [110488-70-5] + TX, SYP-LI90 (Flumorph) [211867-47-9] + TX, dithianon [3347-22-6] + TX, ethaboxam [162650-77-3] + TX, etridiazole [2593-15-9] + TX, famoxadone [131807-57-3] + TX, fenamidone [161326-34-7] + TX, fenoxanil [115852- 48-7] + TX, fentin [668-34-8] + TX, ferimzone [89269-64-7] + TX, fluazinam [79622-59-6] + TX, fluopicolide [239110-15-7] + TX, flusulfamide [106917-52-6] + TX, fenhexamid

[126833-17-8] + TX, fosetyl-aluminium [39148-24-8] + TX, hymexazol [10004-44-1] + TX, iprovalicarb [140923-17-7] + TX, IKF-916 (Cyazofamid) [120116-88-3] + TX,

kasugamycin [6980-18-3] + TX, methasulfocarb [66952-49-6] + TX, metrafenone [220899- 03-6] + TX, pencycuron [66063-05-6] + TX, phthalide [27355-22-2] + TX, polyoxins

[11113-80-7] + TX, probenazole [27605-76-1] + TX, propamocarb [25606-41-1] + TX, proquinazid [189278-12-4] + TX, pyroquilon [57369-32-1] + TX, quinoxyfen [124495-18-7] + TX, quintozene [82-68-8] + TX, sulphur [7704-34-9] + TX, tiadinil [223580-51-6] + TX, triazoxide [72459-58-6] + TX, tricyclazole [41814-78-2] + TX, triforine [26644-46-2] + TX, validamycin [37248-47-8] + TX, zoxamide (RH7281) [156052-68-5] + TX, mandipropamid [374726-62-2] + TX, isopyrazam [881685-58-1] + TX, sedaxane [874967-67-6] + TX, 3- difluoromethyl- 1 -methyl- 1 H-pyrazole-4-carboxylic acid (9-dichloromethylene- 1 ,2,3 ,4- tetrahydro-l,4-methano-naphthalen-5-yl)-amide (dislosed in WO 2007/048556) + TX, 3- difluoromethyl- 1 -methyl- 1 H-pyrazole-4-carboxylic acid [2-(2,4-dichlorophenyl)-2-methoxy- l-methyl-ethyl]-amide (disclosed in WO 2008/148570) + TX, l-[4-[4-[(5S)5-(2,6- difluorophenyl)-4,5-dihydro-l,2-oxazol-3-yl]-l,3-thiazol-2-yl]piperidin-l-yl]-2-[5-methyl-3- (trifluoromethyl)-lH-pyrazol-l-yl]ethanone + TX, l-[4-[4-[5-(2,6-difluorophenyl)-4,5- dihydro-l,2-oxazol-3-yl]-l,3-thiazol-2-yl]piperidin-l-yl]-2-[5-methyl-3-(trifluorometh lH-pyrazol-l-yl]ethanone [1003318-67-9], both disclosed in WO 2010/123791, WO

2008/013925, WO 2008/013622 and WO 2011/051243 page 20) +TX, S)-[3-(4-Chloro-2- fluoro-phenyl)-5 -(2,4-difluoro-phenyl)-isoxazol-4-y l]-pyridin-3-yl-methanol + TX, 3-(4- Chloro-2-fluoro-phenyl)-5 -(2,4-difluoro-phenyl)-isoxazol-4-y l]-pyridin-3-yl -methanol + TX, 3-difluoromethyl-l -methyl- lH-pyrazole-4-carboxylic acid (3',4',5'-trifluoro-biphenyl-2- yl)-amide (disclosed in WO 2006/087343) + TX, 3-(difluoromethyl)-N-methoxy-l-methyl- N-[l-methyl-2-(2,4,6-trichlorophenyl)ethyl]-lH-Pyrazole-4-carboxamide + TX, 4-[(5S)-5- (3 ,5 -dichlorophenyl)-5 -(trifluoromethyl)-4H-isoxazol-3 -yl] -2-methyl-N-(thietan-3 - yl)benzamide (WO2011/104089) + TX, 4-[(5i?)-5-(3,5-dichlorophenyl)-5-(trifluoromethyl)- 4H-isoxazol-3-yl]-2-methyl-N-(thietan-3-yl)benzamide (WO2011/104089) + TX, 4-[(5S)-5- (3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(cis-l-oxo-thietan- 3-yl)benzamide (WO2011/104089) + TX, 4-[(5i?)-5-(3,5-dichlorophenyl)-5- (trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(cis-l-oxo-thietan-3-yl)benzamide

(WO2011/104089) + TX, 4-[(55)-5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3- yl]-2-methyl-N-(trans-l-oxo-thietan-3-yl)benzamide (WO2011/104089) + TX, 4-[(5R)-5- (3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(trans-l-oxo- thietan-3-yl)benzamide (WO2011/104089) + TX, 4-[(55)-5-(3,5-dichlorophenyl)-5- (trifluoromethyl)-4H-isoxazol-3 -yl] -N-( 1 , 1 -dioxothietan-3 -yl)-2-methyl-benzamide

(WO2011/104089) + TX, 4-[(5i?)-5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3- yl]-N-(l,l-dioxothietan-3-yl)-2-methyl-benzamide (WO2011/104089) + TX, 4-[(5S)-5-(3,5- dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-[2-oxo-2-(2,2,2- trifluoroethylamino)ethyl]benzamide (WO2011/104089) + TX, 4-[(5R)-5-(3,5- dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-[2-oxo-2-(2,2,2- trifluoroethylamino)ethyl]benzamide (WO2011/104089) + TX, Penflufen [494793-67-8] and TX, 5 - [(5 S)-5 -(3 ,5 -dichlorophenyl)-5 -(trifluoromethyl)-4H-isoxazol-3 -yl] -2-( 1 ,2,4-triazol- 1 - yl)benzonitrile (WO2007/075459) + TX, 5-[(5R)-5-(3,5-dichlorophenyl)-5-(trifluoromethyl)- 4H-isoxazol-3-yl]-2-(l,2,4-triazol-l-yl)benzonitrile (WO2007/075459) + TX. The references in brackets behind the active ingredients, e.g. [3878-19-1] refer to the Chemical Abstracts Registry number. The compounds of the formula A-l to A-26 are described in WO 03/015518 or in WO 04/067528. The compound of the formula A-27 is described in WO 06/022225 and in WO 07/112844. The above described mixing partners are known. Where the active ingredients are included in "The Pesticide Manual" [The Pesticide Manual - A World Compendium; Thirteenth Edition; Editor: C. D. S. TomLin; The British Crop Protection Council], they are described therein under the entry number given in round brackets hereinabove for the particular compound; for example, the compound "abamectin" is described under entry number (1). Where "[CCN]" is added hereinabove to the particular compound, the compound in question is included in the "Compendium of Pesticide Common Names", which is accessible on the internet [A. Wood; Compendium of Pesticide Common Names, Copyright © 1995-2004]; for example, the compound "acetoprole" is described under the internet address http://www.alanwood.net/pesticides/acetoprole.htmL.

Most of the active ingredients described above are referred to hereinabove by a so- called "common name", the relevant "ISO common name" or another "common name" being used in individual cases. If the designation is not a "common name", the nature of the designation used instead is given in round brackets for the particular compound; in that case, the IUPAC name, the IUPAC/Chemical Abstracts name, a "chemical name", a "traditional name", a "compound name" or a "develoment code" is used or, if neither one of those designations nor a "common name" is used, an "alternative name" is employed. "CAS Reg. No" means the Chemical Abstracts Registry Number.

The compounds of formula I according to the invention can also be used in combination with one or more fungicides. In particular, in the following mixtures of the compounds of formula I with fungicides, the term TX preferably refers to a compound selected from one of the Tables 1 to 48 and A and B and C:

TX + (E)-N-methyl-2-[2-(2,5-dimethylphenoxymethyl)phenyl]-2-methoxy- iminoacetamide (SSF-129), TX + 4-bromo-2-cyano-N,N-dimethyl-6-trifluoromethyl- benzimidazole-l-sulphonamide, TX + -[N-(3-chloro-2,6-xylyl)-2-methoxy- acetamido]-y-butyrolactone, TX + 4-chloro-2-cyano-N,N-dimethyl-5-/?-tolylimidazole-l- sulfonamide (IKF-916, cyamidazosulfamid), TX + 3-5-dichloro-N-(3-chloro-l-ethyl-l- methyl-2-oxopropyl)-4-methylbenzamide (RH-7281, zoxamide), TX + N-allyl-4,5,- dimethyl-2-trimethylsilylthiophene-3-carboxamide (MON65500), TX + N-(l-cyano-l ,2- dimethylpropyl)-2-(2,4-dichlorophenoxy)propionamide (AC382042), TX +

N-(2-methoxy-5-pyridyl)-cyclopropane carboxamide, TX + acibenzolar, TX + alanycarb, TX + aldimorph, TX + amisulbrom, TX + anilazine, TX + azaconazole, TX + azoxystrobin, TX + benalaxyl, TX + benalaxyl-M, TX + benomyl, TX + benthiavalicarb, TX + biloxazol, TX + bitertanol, TX + bixafen, TX + blasticidin S, TX + boscalid, TX + bromuconazole, TX + bupirimate, TX + captafol, TX + captan, TX + carbendazim, TX + carbendazim chlorhydrate, TX + carboxin, TX + carpropamid, carvone, TX + CGA41396, TX + CGA41397, TX + chinomethionate, TX + chlazafenone, TX + chlorothalonil, TX + chlorozolinate, TX + clozylacon, TX + copper containing compounds such as copper oxychloride, copper oxyquinolate, copper sulphate, copper tallate and Bordeaux mixture, TX + cyazofamid, TX + cyflufenamid, TX + cymoxanil, TX + cyproconazole, TX + cyprodinil, TX + debacarb, TX + di-2-pyridyl disulphide Ι ,Γ-dioxide, TX + dichlofluanid, TX + diclomezine, TX + dicloran, TX + diethofencarb, TX + difenoconazole, TX + difenzoquat, TX + diflumetorim, TX + ^O-di-zso-propyl-S-benzyl thiophosphate, TX + dimefluazole, TX + dimetconazole, TX + dimethomorph, TX + dimethirimol, TX + dimoxystrobin, TX + diniconazole, TX + dinocap, TX + dithianon, TX + dodecyl dimethyl ammonium chloride, TX + dodemorph, TX + dodine, TX + doguadine, TX + edifenphos, TX + epoxiconazole, TX + ethirimol, TX + ethyl(Z)-N-benzyl-N([methyl(methyl-thioethylideneaminooxycarbonyl)amino]thio)- -β-alaninate, TX + etridiazole, TX + famoxadone, TX + fenamidone (RPA407213), TX + fenarimol, TX + fenbuconazole, TX + fenfuram, TX + fenhexamid (KBR2738), TX + fenoxanil, TX + fenpiclonil, TX + fenpropidin, TX + fenpropimorph, TX +

fenpyrazamine/ipfenpyrazolone, TX + fentin acetate, TX + fentin hydroxide, TX + ferbam, TX + ferimzone, TX + fluazinam, TX + fludioxonil, TX + flumetover, TX + flumorph, TX + fluopicolide, TX + fluopyram, TX + fluoxastrobin, TX + fluoroimide, TX + fluquinconazole, TX + flusilazole, TX + flutianil, TX + flutolanil, TX + fiutriafol, TX + fiuxapyroxad, TX + folpet, TX + fuberidazole, TX + furalaxyl, TX + furametpyr, TX + guazatine, TX + hexaconazole, TX + hydroxyisoxazole, TX + hymexazole, TX + imazalil, TX +

imibenconazole, TX + iminoctadine, TX + iminoctadine triacetate, TX + ipconazole, TX + iprobenfos, TX + iprodione, TX + iprovalicarb (SZX0722), TX + isopropanyl butyl carbamate, TX + isoprothiolane, TX + isopyrazam, TX + isotianil, TX + kasugamycin, TX + kresoxim-methyl, TX + LY186054, TX + LY21 1795, TX + LY248908, TX + mancozeb, TX + mandipropamid, TX + maneb, TX + mefenoxam, TX + mepanipyrim, TX + mepronil, TX + meptyldinocap, TX + metalaxyl, TX + metconazole, TX + metiram, TX + metiram-zinc, TX + metominostrobin, TX + metrafenone, TX + myclobutanil, TX + neoasozin, TX + nickel dimethyldithiocarbamate, TX + nicobifen, TX + nitrothal-z^'sopropyl, TX + nuarimol, TX + ofurace, TX + organomercury compounds, TX + orysastrobin, TX + oxadixyl, TX + oxasulfuron, TX + oxolinic acid, TX + oxpoconazole, TX + oxycarboxin, TX + pefurazoate, TX + penconazole, TX + pencycuron, TX + penthiopyrad, TX + phenazin oxide, TX + phosetyl-Al, TX + phosphorus acids, TX + phthalide, TX + picoxystrobin (ZA1963), TX + polyoxin D, TX + polyram, TX + probenazole, TX + prochloraz, TX + procymidone, TX + propamocarb, TX + propiconazole, TX + propineb, TX + propionic acid, TX + proquinazid, TX + prothioconazole, TX + pyraclostrobin, TX + pyrazophos, TX + pyribencarb, TX + pyrifenox, TX + pyrimethanil, TX + pyroquilon, TX + pyroxyfur, TX + pyrrolnitrin, TX + quaternary ammonium compounds, TX + quinomethionate, TX + quinoxyfen, TX + quintozene, TX + sedaxane, TX + sipconazole (F-155), TX + sodium pentachlorophenate, TX + spiroxamine, TX + streptomycin, TX + sulphur, TX + tebuconazole, TX + tecloftalam, TX + tecnazene, TX + tetraconazole, TX + thiabendazole, TX + thifluzamid, TX +

2-(thiocyanomethylthio)benzothiazole, TX + thiophanate -methyl, TX + thiram, TX + tiadinil, TX + timibenconazole, TX + tolclofos-methyl, TX + tolylfluanid, TX + triadimefon, TX + triadimenol, TX + triazbutil, TX + triazoxide, TX + tricyclazole, TX + tridemorph, TX + trifloxystrobin, TX + triforine, TX + triflumizole, TX + triticonazole, TX + validamycin A, TX + valiphenal, TX + vapam, TX + vinclozolin, TX + zineb and TX + ziram.

The compounds of formula I may be mixed with soil, peat or other rooting media for the protection of plants against seed-borne, soil-borne or foliar fungal diseases. The compounds of formula I according to the invention can also be used in

combination with one or more other synergists. In particular, the following mixtures of the TX, where this term preferably refers to a compound selected from one of the Tables Tables 1 to 48 and A and B and C, are important:

TX + piperonyl butoxide, TX + sesamex, TX + safroxan and TX + dodecyl imidazole.

The compounds of formula I according to the invention can also be used in

combination with one or more other herbicides. In particular, the following mixtures of the TX, where this term preferably refers to a compound selected from one of the Tables 1 to 48 and A and B and C, are important:

TX + acetochlor, TX + acifluorfen, TX + acifluorfen-sodium, TX + aclonifen, TX + acrolein, TX + alachlor, TX + alloxydim, TX + allyl alcohol, TX + ametryn, TX + amicarbazone, TX + amidosulfuron, TX + aminocyclopyrachlor, TX + aminopyralid, TX + amitrole, TX + ammonium sulfamate, TX + anilofos, TX + asulam, TX + atraton, TX + atrazine, TX + azimsulfuron, TX + BCPC, TX + beflubutamid, TX + benazolin, TX

+bencarbazone, TX + benfluralin, TX + benfuresate, TX + bensulfuron, TX + bensulfuron- methyl, TX + bensulide, TX + bentazone, TX + benzfendizone, TX + benzobicyclon, TX + benzofenap, COMPOUND OF THE FORMULA I + bicyclopyrone, TX + bifenox, TX + bilanafos, TX + bispyribac, TX + bispyribac-sodium, TX + borax, TX + bromacil, TX + bromobutide, TX + bromoxynil, TX + butachlor, TX + butafenacil, TX + butamifos, TX + butralin, TX + butroxydim, TX + butylate, TX + cacodylic acid, TX + calcium chlorate, TX + cafenstrole, TX + carbetamide, TX + carfentrazone, TX + carfentrazone-ethyl, TX + CDEA, TX + CEPC, TX + chlorflurenol, TX + chlorflurenol-methyl, TX + chloridazon, TX + chlorimuron, TX + chlorimuron-ethyl, TX + chloroacetic acid, TX + chlorotoluron, TX + chlorpropham, TX + chlorsulfuron, TX + chlorthal, TX + chlorthal-dimethyl, TX + cinidon- ethyl, TX + cinmethylin, TX + cinosulfuron, TX + cisanilide, TX + clethodim, TX + clodinafop, TX + clodinafop-propargyl, TX + clomazone, TX + clomeprop, TX + clopyralid, TX + cloransulam, TX + cloransulam-methyl, TX + CMA, TX + 4-CPB, TX + CPMF, TX + 4-CPP, TX + CPPC, TX + cresol, TX + cumyluron, TX + cyanamide, TX + cyanazine, TX + cycloate, TX + cyclosulfamuron, TX + cycloxydim, TX + cyhalofop, TX + cyhalofop-butyl, TX + 2,4-D, TX + 3,4-DA, TX + daimuron, TX + dalapon, TX + dazomet, TX + 2,4-DB, TX + 3,4-DB, TX + 2,4-DEB, TX + desmedipham, TX + dicamba, TX + dichlobenil, TX + ortho-dichlorobenzene, TX + para-dichlorobenzene, TX + dichlorprop, TX + dichlorprop-P, TX + diclofop, TX + diclofop-methyl, TX + diclosulam, TX + difenzoquat, TX +

difenzoquat metilsulfate, TX + diflufenican, TX + diflufenzopyr, TX + dimefuron, TX + dimepiperate, TX + dimethachlor, TX + dimethametryn, TX + dimethenamid, TX + dimethenamid-P, TX + dimethipin, TX + dimethylarsinic acid, TX + dinitramine, TX + dinoterb, TX + diphenamid, TX + diquat, TX + diquat dibromide, TX + dithiopyr, TX + diuron, TX + DNOC, TX + 3,4-DP, TX + DSMA, TX + EBEP, TX + endothal, TX + EPTC, TX + esprocarb, TX + ethalfluralin, TX + ethametsulfuron, TX + ethametsulfuron-methyl, TX + ethofumesate, TX + ethoxyfen, TX + ethoxysulfuron, TX + etobenzanid, TX + fenoxaprop-P, TX + fenoxaprop-P-ethyl, TX + fentrazamide, TX + ferrous sulfate, TX + flamprop-M, TX + flazasulfuron, TX + florasulam, TX + fluazifop, TX + fluazifop-butyl, TX + fluazifop-P, TX + fluazifop-P-butyl, TX + flucarbazone, TX + flucarbazone-sodium, TX + flucetosulfuron, TX + fluchloralin, TX + flufenacet, TX + flufenpyr, TX + flufenpyr- ethyl, TX + flumetsulam, TX + flumiclorac, TX + flumiclorac-pentyl, TX + flumioxazin, TX + fluometuron, TX + fluoroglycofen, TX + fluoroglycofen-ethyl, TX + flupropanate, TX + flupyrsulfuron, TX + flupyrsulfuron-methyl-sodium, TX + flurenol, TX + fluridone, TX + flurochloridone, TX + fluroxypyr, TX + flurtamone, TX + fluthiacet, TX + fluthiacet-methyl, TX + fomesafen, TX + foramsulfuron, TX + fosamine, TX + glufosinate, TX + glufosinate- ammonium, TX + glufosinate-P, TX + glyphosate, TX + glyphosate-trimesium, TX + halosulfuron, TX + halosulfuron-methyl, TX + haloxyfop, TX + haloxyfop-P, TX + HC-252, TX + hexazinone, TX + imazamethabenz, TX + imazamethabenz -methyl, TX + imazamox, TX + imazapic, TX + imazapyr, TX + imazaquin, TX + imazethapyr, TX + imazosulfuron, TX + indanofan, TX + indaziflam, TX + iodomethane, TX + iodosulfuron, TX +

iodosulfuron-methyl-sodium, TX + ioxynil, TX + ipfencarbazone, TX + isoproturon, TX + isouron, TX + isoxaben, TX + isoxachlortole, TX + isoxaflutole, TX + karbutilate, TX + lactofen, TX + lenacil, TX + linuron, TX + MAA, TX + MAMA, TX + MCPA, TX + MCPA-thioethyl, TX + MCPB, TX + mecoprop, TX + mecoprop-P, TX + mefenacet, TX + mefluidide, TX + mesosulfuron, TX + mesosulfuron-methyl, TX + mesotrione, TX + metam, TX + metamifop, TX + metamitron, TX + metazachlor, TX + methabenzthiazuron, TX + methylarsonic acid, TX + methyldymron, TX + methyl isothiocyanate, TX + metobenzuron, TX + metolachlor, TX + S-metolachlor, TX + metosulam, TX + metoxuron, TX +

metribuzin, TX + metsulfuron, TX + metsulfuron-methyl, TX + MK-616, TX + molinate, TX + monolinuron, TX + MSMA, TX + naproanilide, TX + napropamide, TX + naptalam, TX + neburon, TX + nicosulfuron, TX + nonanoic acid, TX + norflurazon, TX + oleic acid (fatty acids), TX + orbencarb, TX + orthosulfamuron, TX + oryzalin, TX + oxadiargyl, TX + oxadiazon, TX + oxasulfuron, TX + oxaziclomefone, TX + oxyfluorfen, TX + paraquat, TX + paraquat dichloride, TX + pebulate, TX + pendimethalin, TX + penoxsulam, TX + pentachlorophenol, TX + pentanochlor, TX + pentoxazone, TX + pethoxamid, TX + petrolium oils, TX + phenmedipham, TX + phenmedipham-ethyl, TX + picloram, TX + picolinafen, TX + pinoxaden, TX + piperophos, TX + potassium arsenite, TX + potassium azide, TX + pretilachlor, TX + primisulfuron, TX + primisulfuron-methyl, TX + prodiamine, TX + profluazol, TX + profoxydim, TX + prometon, TX + prometryn, TX + propachlor, TX + propanil, TX + propaquizafop, TX + propazine, TX + propham, TX + propisochlor, TX + propoxycarbazone, TX + propoxycarbazone-sodium, TX + propyrisulfuron, TX + propyzamide, TX + prosulfocarb, TX + prosulfuron, TX + pyraclonil, TX + pyraflufen, TX + pyraflufen-ethyl, TX + pyrasulfutole, TX + pyrazolynate, TX + pyrazosulfuron, TX + pyrazosulfuron-ethyl, TX + pyrazoxyfen, TX + pyribenzoxim, TX + pyributicarb, TX + pyridafol, TX + pyridate, TX + pyriftalid, TX + pyriminobac, TX + pyriminobac-methyl, TX + pyrimisulfan, TX + pyrithiobac, TX + pyrithiobac-sodium, TX + pyroxsulam, TX + pyroxasulfone, TX + quinclorac, TX + quinmerac, TX + quinoclamine, TX + quizalofop, TX + quizalofop-P, TX + rimsulfuron, TX +saflufenacil, TX + sethoxydim, TX + siduron, TX + simazine, TX + simetryn, TX + SMA, TX + sodium arsenite, TX + sodium azide, TX + sodium chlorate, TX + sulcotrione, TX + sulfentrazone, TX + sulfometuron, TX + sulfometuron-methyl, TX + sulfosate, TX + sulfosulfuron, TX + sulfuric acid, TX + tar oils, TX + 2,3,6-TBA, TX + TCA, TX + TCA-sodium, TX + tebuthiuron, TX + tefuryltrione, TX + tembotrione, TX + tepraloxydim, TX + terbacil, TX + terbumeton, TX + terbuthylazine, TX + terbutryn, TX + thenylchlor, TX + thiazopyr, TX + thiencarbazone, TX +

thifensulfuron, TX + thifensulfuron-methyl, TX + thiobencarb, TX + tiocarbazil, TX + topramezone, TX + tralkoxydim, TX + tri-allate, TX + triasulfuron, TX + triaziflam, TX + tribenuron, TX + tribenuron-methyl, TX + tricamba, TX + triclopyr, TX + trietazine, TX + trifloxysulfuron, TX + trifloxysulfuron-sodium, TX + trifluralin, TX + triflusulfuron, TX + triflusulfuron-methyl, TX + trihydroxytriazine, TX + tritosulfuron, TX + [3-[2-chloro-4- fluoro-5-(l-methyl-6-trifluoromethyl-2,4-dioxo-l,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]- 2-pyridyloxy]acetic acid ethyl ester (CAS RN 353292-31-6), TX + 4-[(4,5-dihydro-3- methoxy-4-methyl-5 -oxo)- 1 H- 1 ,2,4-triazol- 1 -ylcarbonylsulfamoyl] -5 -methylthiophene-3 - carboxylic acid (BAY636), TX + BAY747 (CAS RN 335104-84-2), TX + topramezone (CAS RN 210631 -68-8), TX + 4-hydroxy-3-[[2-[(2-methoxyethoxy)methyl]-6-(trifluoro- methyl)-3-pyridinyl]carbonyl]-bicyclo[3.2.1]oct-3-en-2-one (CAS RN 352010-68-5), and TX + 4-hydroxy-3 - [ [2-(3 -methoxypropyl)-6-(difluoromethyl)-3 -pyridinyl] carbonyl] - bicyclo [3.2.1 ]oct-3 -en-2-one. The compounds of formula (I) according to the invention can also be used in combination with safeners. Preferably, in these mixtures, the compound of the formula (I) is one of those compounds listed in Tables 1 to 48 and A and B and C above. The following mixtures with safeners, especially, come into consideration: compound of formula (I) + cloquintocet-mexyl, compound of formula (I) + cloquintocet acid and salts thereof, compound of formula (I) + fenchlorazole-ethyl, compound of formula (I) + fenchlorazole acid and salts thereof, compound of formula (I) + mefenpyr-diethyl, compound of formula (I) + mefenpyr diacid, compound of formula (I) + isoxadifen-ethyl, compound of formula (I) + isoxadifen acid, compound of formula (I) + furilazole, compound of formula (I) + furilazole R isomer, compound of formula (I) + benoxacor, compound of formula (I) + dichlormid, compound of formula (I) + AD-67, compound of formula (I) + oxabetrinil, compound of formula (I) + cyometrinil, compound of formula (I) + cyometrinil Z-isomer, compound of formula (I) + fenclorim, compound of formula (I) + cyprosulfamide, compound of formula (I) + naphthalic anhydride, compound of formula (I) + flurazole, compound of formula (I) + N-(2-methoxybenzoyl)-4- [(methylaminocarbonyl)amino]benzenesulfonamide, compound of formula (I) + CL 304,415, compound of formula (I) + dicyclonon, compound of formula (I) + fluxofenim, compound of formula (I) + DKA-24, compound of formula (I) + R-29148 and compound of formula (I) + PPG- 1292. A safening effect can also be observed for the mixtures compound of the formula (I) + dymron, compound of the formula (I) + MCPA, compound of the formula (I) + mecoprop and compound of the formula (I) + mecoprop-P.

The mixing partners of the TX may also be in the form of esters or salts, as mentioned e.g. in "The Pesticide Manual" [The Pesticide Manual - A World Compendium; Thirteenth Edition; Editor: C. D. S. TomLin; The British Crop Protection Council].

In the above different lists of active ingredients to be mixed with a TX, the compound of the formula I is preferably a compound from the Tables 1 to 48 and A and B and C; and more preferably a compound TX is selected from Al, A2, A3, A4, A8, A15, A16, A17, A18, A19, A23, A24, A26, A28, A30, A31, A38, A40, A41, A48, A69, A72, A73, A74, A75, A78, A79, A80, A81, A82, A85, A86, or TX is preferably selected from Al, A2, A3, A4, A5, A8, A15, A16, A17, A26, A30, A31, A32, A33, A34, A37, A38, A40, A41, A45, A48, A51, A67, A68, A69, A70, A75, A79, A80, A81, A82, A83, A85, A86, or TX is selected from Al, A2, A3, A4, A5, A8, Al l, A15, A16, A18, A21, A23, A24, A26, A27, A28, A29, A30, A31, A34, A37, A38, A41, A47, A48, A68, A72, A73, A79, A80, A81, A82, A85, A86, or TX is preferably selected from Al, A2, A4, A8, A21, A30, A38, A40, A73, A81, or TX is preferably selected from Al, A2, A4, A8, A12, A15, A19, A23, A24, A30, A38, A40, A49, or TX is preferably selected from Al, A2, A4, A23, A24, A29, or TX is preferably selected from Al, A2, A4, A23, A24, A29, A30, A31, A38, A41, A80, A81, or TX is preferably selected from Al, A2, A4, A5, A7, A8.

In the above-mentioned mixtures of compounds of formula I, in particular a compound selected from said Tables 1 to 48 and A and B and C, with other insecticides, fungicides, herbicides, safeners, adjuvants and the like, the mixing ratios can vary over a large range and are, preferably

100: 1 to 1 :6000, especially 50: 1 to 1 :50, more especially 20: 1 to 1 :20, even more especially 10: 1 to 1 : 10. Those mixing ratios are understood to include, on the one hand, ratios by weight and also, on other hand, molar ratios.

The mixtures can advantageously be used in the above-mentioned formulations (in which case "active ingredient" relates to the respective mixture of TX with the mixing partner).

The mixtures comprising a TX selected from Tables 1 to 48 and A and B and C and one or more active ingredients as described above comprises a compound selected from table P and an active ingredient as described above preferably in a mixing ratio of from 100: 1 to 1 :6000, especially from 50: 1 to 1 :50, more especially in a ratio of from 20: 1 to 1 :20, even more especially from 10: 1 to 1 :10, very especially from 5: 1 and 1 :5, special preference being given to a ratio of from 2: 1 to 1 :2, and a ratio of from 4: 1 to 2: 1 being likewise preferred, above all in a ratio of 1 : 1, or 5: 1, or 5:2, or 5:3, or 5:4, or 4: 1, or 4:2, or 4:3, or 3: 1, or 3:2, or 2: 1, or 1 :5, or 2:5, or 3:5, or 4:5, or 1 :4, or 2:4, or 3:4, or 1 :3, or 2:3, or 1 :2, or 1 :600, or 1 :300, or 1 : 150, or 1 :35, or 2:35, or 4:35, or 1 :75, or 2:75, or 4:75, or 1 :6000, or 1 :3000, or 1 : 1500, or 1 :350, or 2:350, or 4:350, or 1 :750, or 2:750, or 4:750. Those mixing ratios are understood to include, on the one hand, ratios by weight and also, on other hand, molar ratios.

Some mixtures may comprise active ingredients which have significantly different physical, chemical or biological properties such that they do not easily lend themselves to the same conventional formulation type. In these circumstances other formulation types may be prepared. For example, where one active ingredient is a water insoluble solid and the other a water insoluble liquid, it may nevertheless be possible to disperse each active ingredient in the same continuous aqueous phase by dispersing the solid active ingredient as a suspension (using a preparation analogous to that of an SC) but dispersing the liquid active ingredient as an emulsion (using a preparation analogous to that of an EW). The resultant composition is a suspoemulsion (SE) formulation.

The mixtures comprising a TX selected from Tables 1 to 48 and A and B and C and one or more active ingredients as described above can be applied, for example, in a single "ready-mix" form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a "tank-mix", and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days. The order of applying the compounds of formula I selected from Tables 1 to 12 and A and the active ingredients as described above is not essential for working the present invention.

The compounds of formula (I) may be mixed with soil, peat or other rooting media for the protection of plants against seed-borne, soil-borne or foliar fungal diseases.

Examples of suitable synergists for use in the compositions include piperonyl butoxide, sesamex, safroxan and dodecyl imidazole.

Suitable herbicides and plant-growth regulators for inclusion in the compositions will depend upon the intended target and the effect required.

An example of a rice selective herbicide which may be included is propanil. An example of a plant growth regulator for use in cotton is PIX™.

Some mixtures may comprise active ingredients which have significantly different physical, chemical or biological properties such that they do not easily lend themselves to the same conventional formulation type. In these circumstances other formulation types may be prepared. For example, where one active ingredient is a water insoluble solid and the other a water insoluble liquid, it may nevertheless be possible to disperse each active ingredient in the same continuous aqueous phase by dispersing the solid active ingredient as a suspension (using a preparation analogous to that of an SC) but dispersing the liquid active ingredient as an emulsion (using a preparation analogous to that of an EW). The resultant composition is a suspoemulsion (SE) formulation. Preparation of Examples

2,6-Dichloro-4-( 1 ,2,2,2-tetrafluoro- 1 -trifluoromethyl-ethyl)-phenylamine (prepared according to WO2009030457)

Intermediate II : 2-Azido- 1 ,3 -dichloro-5-( 1 ,2,2,2-tetrafluoro- 1 -trifluoromethyl-ethyl)- benzene

N^"

2,6-Dichloro-4-( 1 ,2,2,2-tetrafluoro- 1 -trifluoromethyl-ethyl)-phenylamine (prepared according to WO2009030457, 5 g; 15 mmol) in 40 mL of tertButanol was added to a mixture of water (40 ml) and concentrated HC1 (aq) (80 ml) and the mixture was stirred at room temperature for 30 minutes. Sodium nitrite (1.0 g; 15 mmol) dissolved in water (5 ml) was added in a dropwise manner to the mixture, which was kept at a temperature between 0 to 5°C. After the mixture had been stirred for 1.5 hours at this temperature, sodium azide (0.98 g; 15 mmol) dissolved in water (5 ml) was added in a dropwise manner to the mixture, and the mixture was stirred overnight at RT. After the reaction was complete the mixture was extracted with dichloromethane (3x40 ml), and the extract was dried (Na₂SC"4). The dichloromethane was evaporated and the residue was chromatographed on silica gel

(Cyclohexane), giving the corresponding azide (3.8 g; 70%) as an orange-brown oil. This compound was used without extra purification (it still contained starting material). 1H NMR (400MHz, CDC1₃):7.55 (s, 2H)

Intermediate 12: 2-Chloro-5-ethvnyl-benzoic acid methyl ester

A solution of 25 mL of 5-Bromo-2-chlorobenzoic acid methyl ester (commercially available, 100.2 mmol), 22.94 ml of ethynyltrimethylsilane (162.3 mmol), 0.45 g of palladium(II) acetate (2.0 mmol), and 1.05 g of triphenylphosphine (4.0 mmol) in 300mL of anhydrous triethylamine was rapidly heated to reflux under argon overnight. The mixture was cooled and the crystalline white solid of triethylamine hydrobromide was isolated by filtration. The dark brown filtrate was concentrated, mixed with 250 mL of aqueous sodium bicarbonate, and extracted with dichloromethane (3 x 100ml). The organic fractions were combined, dried over magnesium sulfate, and concentrated to yield an oil, which was dissolved in 200ml of THF and treated with 300ml of methanol and 500 mg of potassium carbonate. The mixture was stirred for 1 hour and concentrated. The concentrated solution was mixed with 250 mL of aqueous sodium bicarbonate, and extracted with ethyl acetate (3 x 100ml). The organic fractions were combined, dried over magnesium sulfate, and concentrated in vacuo, and chromatographed with cyclohexane / ethyl acetate (3: 17) to give 2-Chloro-5-ethynyl -benzoic acid methyl ester (14.0g, 74% yield). 1H NMR (400MHz, CDC1₃): 7.96(s, 1H), 7.5 (d, 1H), 7.42(d, 1H), 3.93 (s, 3H), 3.14 (s, 1H) ppm.

Intermediate 13 : Bl : 2-Chloro-5-(l-r2,6-dichloro-4-(l,2,2,2-tetrafluoro-l-trifluoromethyl- ethyl)-phenyll-lH-[l,2,31triazol-4-yl|-benzoic acid methyl ester

2-Chloro-5-ethynyl-benzoic acid methyl ester (Intermediate 12,2. lg, 11 mmol) and 2-Azido- l,3-dichloro-5-(l,2,2,2-tetrafluoro-l-trifluoromethyl-ethyl)-benzene (Intermediate II, 3.8 g, 11 mmol) were suspended in a mixture of water and t-BuOH (25 mL). Sodium ascorbate (0.600 ml 1 M sol. in water, freshly prepared) was added to the mixture followed by copper (II) sulfate pentahydrate (0.053 g). The resulting heterogeneous mixture was stirred vigorously for 96 hours. The reaction mixture was diluted with water and the product was extracted with ethyl acetate. The organic phase was washed with brine, dried over magnesium sulphate and evaporated. The resisue was subjected to silica gel column chromatography (c-HEX/EtOAc 1 to 10%) affording the desired product 2-Chloro-5-{l-[2,6- dichloro-4-( 1 ,2,2,2-tetrafluoro- 1 -trifluoromethyl-ethyl)-phenyl]- 1 H-[ 1 ,2,3]triazol-4-yl} - benzoic acid methyl ester (Compound Bl, 43% yield). 1H NMR (400MHz, CDC1₃): 8.38(s, 1H), 8.04 (dd, 1H), 8.06 (s, 1H), 7.31 (s, 2H), 7.58 (d, 1H), 3.87 (s, 3H) ppm. LC-MS RT 2.16, 552 (M+H⁺)

Intermediate 14: CI : 2-Chloro-5-(l-[2,6-dichloro-4-(l,2,2,2-tetrafluoro-l-trifluoromethyl- -phenyll-lH-[l, 2, 31triazol-4-yl| -benzoic acid

2-Chloro-5- { 1 -[2,6-dichloro-4-( 1 ,2,2,2-tetrafluoro- 1 -trifluoromethyl-ethyl)-phenyl] - 1 H- [1, 2, 3]triazol-4-yl} -benzoic acid methyl ester (Intermediate 13,2.5g, 4.5 mmol) was suspended in a mixture of water and tetrahydrofuran (1 :5, 50 mL) and lithium hydroxide (0.33 g, 14 mmol) was added. The resulting mixture was stirred vigorously for 15 hours at 50°C. The reaction mixture was diluted with water and acidified with hydrogen chloride (IN). The aqueous phase was extracted twice with AcOEt, dried over MgS0₄ and concentrated under vacuum to afford the desired product 2-Chloro-5-{l-[2,6-dichloro-4- ( 1 ,2,2,2-tetrafluoro- 1 -trifluoromethyl-ethyl)-phenyl] - 1 H-[ 1 ,2, 3]triazol-4-yl} -benzoic acid. This compound was used without extra purification (Compound CI). 1H NMR (400MHz, CDC1₃): 8.52(s, 1H), 8.12 (dd, 1H), 8.10 (Is, 1H), 7.78 (s, 2H), 7.64 (d, 1H) ppm. LC-MS RT 2.09, 534 (M-H⁺).

Example PI : 2-Chloro-N-cyclopropyl-5-{l-[2,6-dichloro-4-(l,2,2,2-tetrafluoro-l- trifluoromethyl-ethyl)-phenyl]- 1 H-[ 1 ,2,3]triazol-4-yl} -benzamide (Compound

Al)

To a solution of 2-Chloro-5-{l-[2,6-dichloro-4-(l,2,2,2-tetrafluoro-l-trifluoromethyl- ethyl)-phenyl]-lH-[l,2,3]triazol-4-yl}-benzoic acid (Example 14) (0.15 g, 0.28 mmol) and N,N-dimethylformamide (2 drops) in dichloromethane (6 ml) under a nitrogen atmosphere was added oxalyl chloride (0.49 ml, 5.6 mmol). The reaction mixture was stirred for one hour at 50°C. The reaction mixture was concentrated under vaccum and the residue dissolved in tetrahydrofuran (3 ml). The solution was added dropwise to a solution of cyclopropyl amine (0.032 g, 0.56 mmol) and pyridine (0.088 g, 1.1 mmol) in tetrahydrofuran (3 ml). The reaction mixture was stirred at ambient temperature for 4 hours at 60°C, then at 90°C overnight. The reaction was not complete (only 10-20% conversion), then 2 eq. of BOP-Cl and pyridine were added. After 4 hours at 90°C, the reaction was completed. The mixture reaction was poured into aqueous sodium hydrogen carbonate (1M) and the mixture extracted three times with ethyl acetate. The combined organic phases were dried over sodium sulfate and concentrated. The residue was purified by column chromatography on silica gel (eluent: ethyl acetate / cyclohexane 1 : 3) to give Compound No. Al of Table A (0.1 g, 62% yield). M.p. 222-225°C. 1H NMR (400 MHz, CDC1₃): 8.13 (m, 1H), 8.05 (s, 1H), 8.02 (d, 1H), 7.78 (s, 2H), 6.41 (sb, 1H), 2.95 (m, 1H), 0.92 (m, 2H), 0.68 (m, 2H) ppm. LC-MS: RT : 2.02, ES+ [575, M+H⁺]

Compounds A2 (2-Chloro-N-(l-cyano-cyclopropyl)-5-{l-[2,6-dichloro-4-(l, 2,2,2- tetrafluoro-l-trifluoromethyl-ethyl)-phenyl]-lH-[l,2,3]triazol-4-yl}-benzamide) from table A was prepared by the same method. 1H NMR (400 MHz, CDC1₃): 8.18(d, 1H), 8.11 (dd, 1H), 8.08 (s, 1H), 7.80 (s, 2H), 7.54 (d, 1H), 6.94 (sb, 1H), 1.7 (m, 2H), 1.42 (m, 2H) ppm. LC-MS:, RT: 2.00, ES+ [602, M+H] Example P2: General method for the acylation of an amino-benzamide in parallel

To a solution of the appropriate carboxylic acid (30 μιτιοΐ), for example 2-Chloro-5-{l-[2,6- dichloro-4-( 1 ,2,2,2-tetrafluoro- 1 -trifluoromethyl-ethyl)-phenyl]- 1 H-[ 1 ,2,3]triazol-4-yl} - benzoic acid (Example 14) in the case of Compound No. A20 of Table A, in

dimethylacetamide (0.4 ml) was added successively a solution of an amine of formula HNR'Q¹ (36 μιτιοΐ), for example 3-methyl-thietan-3-yl-amine (preparation described in, for example, WO2007/080131) in the case of Compound No. A21 of Table A, in

dimethylacetamide (0.145 ml), diisopropylethylamine (Hunig's Base) (0.03 ml, 180 μιτιοΐ), and a solution of bis(2-oxo-3-oxazolidinyl)phosphonic chloride ("BOP-C1") (11.5 mg) in dimethylacetamide (0.2 ml). The reaction mixture was stirred at 80°C for 16 hours. The reaction mixture was diluted with acetonitrile / dimethylformamide (4: 1) (0.8 ml) and purified by HPLC. This method was used to prepare a number of compounds (Compound Nos. A3 to A29 and A39 to 87 of Table A) in parallel.

The intermediate compounds B2 and C2 were prepared by the same methods as described above for intermediates Bl and CI, respectively.

Method A:

LC-MS Method (positive or negative) for compounds Bl, CI, Al and A2:

ZQ Mass Spectrometer from Waters (Single quadrupole mass spectrometer)

Instrument Parameter:

Ionization method: Electrospray

Polarity: positive or negative ions Capillary (kV) 3.00, Cone (V) 30.00, Extractor (V) 2.00, Source Temperature (°C) 100, Desolvation Temperature (°C) 250, Cone Gas Flow (L/Hr) 50, Desolvation Gas Flow (L/Hr) 400

Mass range: 100 to 900 Da

HP 1100 HPLC from Agilent: solvent degasser, binary pump, heated column compartment and diode-array detector.

Column: Phenomenex Gemini CI 8, 3 μιη, 30 x 3 mm,

Temp: 60 °C

DAD Wavelength range (nm): 210 to 500

Solvent Gradient:

A = water + 5% MeOH + 0.05 % HCOOH

B= Acetonitril + 0.05 % HCOOH

Method B:

LC-MS Method (positive) for compounds A3 to A29 and A39 to A87:

ACQUITY SQD Mass Spectrometer from Waters (Single quadrupole mass spectrometer) Ionisation method: Electrospray

Polarity: positive ions

Capillary (kV) 3.00, Cone (V) 20.00, Extractor (V) 3.00, Source Temperature (°C) 150,

Desolvation Temperature (°C) 400, Cone Gas Flow (L/Hr) 60, Desolvation Gas Flow (L/Hr) 700 Mass range: 100 to 800 Da

DAD Wavelength range (nm): 210 to 400 Method Waters ACQUITY UPLC with the following HPLC gradient conditions

(Solvent A: Water/Methanol 9: 1,0.1% formic acid and Solvent B: Acetonitrile,0.1% formic acid) Time (minutes) A (%) B (%) Flow rate (ml/min)

0 100 0 0.75

2.5 0 100 0.75

2.8 0 100 0.75

3.0 100 0 0.75

Type of column: Waters ACQUITY UPLC HSS T3; Column length: 30 mm; Internal diameter of column: 2.1 mm; Particle Size: 1.8 micron; Temperature: 60°C.

Table A: Compounds of formula (I):

RT MP

Ex. Q¹ R¹ A¹ A⁴ Y¹ Y⁵ (M+H)⁺

(min) °C

H C- c-

Al cyclopropyl CI CI 2.02 572 225

Cl H

H c- c-

A2 1 -cyano-cyclopropyl CI CI 2.00 602 245

Cl H

H c- C-

A3 2,2,2-Trifluoro-ethyl CI CI 1.98 617.13

Cl H

H c- C-

A4 Ethyl CI CI 1.88 563.17

Cl H RT MP

Ex. Q¹ R¹ A¹ A⁴ Y¹ Y⁵ (M+H)⁺

(min) °C

H C- c-

A5 n-Butyl CI CI 2.05 591.15

Cl H

H c- c-

A6 2-Methoxy- 1 -methyl-ethyl CI CI 1.93 607.17

Cl H

(2,2,2-Trifluoro- H c- c-

A7 CI CI 1.85 674.17

ethy Icarbamoy 1) -methyl Cl H

H c- c-

A8 3 ,3 ,3 -Trifluoro-propyl CI CI 1.99 631.1

Cl H

H c- c-

A9 sec-Butyl CI CI 2.03 591.19

Cl H

(Tetrahydro-furan-2-yl)- H c- C-

A10 CI CI 1.92 619.16

methyl Cl H

H c- C-

Al l Benzyl CI CI 2.05 625.17

Cl H

H c- C-

A12 2-Fluoro-benzyl CI CI 2.06 643.16

Cl H

H c- C-

A13 1-Phenyl-ethyl CI CI 2.1 639.16

Cl H

H c- C-

A14 4-Methoxy-benzyl CI CI 2.03 655.22

Cl H

H c- C-

A15 1 , 1 -Dioxo-thietan-3 -yl CI CI 1.78 639.11

Cl H

(6-Chloro-pyridin-3-yl)- H c- C-

A16 CI CI 1.96 660.13

methyl Cl H

H c- C-

A17 3-Fluoro-phenyl CI CI 2.12 629.2

Cl H

H c- C-

A18 (pyridin-2-yl)-methyl CI CI 1.77 626.16

Cl H

2,5 -Dimethyl -2H-pyrazol- H c- C-

A19 CI CI 1.87 629.19

3-yl Cl H RT MP

Ex. Q¹ R¹ A¹ A⁴ Y¹ Y⁵ (M+H)⁺

(min) °C

H C- C-

A20 4-Methyl-thiazol-2-yl CI CI 2.06 632.12

Cl H

H c- C-

A21 3-Methyl-thietan-3-yl CI CI 2.05 621.13

Cl H

l,l-Dimethyl-2- H c- C-

A22 CI CI 2.14 637.18

methylsulfanyl-ethyl Cl H

H c- C-

A23 1 -Oxo-thietan-3-yl CI CI 1.68 623.14

Cl H

H c- C-

A24 Thietan-3-yl CI CI 1.96 607.14

Cl H

H c- C-

A25 Bicyclo[2.2.1]hept-2-yl CI CI 2.16 629.27

Cl H

H c- C-

A26 Cyclobutyl CI CI 2 589.22

Cl H

H c- C-

A27 2-Methanesulfinyl-ethyl CI CI 1.64 625.12

Cl H

H c- C-

A28 2-Methylsulfanyl-ethyl CI CI 1.96 609.14

Cl H

H c- C-

A29 Tetrahy dro -thiophen-3 -yl CI CI 1.99 621.16

Cl H

A30 cyclopropyl H c- C- CI Br 74-

H F 76

A31 cyclopropyl ethyl c- C- CI Br 79-

H F 81

A32 benzyl H c- C- CI Br 80-

H F 82

A33 benzyl ethyl c- C- CI Br 83-

H F 85

A34 4-pyridyl H c- C- CI Br 147-

H F 149 RT MP

Ex. Q¹ R¹ A¹ A⁴ Y¹ Y⁵ (M+H)⁺

(min) °C

A35 4-pyridyl ethyl C- C- CI Br 119- H F 121

A36 1 -oxidopyridin- 1 -ium-4-yl H C- C- CI Br 255- H F 257

A37 1 -oxidopyridin- 1 -ium-4-yl ethyl C- C- CI Br 249- H F 251

A38 1 -cyanocyclopropyl H C- C- CI Br 121- H F 123

A39 ( 1 -methylimidazol-4- H C- C- CI Br

1.37 657.3 yl)methyl H F

A40 3-chloropropyl H C- C- CI Br

2.06 638.5 H F

A41 3 , 3 ,3 -trifluoropropy 1 H C- C- CI Br

2.08 659.2

H F

A42 (i- H C- C- CI Br

2.07 675.2 hydroxycyclohexyl)methyl H F

A43 2-oxotetrahydrothiophen- H C- C- CI Br

1.99 663.2

3-yl H F

A44 2-dimethylaminoethyl H C- C- CI Br

1.34 634.2

H F

A45 sec-butyl H C- C- CI Br

2.12 619.2

H F

A46 1 -(hydroxymethyl)propyl H C- C- CI Br

1.9 635.2

H F

A47 2-methoxy- 1 -methyl-ethyl H C- C- CI Br

2.03 635.2

H F

A48 2,2-difluoroethyl H C- C- CI Br

2 627.2

H F

A49 1 -ethynylcyclohexyl H C- C- CI Br

2.24 669.2

H F RT MP

Ex. Q¹ R¹ A¹ A⁴ Y¹ Y⁵ (M+H)⁺

(min) °C

A50 2-(l ,3-dioxolan-2-yl)ethyl H C- C- CI Br

1.97 663.2 H F

A51 tetrahydrofuran-2- H C- C- CI Br

2.01 647.2 ylmethyl H F

A52 2-morpholinoethyl H C- C- CI Br

1.35 676.2 H F

A53 3 -pyrrolidin- 1 -ylpropyl H C- C- CI Br

1.38 674.3 H F

A54 3 -pyridy lmethy 1 H C- C- CI Br

1.63 654.2 H F

A55 (2-fluorophenyl)methyl H C- C- CI Br

2.14 671.2 H F

A56 1-phenylethyl H C- C- CI Br

2.19 666.6 H F

A57 phenethyl H C- C- CI Br

2.17 666.5 H F

A58 2-(2-thienyl)ethyl H C- C- CI Br

2.15 673.2 H F

A59 2-phenoxyethyl H C- C- CI Br

2.17 683.2 H F

A60 (3 -chlorophenyl)methyl H C- C- CI Br

2.21 687.2 H F

A61 2-acetamidoethyl H C- C- CI Br

1.77 648.2 H F

A62 (4 -methoxypheny l)methy 1 H C- C- CI Br

2.11 683.2 H F

A63 2-methylsulfanylethyl H C- C- CI Br

2.05 636.5 H F

A64 2-furylmethyl H C- C- CI Br

2.05 643.2 H F RT MP

Ex. Q¹ R¹ A¹ A⁴ Y¹ Y⁵ (M+H)⁺

(min) °C

A65 2-chlorophenyl H C- C- CI Br

2.34 673.1 H F

A66 4-isopropylphenyl H C- C- CI Br

2.35 681.3 H F

A67 o-tolyl H C- C- CI Br

2.2 653.2 H F

A68 2-chloro-6-methyl-phenyl H C- C- CI Br

2.19 687.2 H F

A69 3 -fluorophenyl H C- C- CI Br

2.2 656.6 H F

A70 lH-indazol-5-yl H C- C- CI Br

1.94 679.2 H F

A71 2-methylsulfanylphenyl H C- C- CI Br

2.33 685.2 H F

A72 2,5 -dimethylpyrazol-3 -yl H C- C- CI Br

1.95 656.6 H F

A73 4-methylthiazol-2-yl H C- C- CI Br

2.15 660.2 H F

A74 5 -methylsulfanyl- 1 H- H C- C- CI Br

2.08 676.2 l,2,4-triazol-3-yl H F

A75 3 -methyl-2-pyridyl H C- C- CI Br

1.95 654.2 H F

A76 4-hydroxy-6-methyl- H C- C- CI Br

1.91 671.2 pyrimidin-2-yl H F

A77 9H-purin-6-yl H C- C- CI Br

1.82 681.2 H F

A78 5-methyl-l,3,4-thiadiazol- H C- C- CI Br

2 661.1 2-yl H F

A79 2,2,2-trifiuoroethyl H C- C- CI Br

2.07 644.5 H F RT MP

Ex. Q¹ R¹ A¹ A⁴ Y¹ Y⁵ (M+H)⁺

(min) °C

A80 1 -oxothietan-3 -yl H C- C- CI Br

1.78 650.7 H F

A81 thietan-3-yl H C- C- CI Br

2.05 635.2 H F

A82 cyclobutyl H C- C- CI Br

2.09 617.2 H F

A83 phenyl H C- C- CI Br

2.16 639.2 H F

A84 4-cyano-2 -methyl -phenyl H C- C- CI Br

2.17 678.2 H F

A85 2-fluoro- 1 -methyl-ethyl H C- C- CI Br

2.02 623.2 H F

A86 2-methylcyclohexyl H C- C- CI Br

2.27 658.6 Diastereomer A H F

A87 2-methylcyclohexyl H C- C- CI Br

2.31 659.2 Diastereomer B H F

Table B: Compound of formula (Illb):

Compound RT

A¹ A⁴ Y¹ Y² M + H⁺mesured MP°C No. (min) Compound RT

A¹ A⁴ Y¹ Y² M + H⁺mesured MP°C

No. (min)

Bl C-Cl C-H CI CI 2.16 552

B2 C-H C-F CI Br 155-157

Table C: Compound of formula (III):

Biological examples

This illustrates the pesticidal/insecticidal properties of compounds of formula (I). Tests were performed as follows:

Spodoptera littoralis (Egyptian cotton leafworm):

Cotton leaf discs were placed on agar in a 24-well microtiter plate and sprayed with test solutions at an application rate of 200 ppm. After drying, the leaf discs were infested with 5 LI larvae. The samples were checked for mortality, feeding behaviour, and growth regulation 3 days after treatment (DAT). The following compounds gave at least 80% control of Spodoptera littoralis: Al , A2, A3, A4, A8, A15, A16, A17, A18, A19, A23, A24, A26, A28, A30, A31, A38, A40, A41, A48, A69, A72, A73, A74, A75, A78, A79, A80, A81, A82, A85, A86. Heliothis virescens (Tobacco budworm):

Eggs (0 to 24 h old) were placed in 24-well microtiter plate on artificial diet and treated with test solutions at an application rate of 200 ppm (concentration in well 18 pm) by pipetting.

After an incubation period of 4 days, samples were checked for egg mortality, larval mortality, and growth regulation.

The following compounds gave at least 80%> control of Heliothis virescens: Al, A2, A3, A4, A5, A8, A15, A16, A17, A26, A30, A31, A32, A33, A34, A37, A38, A40, A41, A45, A48, A51, A67, A68, A69, A70, A75, A79, A80, A81, A82, A83, A85, A86.

Plutella xylostella (Diamond back moth):

24-well microtiter plate (MTP) with artificial diet was treated with test solutions at an application rate of 200 ppm (concentration in well 18 ppm) by pipetting. After drying, the MTP's were infested with L2 larvae (7 to 12 per well). After an incubation period of 6 days, samples were checked for larval mortality, and growth regulation.

The following compounds gave at least 80%> control of Plutella xylostella: Al, A2, A3, A4, A5, A8, Al l, A15, A16, A18, A21, A23, A24, A26, A27, A28, A29, A30, A31, A34, A37, A38, A41, A47, A48, A68, A72, A73, A79, A80, A81, A82, A85, A86.

Diabrotica balteata (Corn root worm):

A 24-well microtiter plate (MTP) with artificial diet was treated with test solutions at an application rate of 200 ppm (concentration in well 18 ppm) by pipetting. After drying, the MTP's were infested with L2 larvae (6 to 10 per well). After an incubation period of 5 days, samples were checked for larval mortality and growth regulation.

The following compound gave at least 80%> control of Diabrotica balteata: Al, A2, A4, A8, A21, A30, A38, A40, A73, A81.

Tetranychus urticae (Two-spotted spider mite):

Bean leaf discs on agar in 24-well microtiter plates were sprayed with test solutions at an application rate of 200 ppm. After drying, the leaf discs were infested with mite populations of mixed ages. 8 Days later, discs were checked for egg mortality, larval mortality, and adult mortality.

The following compounds gave at least 80%> control of Tetranychus urticae: Al, A2, A4, A8, A12, A15, A19, A23, A24, A30, A38, A40, A49. Thrips tabaci (Onion thrips):

Sunflower leaf discs were placed on agar in a 24-well microtiter plate and sprayed with test solutions at an application rate of 200 ppm. After drying, the leaf discs were infested with an aphid population of mixed ages. After an incubation period of 7 days, samples were checked for mortality.

The following compounds gave at least 80% control of Thrips tabaci: Al, A2, A4, A23, A24, A29, A30, A31, A38, A41, A80, A81. Myzus persicae (Green peach aphid):

Sunflower leaf discs are placed on agar in a 24-well microtiter plate and sprayed with test solutions at an application rate of 200 ppm. After drying, the leaf discs are infested with an aphid population of mixed ages. After an incubation period of 6 DAT, samples are checked for mortality.

The following compounds gave at least 80%> control of Myzus persicae: Al, A2, A4, A5, A7, A8.

Claims

1. A compound of formul

wherein

A¹, A², A³ and A⁴ are each independently C-X or nitrogen, wherein each X may be the same or different, and provided that no more than two of A¹, A², A³ and A⁴ are nitrogen;

R¹ is hydrogen, C₁-C₄alkyl, H₂NC(0)-C₁-C₄alkyl, or C₁-C₄alkylcarbonyl;

R² is hydrogen, halogen, Ci-C₄alkyl, Ci-C₆ haloalkyl or cyano;

G¹ is oxygen or sulfur;

or Q¹ is Ci-C₈alkyl or Ci-C₈alkyl substituted by one to five R⁴, C₂-C₈alkenyl, C₂-C₈alkenyl substituted by one to five R⁴, C2-C₈alkynyl, C2-C₈alkynyl substituted by one to five R⁴, C₃- Ciocycloalkyl, C₃-Ciocycloalkyl substituted by one to five R⁴ or Ci-C₈alkyl-(CO)-N-Ci- C₈alkyl or Ci-C₈alkyl-(CO)-N-C C₈alkyl substituted by one to five R⁴;

R³ is selected from cyano, amino, nitro, hydroxy, halogen, Ci-C₄alkyl, Ci-C₄haloalkyl, C2-C₄alkenyl, C2-C₄haloalkenyl, C2-C₄alkynyl, C2-C₄haloalkynyl, C₃-C₆cycloalkyl, C₃-Cehalocycloalkyl, Ci-C₃alkoxy, Ci-C₃haloalkoxy, Ci-C₃alkylthio, Ci-C₃haloalkylthio, Ci-C₃alkylsulfinyl, Ci-C₃haloalkylsulfinyl, Ci-C₃alkylsulfonyl, Ci-C₃haloalkylsulfonyl, Ci-C₄alkylamino, di-(Ci-C₄alkyl)amino, Ci-C₄alkylcarbonyl, Ci-C₄alkylcarbonyloxy, Ci-C₄alkoxycarbonyl, Ci-C₄alkylcarbonylamino and phenyl;

each R⁴ is independently halogen, cyano, nitro, hydroxy, Ci-C₈alkoxy-, Ci-C₈haloalkoxy-, Ci-C₈alkylthio-, Ci-C₈haloalkylthio-, Ci-C₈alkylsulfinyl-, Ci-C₈haloalkylsulfinyl-, Ci-

C₈alkylsulfonyl-, Ci-C₈haloalkylsulfonyl-, Ci-C₈alkylcarbonyl-, Ci-C₈alkoxycarbonyl-, aryl or aryl substituted by one to five R³, or heterocyclyl or heterocyclyl substituted by one to five R³;

wherein

Y¹ and Y⁵ are independently of each other halogen, cyano, Ci-Csalkyl, Ci-Cshaloalkyl, d- C₄alkoxy-Ci-C₄-alkyl-, Ci-Csalkylthio-, Ci-Cshaloalkylthio-, Ci-Csalkylsulfmyl-, Ci-

Cshaloalkylsulfinyl-, Ci-Csalkylsulfonyl-, or Ci-Cshaloalkylsulfonyl-;

Y³ is C₂-C₈perfiuoroalkyl, Ci-dperfluoroalkylthio-, Ci-dperfluoroalkylsulfinyl-, Ci-dper- fluoroalkylsulfonyl, or C₂-C₈ fluoroalkyl substituted by a phenyl optionnaly substituted by one to five halogen, cyano, Ci-dalkyl, Ci-Cshaloalkyl ;

Y² and Y⁴ are independently of each other hydrogen, halogen, or d-C₈alkyl;

Y⁶ and Y⁹ are independently of each other halogen, cyano, Ci-dalkyl, Ci-dhaloalkyl, Ci-

C₄alkoxy-Ci-C₄-alkyl-, Ci-dalkylthio-, Ci-dhaloalkylthio-, Ci-dalkylsulfinyl-, Ci-

Cshaloalkylsulfinyl-, Ci-Csalkylsulfonyl-, or Ci-Cshaloalkylsulfonyl-;

Y⁸ is C₂-C₈perfluoroalkyl, Ci-Csperf uoroalkylthio-, Ci-Csperfluoroalkylsulfinyl-, or d- Csperfluoroalkylsulfonyl-;

Y⁷ is hydrogen, halogen, or Ci-Csalkyl; or a salt or N-oxide thereof.

2. A compound according to claim 1, characterized in that

A¹, A², A³ and A⁴ are C-X and each X is independently selected from hydrogen, halogen, cyano, methyl, trifluoromethyl and methoxy;

3. A compound according to claim 2, characterized in that

R¹ is hydrogen, methyl, ethyl or acetyl;

R² is hydrogen, methyl, trifluoromethyl or halogen;

G¹ is oxygen;

Q¹ is aryl or heterocyclyl or C3-Ciocycloalkyl or Ci-Csalkyl; each optionally substituted by one to five substituents independently selected from cyano, nitro, hydroxy, bromo, chloro, fluoro, methyl, trifluoromethyl, methoxy, trifiuoromethoxy, methylthio, methylsulfmyl, methylsulfonyl and phenyl.

Q² is is a moiety of formula (II)

Y³ is heptafluoro-propyl, heptafluoro-prop-2-yl, heptafluoro-propylthio-, heptafluoro- propylsulfmyl-, heptafluoro-propylsulfonyl-, heptafluoro-prop-2-ylthio-, heptafluoro-prop-2- ylsulfinyl-, heptafluoro-prop-2-ylsulfonyl-, or nonafluoro-but-2-yl.

Y³ is C₂-C₆perfiuoroalkyl, most preferably Y³ is heptafluoro-prop-2-yl or nonafluoro-but-2- yi.

Y⁴ is hydrogen, chloro, fluoro, or methyl, most preferably hydrogen.

4. A compound according to claim 2, characterized in that

R¹ is hydrogen, methyl or ethyl;

R² is hydrogen, trifluoromethyl or halogen;

Q¹ is cyclopropyl, cyclobutyl, cyclopentyl, benzyl, Pyridin-2-yl -methyl, thietan3-yl, ethyl, propyl, butyl, phenyl, 2-pyridyl; each optionally substituted by one to four substituents independently selected from cyano, nitro, hydroxy, bromo, chloro, fluoro, methyl, trifluoromethyl, methoxy, trifiuoromethoxy, methylthio, methylsulfmyl, methylsulfonyl and phenyl.

Q² is is a moiety of formula (II).

Y¹ is halogen, cyano, methyl, ethyl, trifluoromethyl, or methoxymethyl,

Y² is hydrogen, chloro, fluoro, or methyl,

Y⁴ is hydrogen, chloro, fluoro, or methyl,

Y⁵ is halogen, cyano, methyl, ethyl, or trifluoromethyl,

5. A compound according to claim 2, characterized in that

R¹ is hydrogen, methyl or ethyl;

R² is hydrogen or halogen;

Q² is is a moiety of formula (II).

Y¹ is bromo, chloro, methyl, ethyl, methoxymethyl

Y² is hydrogen.

Y⁴ is hydrogen.

Y⁵ is bromo, chloro, methyl, or ethyl.

6. A compound according to claim 2, characterized in that

following meaning:

R¹ is hydrogen;

R² is hydrogen

Q² is is a moiety of formula (II).

Y¹ is bromo, chloro, methyl, ethyl.

Y² is hydrogen.

Y³ is heptafluoro-prop-2-yl, nonafluoro-but-2-yl.

Y⁴ is hydrogen.

Y⁵ is bromo, chloro, methyl, or ethyl.

7. A compound according to claim 2, characterized in that

Q² is 2-ethyl-6-methyl-4-(heptafluoro-prop-2-yl)-phenyl, or Q² is 2-bromo-6-methyl-4- (heptafluoro-prop-2-yl)-phenyl, or Q² is 2-bromo-6-ethyl-4-(heptafluoro-prop-2-yl)-phenyl, or Q² is 2,6-dichloro-4-(heptafluoro-prop-2-yl)-phenyl, or Q² is 2,6-dibromo-4-(heptafluoro- prop-2-yl)-phenyl, or Q² is 2-bromo-6-chloro-4-(heptafluoro-prop-2-yl)-phenyl, or Q² is 2- ethyl-6-methyl-4-(nonafluoro-but-2-yl)-phenyl, or Q² is 2-bromo-6-methyl-4-(nonafluoro- but-2-yl)-phenyl, or Q² is 2-bromo-6-ethyl-4-(nonafluoro-but-2-yl)-phenyl, or Q² is 2,6- dichloro-4-(nonafluoro-but-2-yl)-phenyl, or Q² is 2,6-dibromo-4-(nonafiuoro-but-2-yl)- phenyl, or Q² is 2-bromo-6-chloro-4-(nonafluoro-but-2-yl)-phenyl, or Q² is 2-ethyl-6- methyl-4-(heptafluoro-prop-2-yl)-phenyl, or Q² is 2-bromo-6-methyl-4-(heptafluoro-prop-2- yl)-phenyl.

8. A method of combating and controlling insects, acarines, nematodes or molluscs which comprises applying to a pest, to a locus of a pest, or to a plant susceptible to attack by a pest or to a plant propagation material an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I) as defined in any one of claims 1 to 6.

9. An insecticidal, acaricidal or nematicidal composition comprising an insecticidally, acaricidally or nematicidally effective amount of a compound of formula (I) as defined in any one of claims 1 to 6.

10. A compounds of formul

wherein A 1 , A 2 , A 3 , A 4 , R 2 and Q 2 are as defined in relation to formula (I) according to claim 1 ; or a salt thereof.

11. A compound of formula (Illb), wherin forms a further aspect of the invention

1 2 3 4 2 2

wherein R is Ci-C₆ alkyl and A , A , A , A , R and Q are as defined in relation to formula

(I) according to claim 1 ; or a salt thereof.